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introduCtion and outlinE of this thEsis
Esophageal carcinoma
In the last two decades, the incidence of esophageal cancer has risen. In 1990, 789 patients 
were diagnosed with esophageal cancer in the Netherlands, and in 2016 this number in-
creased to 2540 patients. Mechanisms of tumor genesis in esophageal cancer are not com-
pletely understood. The disease has the highest incidence in parts of China, Korea and Japan, 
but also in South America.1 The high incidence in this Eastern part of the world is mostly due 
to the frequent occurrence of squamous cell carcinoma. Tobacco and alcohol consumption 
are the primary cause of squamous cell carcinoma. The incidence is lower than in the Western 
world, where the predominantly adenocarcinoma has increased sharply since the 80s and 
90s of last century.2 The sharp rise in adenocarcinomas is parallel to the rise of obesity, and is 
possibly explained by the rise in incidence of gastro-intestinal reflux, leading to Barrett’s dys-
plasia and eventually to adenocarcinoma. Evidence of a relation between diet, environment 
and esophageal carcinoma comes from a different incidence in various parts of the world.3 
Previously mentioned obesity increases intra-abdominal pressure and gastro-intestinal reflux, 
and adipose tissue itself influences tumor development.4, 5 
Esophageal cancer is now number eight in the top ten most common malignancies in men 
(3.7% of men with cancer are diagnosed with esophageal cancer). In women, the percentage 
is 1.1%.2 The male-female ratio in relation to incidence in the Netherlands increased to 3.5, 
and is one of the highest of all tumors.6
The five-year relative survival of patients with esophageal cancer in the Netherlands is com-
parable to the European average, and rose from 8% in 1988-1992 to 15% in 2003-2007.2,6 In 
patients with adenocarcinoma of the (distal) esophagus who were operated with curative 
intent, five-year survival is between 37% and 51%, depending on stage, the surgical approach, 
(neo-)adjuvant therapy and unknown factors.7
Treatment
Esophagectomy with or without (neo-) adjuvant chemo (radiation) therapy is considered the 
preferred treatment for cT1-4aN0-3M0 cancer of the esophagus and the gastro-esophageal junc-
tion. At presentation of the disease, most patients suffer from dysphagia and subsequently 
weight loss. Hence, within the light of a reasonable 5-year survival, long term relief of dyspha-
gia is an important goal of the surgical procedure. This can be achieved by a safe operation 
and an optimal esophago-gastric anastomosis. Surgical technique and the poor blood circula-
tion of the gastric tube are risk factors for anastomotic leakage or stricture.8-12 Prevention of 
anastomotic leakage is also important for reducing associated morbidity, prevention of long 
term hospital admission and reducing mortality.13-17 Prevention of late benign strictures is 
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important since this reduces food intake with subsequent weight loss and reduces health 
related quality of life.13 Risk factors for anastomotic leakage include atherosclerosis18, a low 
preoperative19 albumin level, radiotherapy and the use of steroids.20 
Surgery
Surgery for cancer of the esophagus is considered to be one of the most extensive and trau-
matic oncological surgical procedures. Surgical resection and reconstruction not only involves 
a long operation time but also necessitates post-operative care in the intensive care unit, an 
extended in-hospital recovery with decreased quality of life and carries a significant risk of 
morbidity and mortality.
The effect of the extend of the operation, or the surgical approach (transhiatal versus trans-
thoracic) is proven to be comparable in hospital mortality, overall survival and cancer-specific 
survival.21 Transthoracic esophagectomy can result in a more extended lymph node resection, 
but shows no significantly difference in long-term survival, although one study suggests a 
trend in improved survival with a transthoracic approach.22 Early survival is significantly higher 
for patients who underwent an transhiatal approach.23 Benefits of transhiatal esophagectomy 
are shorter hospital admission and stay in the Intensive Care Unit. Complications, and more 
specific, pulmonary complications, do not differ between the two surgical approaches. Re-
search on minimally invasive esophagectomy (MIE) has shown faster postoperative recovery 
and a marked decrease in pulmonary complications. The TIME53 study was updated in Febru-
ary 2017 with three-year outcomes, and shows no differences in disease-free and overall 
3-year survival between open and minimally invasive esophagectomy. Literature suggests 
that minimally invasive esophagectomy might reduce postoperative morbidity (especially 
pulmonary complications). The debate about oncological results remains, but this study53 
shows that the type of resected specimen and lymph nodes are comparable with the open 
series and disease-free and overall survival reported for minimally invasive surgery and open 
resection are comparable. 
Chapter 2 consists of a systematic literature review focusing on anastomotic leakage, stricture 
rate and hospital mortality for cervical versus intrathoracic anastomoses and stapled versus 
hand-sewn anastomoses. In many centers, the end-to-end (ETE) cervical anastomosis has 
become the procedure of choice for esophageal reconstruction. In other parts of the gastro-
intestinal tract however, end-to-side (ETS) or side-to-side (STS) anastomosis proved superior 
to end-to-end anastomosis regarding post-operative leakage rate and stricture formation.24 
In Chapter 3, a randomized controlled trial is described comparing the rate of post-oper-
ative stricture formation after one year between a cervical single-layered hand-sewn ETE-
anastomosis and a cervical single-layered hand-sewn ETS-anastomosis. Early postoperative 
complications, hospital stay and mortality were also evaluated. 
Introduction and outline of this thesis
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Leakage of the anastomosis between the remnant esophagus and gastric tube after esopha-
gectomy which occurs in approximately 5-25% of patients was the reason for a search for 
novel surgical techniques.25-28 In 1998 Collard29 et al. published a technique for creating a 
semi-mechanical anastomosis. Retrospective studies have suggested that this semi-mechan-
ical side-to-side (SMA) anastomosis is associated with low anastomotic leak rates and low 
rates of anastomotic strictures. The aim of the randomized controlled trial in Chapter 4 was to 
assess the leak and stricture rate of ETE compared to SMA technique. We hypothesized that 
SMA reduces the anastomotic leak rate and anastomotic stricture rate.
In Chapter 5, the outcome after colon interposition for restoration of the continuity of the 
upper gastrointestinal tract after esophagectomy is described. While health related quality 
of life after colon interposition is reported by some to have an equal outcome compared to 
gastric tube reconstruction, gastric tube interposition is still the standard technique for recon-
struction after esophagectomy. At present, colon interposition is only used for reconstruction 
in patients with previous gastric resections, incomplete vascularization of the stomach and 
patients that need a esophagogastrectomy for malignant or benign disorders.30-35 Studies de-
scribing the outcome after colonic interposition are scarce. Hence, the aim of this study was 
to assess morbidity and mortality including anastomotic leakage in a large series of patients 
from a single institution.
Leakage of the cervical esophagogastrostomy after esophagectomy with gastric tube recon-
struction occurs in 5-25% of patients, is associated with significant morbidity and accounts 
for 25-50% of postoperative deaths.36-38 In order to detect anastomotic leakage before clinical 
signs develop and the patients deteriorate, contrast swallow and/or endoscopy are often 
performed within the first week after surgery. However, it has been reported that contrast 
swallow studies have a low sensitivity and specificity, failing to contribute to clinical decision 
making. There is also a risk of aspiration leading to pulmonary complications. Upper gastroin-
testinal endoscopy has the advantage of direct visualization and quantification of dehiscence, 
necrosis or ulcers and it may be performed in patients who are sedated and intubated.39-42 On 
the other hand, there is a possibility of iatrogenic injuries and of worsening the anastomotic 
dehiscence.41 Therefore, in Chapter 6, we published a study which investigated the diagnostic 
and predictive value of systematically routine contrast swallow study and endoscopy in the 
postoperative management of patients with a cervical anastomosis after esophagectomy 
and gastric tube reconstruction (GTR) for esophageal carcinoma. We analyzed our data and 
hypothesized that routine diagnostic studies do not contribute to the early detection of 
anastomotic leakage. 
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Comprehensive Complication Index (CCI)
A major challenge in designing randomized controlled trials (RCTs) is the choice of objective, 
concise and clinically relevant endpoints. Mortality is not always the best primary endpoint in 
surgical studies given the sharp decline in mortality for most procedures in the past decades 
and hence large numbers of patients are needed. Morbidity is often poorly defined, which has 
led to inconsistent reporting and confusion in the literature.43-48 Furthermore, most authors 
have reported only the most severe complications or only events judged to be relevant, but 
ignored complications of lesser magnitude as well as the total number of complications.49 To 
address this issue, the Comprehensive Complication Index (CCI) was developed. It integrates 
all postoperative complications with their respective severities, on a scale ranging from 0 (no 
burden from complications) to 100 (death).49 The CCI, summarizing the entire postoperative 
experience of the patient with respect to complications, is based on the widely established 
Clavien-Dindo classification.50 Validations from four different perspectives showed that the 
CCI is a valid endpoint for postoperative overall morbidity. While the CCI is an attractive novel 
tool, which may serve as a primary or secondary endpoint in many types of studies, the ex-
ternal validity has not been tested in RCTs. Therefore, the aim of Chapter 7 was to externally 
evaluate whether the CCI is more sensitive than traditional primary endpoints in detecting 
between-group differences. 
The largest published randomized clinical trial on the value of neoadjuvant chemo radiother-
apy (CROSS-trial)51 shows a survival benefit for patients with nCRT followed by surgery. Impor-
tantly, there was no difference in the frequency of complications and postoperative mortality 
between the patients who were treated with neoadjuvant chemo radiotherapy followed by 
surgery and the patients who underwent surgery alone. While traditional endpoints showed 
no significant differences in incidence of postoperative complications within the CROSS trial, 
Chapter 8 was designed to evaluate the overall effect of neoadjuvant chemo radiotherapy on 
the severity of postoperative complications, and the overall burden in patients of the CROSS 
trial. Therefore, the CCI between patients with esophageal or esophagogastric junction can-
cer who underwent chemo radiotherapy plus surgery versus patients who underwent surgery 
alone was compared.52 
Chapter 9 summarizes all presented studies and in Chapter 10 a Dutch summary is presented. 
In Chapter 11, all subjects are discussed more extendedly as well as future prospectives.
Introduction and outline of this thesis
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abstraCt
Objective: To review the literature regarding the effect of the site of the esophagogastric 
anastomosis and  the technique of the anastomosis after esophageal resection and gastric 
tube reconstruction. 
Background data: Esophageal resection and reconstruction with a gastric tube plays an im-
portant role in the treatment of esophageal cancer. The technique and influence of technique 
on postoperative complications, especially leakage, remains subject of many research. This 
article reviews the current literature for the site of the anastomosis (cervical or intra-thoracic) 
and the technique for the esophago-gastric anastomosis (circular stapled, linear stapled or 
hand-sewn) and impact on anastomotic leakage after operation.
Methods and data sources: Comprehensive searches were carried out in Embase, MEDLINE OvidSP, 
Web of Science, Google Scholar, CENTRAL (the Cochrane Library 2013, issue 5). The search was 
performed for articles published until November 2016 relevant to leakage of the gastro-esophageal 
anastomosis after esophagectomy for esophageal cancer. Endpoints were anastomotic leakage, 
postoperative stricture rate, dysphagia, overall morbidity and in-hospital mortality. 
Results: Of the 1341 studies identified, 61 studies were eligible for this review. After careful 
consideration, 25 studies remained after exclusion. The first three studies compare cervical 
anastomoses with intra-thoracic anastomoses, and show that both techniques are equally 
safe, with a trend (p = 0.08) towards more leakage in patients with a cervical anastomosis. 
Stapled (circular, linear, totally mechanic, semi-mechanic cervical, intra-thoracic) versus hand-
sewn was the subject of the next 22 studies, and show that semi-mechanical anastomoses do 
not result in lower leakage rates (%) in comparison with a hand-sewn anastomosis. There are 
higher incidences reported in dysphagia and stricture rate (p = < 0.01), however.  
Conclusion: Cervical and intra-thoracic anastomoses are equally safe, although there is a trend 
towards more leakage in the groups with patients with a cervical anastomosis. Comparison of 
a stapled (either circular, linear or semi-mechanical) anastomosis to a hand-sewn anastomo-
sis does not minimize anastomotic leakage, but there are higher incidence of dysphagia and 
stricture rate reported in the circular stapled anastomosis. Overall morbidity and mortality 
are not statistically different between groups.  
Review: The influence of surgical technique on anastomotic leakage
2
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introduCtion
Esophageal resection and reconstruction with a gastric tube plays an important role in the 
curative treatment of esophageal cancer. Unfortunately, surgical morbidity remains high. 
Retrospective studies report overall complication rates around 50%.1, 2 Leakage of the esopha-
gogastrostomy occurs in 5-25% of patients1 and 30-40% patients need endoscopic dilatations 
for an anastomotic stricture.3, 4 The anastomotic leak and stricture formation the anastomosis 
has a great impact on patients’ quality of life.5 Anastomotic complications may also lead to 
significant morbidity and even mortality. The diversity of anastomotic techniques described 
as well as the ongoing debate about the optimal location of the anastomosis (neck versus 
chest) indicates that there is not one superior technique. 
Anastomotic leakage is likely to be caused by an inadequate perfusion of the gastric con-
duit. Arterial insufficiency or venous congestion due to absence of direct vascular branches 
from the gastro-epiploic arcade at the fundus of the stomach is thought to be the underlying 
phenomenon. Neoadjuvant (chemo)radiation, surgical technique and patient-related factors 
including generalized atherosclerosis, smoking, diabetes mellitus and use of steroids are 
other risk factors for anastomotic leakage.6 In this review, we focus on two main aspects of 
anastomotic leakage and strictures being the location (cervical versus an intrathoracic) and 
the technique (stapled versus hand-sewn).
mEthods
All aspects of the Cochrane Handbook for Interventional Systematic Reviews were followed7, 
and the manuscript was written according to the PRISMA statement.8
Comprehensive searches were carried out in Embase, MEDLINE OvidSP, Web of Science, 
Google Scholar, CENTRAL (the Cochrane Library 2013, issue 5). Search terms for each search-
engine are provided as Supplementary methods. The search was performed in December 
2016 for articles published until November 2016. Studies comparing two surgical techniques 
(cervical versus intra-thoracic anastomosis or hand-sewn versus stapled anastomosis) in pa-
tients who underwent esophagectomy for esophageal cancer and gastric tube reconstruction 
were included. The English language restriction was used.
Studies were evaluated by a single investigator. All abstracts were reviewed for relevance 
and reporting of selected endpoints, and if eligible, the full text was assessed and reviewed. 
Excluded were studies not yet published, case-reports, letters, editorials, case-series, animal 
studies, studies on children (< 18 years), or if the abstract revealed no relevance to the sub-
ject. For publications without abstract, the full text was acquired. The following data were 
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extracted from the studies and entered in a table: study design, number of patients, baseline 
characteristics, surgical characteristics, site of anastomosis (neck versus chest), type of anas-
tomosis, technical details of the anastomosis and outcome measures. Outcome measures 
were anastomotic leakage, stricture, dysphagia and in-hospital mortality. Manual reference 
checks of included papers were performed to search for missing studies.
 All studies were imported in to the GRADE tool9, in which risk of bias (not serious/serious/
very serious), inconsistency (not serious/serious/very serious), indirectness (not serious/
serious/very serious), imprecision (not serious/serious/very serious), publication bias (unde-
tected/strongly suspected), effect size (no/large/very large), plausible confounding (no/would 
reduce demonstrated effect/would suggest spurious effect) and dose response gradient (yes/
no) were graded.
statistiCal analysis 
There was no meta-analysis performed given the clinical heterogeneity of the studies with 
regard to surgical techniques, method and time of follow up, type of outcomes measures 
and definition of the outcomes. Values in tables represent the number of patients that had a 
complication with the percentages in brackets. The follow-up is presented as median values 
(months). When reported, odds ratio, relative risk and 95% confidence intervals, as well as 
p-values are presented in the tables. 
list of abbrEviations
SMA  semi-mechanical anastomosis
HS hand-sewn
CS circular stapled
LS linear stapled
NGT narrow gastric tube
WS whole stomach
TM totally mechanic anastomosis
NS not statistically significant
NR not reported
ETE end-to-end
ETS end-to-side
SSS stapled side-to-side
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rEsults
Figure 1 shows the inclusion and exclusion of studies, and results of the search strategy 
(supplementary fi le 1). Aft er removal of the duplicates, 1341 studies remained (1143 found 
on Embase and 1132 found on MedLine Ovid SP, Web-of-Science, Cochrane Central and 
Google Scholar). Reasons for exclusion were: unavailable in full-text, studies on children 
or animals, no clinical study, studies reporti ng minimally invasive anastomoti c techniques, 
pati ents who underwent damage control surgery (palliati ve surgery or surgery for complica-
ti ons), no esophagectomy performed, studies on vascular enhancement of the gastric tube 
and not on surgical techniques of the anastomosis itself. 
figure 1. Overview of search results; PRISMA fl ow chart
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
For	more	information,	visit	www.prisma-statement.org. 
 
 
Records	identified	through	
database	searching	
(n	=	1143)	
Sc
re
en
in
g	
In
cl
ud
ed
	
El
ig
ib
ili
ty
	
Id
en
ti
fic
at
io
n	
Additional	records	identified	
through	other	sources	
(n	=1031)	
Records	after	duplicates	removed	
(n	=1341)	
Records	screened	
(n	=1341)	
Records	excluded*	
(n	=1280)	
Full-text	articles	assessed	
for	eligibility	based	on	
abstract	
(n	=61)	
Full-text	articles	
excluded**		
(n	=34)	
Studies	included	in	
qualitative	synthesis	
(n	=25) 	
*  Reasons for exclusion were: unavailable in full-text, studies on children or animals, histomorphological research, 
minimally invasive techniques, pati ent with damage control surgery (palliati ve), no esophagectomy performed, 
studies on vascular enhancement of the gastric tube.
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vascular enhancement of the gastric tube.
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Cervical versus intra-thoracic anastomosis
In Table 1, a summary of findings is presented of two cohort studies and one randomized 
trial comparing a cervical with an intra-thoracic anastomosis. The methodological quality of 
the two cohort studies is low given the fact that the decision on the site of the anastomosis 
was determined by the surgeon based on pre- or intraoperative evaluations (e.g. resection 
margin) and not by chance. The study by Shah10 et al. includes patients from multiple centers. 
The authors tried to select a more homogenous study group by excluding patients who un-
derwent esophagectomy for non-malignant diseases and patients with malignancies located 
in the upper or middle third of the esophagus. Hence, tumor location could not influence the 
choice for the site of the anastomosis. Another randomized controlled trial11 included patients 
with benign and malignant esophageal disease. In contrast to the other studies, exclusion 
criteria were preoperative chemo radiation therapy or location of the tumor in the proximal 
intra-thoracic esophagus. The studies did no show a statistically significant difference in leak 
rate between a cervical or intra-thoracic anastomosis.5, 10, 11 
Hand-sewn versus stapled anastomoses
A summary of studies comparing hand-sewn with stapled anastomosis is presented in Table 
2.2, 4, 12-24 The randomized controlled trials included in systematic reviews and meta-analyses 
are shown in Table 3.23, 25-30 Stricture formation was statistically significant higher in patients 
that underwent a circular stapled anastomosis (in 6 of 15 studies). Consequently, the per-
centage of patients reporting dysphagia was higher after a circular stapled anastomosis. The 
randomized trials are further described in Table 4.4, 14, 16-19, 22, 31 The studies are clinically het-
erogeneous regarding surgical techniques used and (definition of) endpoints. The reporting 
of most trials is not according to current standards (CONSORT)8 and the surgical techniques 
used are mostly poorly described. 
disCussion
This review summarizes the studies on the association between surgical technique, location 
of anastomosis and anastomotic leakage, stricture, dysphagia and in-hospital mortality. Co-
hort studies, RCTs and meta-analyses were included and critically appraised. 
The cohort studies suggest that the intra-thoracic anastomoses are associated with a higher 
risk of complications and postoperative death.32 At the same time, leak rate for an intra-tho-
racic anastomosis are reported to be lower than for a cervical anastomosis. The three studies 
identified found no statistically significant difference in complication rates between intra-
thoracic and cervical anastomosis. The main limitations of two studies were the incomplete 
Review: The influence of surgical technique on anastomotic leakage
2
25
description of the operative techniques used and the decision for the type of anastomosis 
was based on the location of tumor.
The use of staplers is thought to be a method of reducing of esophagogastric leaks, but 
this remains controversial. The largest systematic review by Kim26 et al. showed a leak rate 
of 4.7% in the SMA group versus 20% in the ETE/hand-sewn group. Others21 have described 
an absolute difference of 17% in favor of totally mechanical anastomosis, but compared this 
anastomosis with a hand-sewn anastomosis or a semi-mechanical anastomosis. Therefore, 
the study does not reflect a clear comparison between hand-sewn and stapled anastomoses. 
Limitations of the reviews are that suture materials and surgical techniques vary considerably 
between studies, as shown in Table 4. There is no uniform technique for the creation of a 
stapled or hand-sewn anastomosis. Single-layered and double-layered hand-sewn anastomo-
sis are included, and different kind of staplers (linear and circular). There was also a significant 
variation in reporting of mortality among studies; from ‘early postoperative mortality’ to in-
hospital mortality or 30-day mortality. Some studies even reported 1 and 3-months mortality 
numbers. And there is variation in the application of neoadjuvant treatment regimes. 
The eight RCTs described in this review differ in participants, definitions of complications and 
endpoints are not clear, blinding is not described and the method of randomization and al-
location is not clearly described in detail. This hampers a formal comparison between studies 
as well as a meta-analysis of studies. There is a need for a large controlled trial with a clear 
definition of endpoints (leakage, stricture, morbidity and mortality). Follow-up time is very 
important for the assessment of late complications including stricture formation. In several 
studies, leakage was defined as abnormality on radiological tests, but recent studies showed 
that clinical features of leakage are at least as important as radiological findings, because of 
low sensitivity and specificity of contrast swallow studies. 
The present review validates the published literature, using the GRADE tool and a checklist 
to check for heterogeneity. From the data presented in the present study, it can be concluded 
that there is no evidence for the superiority of a cervical or intra-thoracic anastomosis. Al-
though, a circular stapled anastomosis does not show a significant lower leakage rate com-
pared to a hand-sewn anastomosis, they are associated with a higher rate of strictures. The 
linear stapled anastomosis (Collard or Orringer) may decrease leakage and stricture formation 
in comparison with hand-sewn and circular anastomoses.
A valid comparison of the surgical techniques for the formation of a esophago-gastrostomy 
after esophagectomy is hampered by intra-study heterogeneity. A large randomized controlled 
trial, in which the operation techniques are clearly defined, and postoperative protocol for 
complications (and endpoints) is rigidly described, is still missing. Also, quality of life which 
is influenced by leakage and stricture formation as well other postoperative complications 
should be included as an endpoint. 
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abstraCt
Objective: To compare a single-layered hand-sewn cervical end-to-side (ETS) anastomosis 
with end-to-end (ETE) anastomosis in a prospective randomized fashion.
Background: The preferred organ used for reconstruction after esophagectomy for cancer 
is the stomach. Previous studies attempted to define the optimal site of anastomosis and 
anastomotic techniques. However, anastomotic stricture formation and leakage still remain 
an important clinical problem. 
Methods: From May 2005 to September 2007, 128 patients (64 in each group) were random-
ized between ETE- and ETS-anastomosis after esophagectomy for cancer with gastric tube re-
construction. Routine contrast swallow studies and endoscopy were performed. Anastomotic 
stricture within 1 year, requiring dilatation, was the primary endpoint. Secondary endpoints 
were anastomotic leak rate and mortality.
Results: Ninety-nine men and 29 women underwent esophagectomy and gastric tube recon-
struction. Benign stenosis of the anastomosis, for which dilatation was required, occurred 
more often in the ETE group (40% vs. ETS 18%, p < 0.01) after 1 year of follow-up. The overall 
(clinical and radiological) anastomotic leak rate was lower in the ETE group (22% vs. ETS 41%, 
p = 0.04). Patients with an ETE-anastomosis suffered less often from pneumonia; 17% versus 
ETS 44%, p = 0.002 and had subsequently significantly shorter in-hospital stay (15 days vs. 22 
days, p = 0.02). In-hospital mortality did not differ between both groups.
Conclusion: ETS-anastomosis is associated with a lower anastomotic stricture rate, compared 
to ETE-anastomosis. However, prevention of stricture formation was at high costs with in-
creased anastomotic leakage and longer in-hospital stay. This study is registered with the 
Dutch Trial Registry and carries the ID number OND1317772.
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introduCtion
Esophagectomy with or without chemo (radio) therapy is considered the best treatment for 
T1–3N0–1M0–1a cancer of the esophagus or gastro-esophageal junction. After esophagectomy, 
the actuarial 5-year survival ranges from 20% to 35%.1–4 Therefore, in many patients, relief 
of complaints is an important goal of the surgical procedure and overall outcome is closely 
related to the success of the esophagogastric anastomosis. This success is also related to 
the relative ischemia to the tip of the gastric tube, which may be influenced by type of 
anastomosis. Ischemia can be a risk factor for leakage or stricture.1 , 3 , 5 – 7 Prevention of late 
benign stricture is important because recurrence of dysphagia defeats one of the main aims 
of surgery, which is to restore normal swallowing function.8 Prevention of early complications 
like anastomotic leakage is also important to decrease associated morbidity, in-hospital stay 
and mortality.8–12
In many centers, the end-to-end (ETE) cervical anastomosis has become the procedure of 
choice for esophageal reconstruction. In other parts of the gastrointestinal tract however, 
end-to-side (ETS) or side-to-side (STS) anastomosis proved superior to ETE-anastomosis re-
garding postoperative leakage rate and stricture formation.13–17 To date no randomized 
study is performed to compare ETE-to ETS-anastomosis in the neck. The aim of this study is 
therefore to compare the rate of postoperative stricture formation after 1 year between a 
cervical single-layered hand-sewn ETE-anastomosis and a cervical single-layered hand-sewn 
ETS-anastomosis. Early postoperative complications, hospital stay and mortality were also 
evaluated.
patiEnts and mEthods
Between May 2005 and September 2007, 175 patients underwent an esophageal resection. 
Inclusion criteria for the study were age above 18 years and biopsy proven T1–3N0–2M0–1a cancer 
of the esophagus or esophago-gastric junction. Exclusion criteria were: previous gastric sur-
gery, benign disease, other reconstruction than gastric tube reconstruction and unwillingness 
to participate in the trial. Randomization, by the sealed envelope method, took place during 
surgery at the moment of cervical anastomosis. Sealed envelopes were prepared and pro-
vided by the Department of Biostatistics. During the hospital stay, 9 patients died (2 in the ETE 
group and 7 in the ETS group) and could not be evaluated for the primary endpoint, stricture 
within 1 year. This study was approved by the Institutional Review Board and registered in the 
Dutch Trial Registry under number OND1317772. Patients were consented before surgery. 
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Operati ve procedure
For tumors of the gastro-esophageal juncti on (Siewert II), transhiatal resecti on (THE) was per-
formed. Tumors of the mid and distal esophagus (Siewert I) were resected by combined right 
transthoracic and transabdominal esophagectomy (TTE). All operati ons were supervised by 1 
of the 2 specialized senior gastro-intesti nal surgeons. Aft er esophageal resecti on, gastric tube 
reconstructi on without pyloroplasty was performed. The gastric tube was created by the aid 
of a linear stapling device, TLC 55 (Ethicon, Johnson & Johnson, Amersfoort, the Netherlands) 
or 60-mm GIA (Autosuture, Covidien, Zaltbommel, the Netherlands), making a 3-cm-wide 
tube along the greater curvature of the stomach. In both groups, the anastomosis was cre-
ated in the neck with a single conti nuous layer of monofi lament suture (PDS 3–0, Ethicon, 
Amersfoort, the Netherlands). 
In the ETE group, as much as possible of the proximal end of the gastric tube was resected 
to improve vascular supply, but without the anastomosis reaching the upper mediasti num to 
prevent intrathoracic leakage. 
In the ETS group, the anastomosis was created at the front wall of the stomach tube, about 
5 cm from the distal end of the gastric tube. Aft er completi on of the ETS-anastomosis, the 
proximal end of the gastric tube was removed by stapling at 2 cm from the anastomosis 
with the same linear stapler. The staple line was oversewn with an additi onal PDS 3–0 suture 
(Figures 1 and 2). 
Post-operati ve period and follow-up
Postoperati vely, pati ents were admitt ed to the intensive care unit for monitoring. The mean 
arterial blood pressure was kept above 80 mmHg with fenylefrine when needed. Pati ents 
were extubated the same day in the ICU. At day 6 aft er surgery a contrast swallow study 
was obtained and video-endoscopy was performed at day 7. Contrast swallow studies 
were performed using water-soluble contrast media. Normal oral intake was allowed aft er 
a b
figure 1a. Photograph of the ETE-anastomosis. 
Arrow points to the anastomosis. Head of the 
pati ent is top of the photograph.
figure 1b. Schemati c drawing of the ETE-
anastomosis. Arrow points to the anastomosis. 
Head of the pati ent is top of the photograph.
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confi rmati on of the integrity of the anastomosis on either investi gati on modaliti es. Routi ne 
postoperati ve follow-up included a 3- and 6-week outpati ent clinic visit. Thereaft er, pati ents 
were seen every 3 months in the fi rst year aft er surgery and every 4 months in the second 
year. 
Defi niti on of post-operati ve complicati ons
Postoperati ve complicati ons were predefi ned and divided into anastomoti c stricture, anasto-
moti c leakage, and other surgical and nonsurgical complicati ons. 
‘Anastomoti c stricture’ was defi ned as reported dysphagia with endoscopic proof of a ste-
nosis through which an 8.8 mm endoscope could not be passed, in the absence of recurrent 
cancer. 
Pati ents were asked every outpati ent clinic visit about dysphagia and evaluated using the 
Mellow-Pinkas score (Table 1).18 When grade II dysphagia or worse was reported (able to 
swallow only semisolid foods), an endoscopy was performed with Savary bougie dilatati on 
over a guide wire when indicated to gradually reach 16–18 mm in diameter. In the case of 
suspect lesions, endoscopic biopsies were taken to rule out local recurrence. Severity of the 
stricture was graded by the number of dilatati ons needed to relieve dysphagia (mild: 1–2, 
severe: ≥ 3).19
‘Anastomoti c leakage’ was defi ned liberally by any extravasati on of water-soluble contrast 
during swallow study, visualizati on of anastomoti c dehiscence or fi stulae during endoscopy or 
visible loss of saliva through the cervical wound. Clinically relevant anastomoti c leakage was 
a b C
figure 2a. Photograph of the ETS-anastomosis. Single arrow points to the anastomosis. Double arrows point to 
the suture line of the gastric tube. Head of the pati ent is top of the photograph. Picture is taken before stapling 
and oversewing the redundant ti p of the gastric tube.
figure 2b. Photograph of the ETS-anastomosis. Single arrow points to the anastomosis. Double arrows point to 
the suture line of the ti p of the gastric tube. Head of the pati ent is top of the photograph.
figure 2c. Schemati c drawing of the ETS-anastomosis. Single arrow points to the anastomosis. Double arrows 
point to the suture line of the ti p of the gastric tube. Head of the pati ent is top of the photograph.
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defined as any leakage, for which the cervical wound was drained, interventions were needed 
or that prolonged in-hospital stay. Anastomotic leaks were never treated with a stent. 
Other predefined ‘surgical complications’ included ischemia or necrosis of the gastric tube, 
chylothorax, postoperative bleeding, wound infection, reoperation and vocal cord paralysis. 
‘Nonsurgical complications’ included pneumonia, ARDS (adult respiratory distress 
syndrome), acute myocardial infarction, congestive heart failure, mediastinitis, sepsis, and 
urinary tract infection. 
‘Operative mortality’ was defined as any death occurring within 30 days of surgery; ‘in-
hospital mortality’ was defined as any death occurring during in-hospital stay. 
table 1. Mellow-Pinkas scoring system for grade of dysphagia
0 Able to eat normal diet/no dysphagia
1 Able to swallow some solid foods
2 Able to swallow only semi-solid foods
3 Able to swallow liquids only
4 Unable to swallow anything/total dysphagia
Statistical analysis
Postoperative anastomotic stenosis was the primary endpoint of the study. The number of pa-
tients included in the study was calculated on a stricture rate of 40% for ETE-anastomosis.20,21 
On the basis of previous studies22 reporting significant lower incidence of anastomotic ste-
nosis in ETS-anastomosis, a noninferiority principle was used with 1-sided testing. To detect 
a 50% reduction in stricture rate (to 20%), 64 patients per study arm were necessary, using 
80% statistical power. Anastomotic leak and in-hospital mortality were chosen as second-
ary endpoints. All patients completed a follow-up period of 1 year or until death. Values 
are shown as means and standard error (SEM) or medians with their range, as appropriate. 
Groups were compared using nonparametrical Mann-Whitney-U test or Student’s T- test, if 
normally distributed. For cross tabulations, Pearson’s χ2-test with continuity correction or 
Fisher’s exact test was used, as appropriate. All statistical analyses were performed on the 
statistical package SPSS 15.0 (SPSS Inc, Chicago, IL, USA). p < 0.05 was considered statistically 
significant. 
rEsults
Of the 175 patients who underwent esophagectomy in the study period, 47 patients were 
not included in this study, because they were not willing to participate (34), use of a colon in-
terposition graft (4), laparoscopic procedure (2), or benign disease (7). Patient characteristics 
are listed in Table 2. More female patients and patients with squamous cell carcinoma were 
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table 2. Basic patient characteristics and clinical data
End-to-end 
(n=64)
% End-to-side 
(n=64)
% p-value
Age (yr) median [range] 60 [35-80] 63 [39-82] 0.11
Sex (M:F) 43:21 56:8
Histology 0.04
-  Squamous cell carcinoma 18 (28%) 9 (18%)
-  Adenocarcinoma with Barrett epithelium 10 (16%) 20 (33%)
-  Adenocarcinoma without Barrett epithelium 30 (47%) 32 (52%)
-  No malignancy left after neoadjuvant treatment 6 (9%) 3 (5%)
Tumor site 0.79
-  Esophagus 42 (67%) 43 (67%)
-  Gastro-esophageal junction 14 (22%) 16 (25%)
-  Gastric cardia 7 (11%) 5 (8%)
Tumor Stage 0.65
-  0 6 (9%) 3 (5%)
-  I 4 (6%) 4 (6%)
-  IIA 12 (18%) 14 (22%)
-  IIB 3 (5%) 6 (9%)
-  III 16 (25%) 11 (17%)
-  IVA 18 (28%) 23 (36%)
-  IVB 5 (8%) 3 (5%)
Radical resection (R0) 42 (66%) 49 (77%) 0.53
(Neo) adjuvant treatment 23 (36%) 21 (33%) 0.36
-  Chemotherapy 11 (17%) 16 (25%)
-  Chemoradiation 12 (19%) 5 (8%)
Co morbidity 40 (63%) 40 (63%) 1,0
-  Cardiovascular 26 (41%) 18 (28%) 0.13
-  Respiratory 5 (8%) 10 (16%) 0.32
-  Diabetes Mellitus 2 (3%) 5 (8%) 0.44
Operating time (min) mean ± SEM 357 ± 12 363 ± 11 0.76
Surgical approach 0.34
-  Transhiatal esophagectomy 41 (64%) 47 (73%)
-  Transthoracic esophagectomy 23 (36%) 17 (28%)
Hospital stay (days) [median (range)]
Intensive Care Unit 3 (1-48) 4 (1-47) 0.19
Hospital stay 15 (9-125) 22 (8-281) 0.02
Mortality
-  30-day 0 (0%) 4 (6%) 0.13
-  In-hospital 2 (3%) 7 (11%) 0.16
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present in the ETE group. No relati on between gender or histology and any of the outcome 
variables was found. The prevalence and doses of fenylefrine and other vasoacti ve drugs were 
equivalent in the 2 groups. 
Anastomoti c stenosis
Dysphagia grade II or worse occurred in 27 pati ents (44%) in the ETE group and in 12 pati ents 
in the ETS group (21%, p = 0.01). There were no diff erences between groups in ti me between 
surgery and onset of stricture (Table 3). At endoscopy a benign anastomoti c stricture, for 
which (multi ple sessions of) dilatati on was indicated, was confi rmed in 25 pati ents in the ETE 
group (40%) and in 10 pati ents in the ETS group (18%, p < 0.01). The remaining 4 pati ents 
had dysphagia due to parti al dissolved suture material, obstructi ng the lumen (n = 2), refl ux 
esophagiti s (n = 1), and biopsy proven local recurrence (n = 1). 
One-year actuarial stricture-free survival was 58% in the ETE group and 83% in the ETS 
group, p = 0.005 (Fig. 3). A mild stenosis occurred in 2 pati ents (3%) in the ETE group com-
pared to 1 pati ent (2%) in the ETS group. Severe stenosis occurred in 23 pati ents (37%) in the 
ETE group and 9 pati ents (16%) in the ETS group, p = 0.01, Table 3. We found no diff erences 
figure 3. Stricture-free survival. Stricture-free survival was 58% in the ETE group and 83% in the ETS group, p = 
0.005. Numbers are pati ents at risk.
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in the persistency of the stenosis between the groups. In the ETE group a median of 6 dilata-
tion sessions were needed (range 1–19) and also 6 sessions were needed in the ETS group 
(range 2–20), p = 0.81. In total, 257 dilatations were performed in these 35 patients, without 
perforation or major bleeding. 
Anastomotic leakage
In 14 patients in the ETE group (22%) clinically observed or radiological detected leakage 
occurred, compared to 26 patients in the ETS group (41%, p = 0.04). When only clinically rel-
evant leaks are taken into consideration, still more patients in the ETS group were diagnosed 
with leakage; 10 patients in the ETE group (16%) compared to 21 patients in the ETS group 
(33%, p = 0.04; Table 3). An inversed relation between anastomotic leakage and stricture for-
mation in our series was found: a stricture developed in 5 of the 40 patients who had leakage 
(13%), and in 30 of the 88 patients without anastomotic leakage (34%, p < 0.02). There was 
no difference between groups in this relation between anastomotic leakage and formation 
of strictures; 3 of the 14 patients with anastomotic leakage in the ETE group developed a 
stenosis (21%) compared to 2 of the 26 patients with leakage in the ETS group (8%, p = 0.32). 
Evaluation of the anastomosis
At video-endoscopy, local ischemia was found in 10 of 60 patients in the ETE group (17%) and 
in 8 of 63 patients in the ETS group (13%, p = 0.71). A trend toward a higher rate of dehiscence 
of the anastomosis was found in the ETE group (8 patients, 13%), compared to 2 patients in 
the ETS group (3%; p = 0.05). There was no statistically significant difference in occurrence of 
ulcers (25% vs. 29%), necrosis (5% vs. 3%) or fistula formation (5% vs. 6%). At contrast-swallow 
study, leakage was noticed in 10 of 58 (17%) patients in the ETE group and 6 of 51 patients in 
the ETS group (12%, p = 0.6). Aspiration during contrast swallow study occurred in 16% of the 
patients in the ETE group and 21% of the patients in the ETS group (p = 0.51, Table 5). 
table 3. Anastomotic stricture and leakage
anastomotic stricture
End-to-end End-to-side
p-valuen=62 n=57
-  Dysphagia ≥ grade 2 (Mellow-Pinkas-score) 27 (44%) 12 (21%) 0.01
-  Benign stricture 25 (40%) 10 (18%) <0.01
-  Onset of stricture (days) [median (range)] 64 [29-258] 68 [42-154] 0.71
-  Severity of stricture (sessions needed) 0.01
o  Mild stricture (1-2 sessions) 2 (3%) 1 (2%) 
o  Severe stricture (≥ 3 sessions) 23 (37%) 9 (16%) 
Anastomotic leakage N=64 N=64
-  Leakage (clinical and radiological) 14 (22%) 26 (41%) 0.04
-  All clinical leakage 10 (16%) 21 (33%) 0.04
50 Chapter 3
Other postoperative complications
A trend toward more surgical site infections of the cervical wound and a higher reoperation 
rate was found in the ETS group (Table 4). Significantly more patients in the ETS group suffered 
from postoperative pneumonia: 11 patients in the ETE group (17%), compared to 28 patients 
in the ETS group (44%), p = 0.002). The localization of pneumonia was significantly different 
between the groups; in the ETE group right-sided pneumonia (site of cervical anastomosis) 
occurred in 10 of 11 patients (91%), in the ETS group this occurred in 12 of 28 patients (43%, 
p = 0.02). In both groups, pneumonia was strongly related to anastomotic leakage, as 21 of 
the 40 patients with anastomotic leakage developed pneumonia (53%), compared to 18 of 88 
patients without leakage (20%), p < 0.001. We also found an overall relation between vocal 
cord paralysis and pneumonia. Of the 12 patients with vocal cord paralysis, 7 developed pneu-
monia (58%), compared to 32 patients of 116 without this complication (28%), p =0.04. There 
was, however, no difference in the number of patients with vocal cord paralysis between the 
two groups (Table 4). Pneumonia after aspiration of water-soluble contrast during swallow 
study occurred in 1 patient in the ETE group (2%) and in 6 patients in the ETS group (10%, p 
= 0.06). A trend toward more patients treated for mediastinal infection in the ETS group was 
found (Table 4). 
Operative (30-day) mortality occurred in 0 patients (0%) in the ETE group, compared to 4 
(6%) in the ETS group, p = 0.13. Overall in-hospital mortality showed no significant differences 
table 4. Postoperative complications
End-to-end End-to-side p-value
surgical complications
-  Re-operation 6 (9%) 15 (23%) 0.05
-  Bleeding 2 (3%) 3 (5%) 1.0
-  Cervical wound infection 5 (8%) 13 (20%) 0.07
-  Pleura empyema 3 (5%) 1 (2%) 0.31
-  Chylothorax 4 (6%) 1 (2%) 0.36
-  Vocal cord paralysis 8 (13%) 4 (6%) 0.36
non-surgical complications
-  Pneumonia 11 (17%) 28 (44%) 0.002
-  ARDS 2 (3%) 3 (5%) 1.0
-  Mediastinitis 3 (5%) 10 (16%) 0.08
-  Congestive heart failure 2 (3%) 1 (2%) 1.0
-  Atrial fibrillation 5 (8%) 5 (8%) 1.0
-  Myocardial infarction 1 (2%) 2 (3%) 1.0
-  Sepsis 3 (5%) 8 (13%) 0.21
-  Delirium 3 (5%) 9 (14%) 0.07
-  Urinary tract infection 2 (3%) 2 (3%) 1.0
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between groups; 2 (3%) in the ETE group compared to 7 (11%) in the ETS group (p = 0.16, 
Table 2). One-year survival was 63% in the ETE group (median survival 315 days, 95% confi-
dence interval 306–400 days) and 72% in the ETS group (median 366 days, 95% confidence 
interval 334–465 days), p = 0.63. 
disCussion
The frequent and still important problem of esophago-gastric anastomotic failure after 
esophagectomy, either stricture or leakage, has stimulated a variety of anastomotic meth-
ods.10 , 23 – 32 The best technique to perform this anastomosis is still subject of debate. 
In several studies, comparing different anastomotic techniques, the hand-sewn ETE-
esophago-gastric anastomosis is regarded by many as the preferred technique, with 9–45% 
anastomotic stricture formation and 4–25% anastomotic leaks.27 – 35 In other parts of the 
gastrointestinal tract however, ETS-or STS-anastomosis proved superior to ETE-anastomosis 
regarding postoperative leakage rate and stricture formation.13–17 
The only two retrospective studies reporting hand-sewn cervical ETS-anastomosis after 
gastric tubulization are from Heitmiller et al.22 and Anikin et al.36 Anastomotic strictures oc-
curred in 26% in the series of Heitmiller and numbers were not provided by Anikin.36 This 
low incidence of stricture formation was in their experience accompanied by a very low 
incidence of anastomotic leaks (1% and 5% of the patients, respectively). These favorable 
results encouraged us to perform a randomized study between hand-sewn ETE-anastomosis 
and ETS-anastomosis in the neck. 
In our study, anastomotic stricture formation was chosen over anastomotic leakage as 
primary endpoint of this study, because it defeats one of the main aims of surgery, which 
is to restore normal swallowing function. Dysphagia occurs in up to 66% of the patients in 
the earlypostoperative period21,37 and negatively affects the quality of life after esophagec-
tomy.38 As dysphagia can be attributed to several anatomic and functional etiologies after 
table 5. Findings at video-endoscopy and contrast swallow study
End to end End to side p-value
Endoscopy N=60 N=63
-  Ischemia 10 (17%) 8 (13%) 0.71
-  Necrosis 3 (5%) 2 (3%) 0.68
-  Ulcer 15 (25%) 18 (29%) 0.81
-  Dehiscence 8 (13%) 2 (3%) 0.05
-  Fistula 3 (5%) 4 (6%) 1.0
Contrast-swallow study N=60 N=51
-  Leakage 10 (17%) 6 (12%) 0.60
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esophagectomy, difficulty in swallowing alone does not prove the presence of an anastomotic 
stricture. In a previous study however, endoscopic proof of narrowing was found in all pa-
tients complaining about newly onset dysphagia after surgery.21 Also in this study we found 
endoscopic proof of stricture formation in the majority (90%) of the patients with dysphagia 
grade II or worse. However, not all patients with anastomotic narrowing—an intuitively objec-
tive outcome measure—complain about dysphagia. We believe that these patients with an 
asymptomatic stricture should not be treated as long as their quality of life is not impaired. 
We therefore considered dysphagia, associated with endoscopically proven anastomotic nar-
rowing, as definition of anastomotic stricture, rather than to perform routine endoscopy at 
1-year follow-up. 
The rate of anastomotic strictures in the ETE group in our study (40%) is in line with the 
results reported in literature (20–45%),21,23,26,33 whereas the 18% anastomotic stricture rate in 
the ETS group compares favorably to the results reported by Heitmiller et al. in their retro-
spective series (26%).22 However, the rate of anastomotic strictures in our study seems higher, 
compared to the results of cervical semimechanical STS-anastomosis, reported by Collard et 
al. (6.3%),39 but follow-up in that series was limited to 2 months, which is the median time 
to onset of stricture formation in our study. We found no significant differences between 
groups in the time to onset of stricture (first dilatation session) or the median number of 
dilatation sessions needed to relief symptoms, when stricture formation occurred. A stricture 
developed in 5 of the 40 patients (13%) who had leakage, and was similar in both groups. This 
number strongly differs from the results of Briel et al.,19 who found that stricture formation 
occurred in half of the patients with leakage and established leakage as an independent risk 
factor for stricture formation. In our study, stents were never used for treatment of leak-
age, and therefore the difference in stricture formation between the two groups cannot be 
explained by this factor. 
The rate of anastomotic leakage in our ETE group is high, but comparable to that reported 
in large series in literature (4–25%),34 , 40 – 42 especially when only clinically relevant leaks are 
considered (16%). One of the technical reasons for the rather high leak rate in our study 
compared to other series could be the standard use of a 3-cm-wide gastric tube. This tech-
nique according to Marmuse43 relies on the right and left gastroepiploic artery as the only 
arterial blood supply for the gastric tube with about 15% of the patients having a Koskas type 
II anatomy44 lacking connections between these 2 arterial branches.45 , 46 However, Tabira et 
al.6 showed in their randomized study that a 3 cm narrow gastric tube has the same outcome 
after esophagectomy, compared to a subtotal stomach pull-up. 
In the ETS group we found however an unexpectedly high rate of anastomotic leaks, with 
significantly more pulmonary complications and longer in-hospital stay. Interestingly, the 
increased anastomotic leaks in this group were not supported by differences in extravasa-
tion of contrast at the anastomotic site in the ETS group at routine contrast swallow. Video-
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endoscopy even showed less partial anastomotic dehiscence in the ETS group, compared to 
the ETE group. This inverse relationship may be explained by the possibility that the increased 
anastomotic leakage does not result from the anastomosis itself, but rather from the blind 
ended most proximal end of the gastric tube. 
Compared to an ETE-anastomosis, the ETS-anastomosis required more length of the gastric 
tube and the most ischemic proximal end is left in situ. Based on experimental work regarding 
the microcirculation in the gastric tube,47 we considered it safer to remove the redundant tip 
and reinforce the staple line by oversewing it. In retrospect, oversewing the staple line may 
have introduced additional ischemia, leading to dehiscence of the suture and staple line. This 
may explain the increased leakage rate in the ETS group, whereas video-endoscopy showed 
intact esophago-gastric anastomoses in this group. This also may indicate why the increased 
leakage (of the tip) in this group was not accompanied by stricture formation (of the anasto-
mosis), as is often reported after anastomotic leaks. 
The observed increased need for reoperations and subsequent increased length of stay 
can be directly attributed to the increased anastomotic leakage in the ETS group. The rela-
tion between pneumonia and leakage is however more difficult to understand. One of the 
hypotheses may be that excessive leakage in the ETS group with mediastinal collection 
formation may provoke pneumonia, either by compression, or by pain, preventing adequate 
coughing. In our study, we found more right-sided pulmonary infiltrates in the ETE group 
(suitable with the anastomosis in the right neck); but in the ETS group infiltrates were both 
left and right-sided. Vocal cord paralysis is a risk factor for pneumonia in our series, but there 
was no difference in vocal cord paralysis between the two groups. Another explanation may 
be that in the ETS group with leakage more swallow studies were performed to follow-up the 
leak. Previous studies showed a relation between contrast swallows and (micro)aspiration. In 
our study, we found indeed a trend toward more aspiration during contrast swallow studies 
in the ETS group. 
In conclusion, an ETS-cervical esophagogastric anastomosis in the neck is associated with 
a lower anastomotic stricture rate, compared to the ETE-technique. However, the ETS-
technique is accompanied by an increased anastomotic leak rate and a longer in-hospital stay. 
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abstraCt 
Objective: The aim of this study was to compare the leak rate between a hand-sewn end-to-
end anastomosis (ETE) and a semi-mechanical anastomosis (SMA) after esophagectomy with 
gastric tube reconstruction.
Background data: The optimal surgical technique for the creation of an anastomosis in the 
neck after esophagectomy is unclear. No randomized controlled studies have been performed 
that compare a hand-sewn ETE-anastomosis with a SMA. 
Methods: Patients with esophageal cancer who were planned for esophagectomy with gastric 
tube reconstruction and cervical anastomosis were eligible for participation after written 
informed consent. Patients were randomized in a 1:1 ratio to ETE- or SMA-anastomosis. The 
primary endpoint was anastomotic leak rate defined as external drainage of saliva from the 
site of the anastomosis or an intra-thoracic manifestation of a leak. Secondary endpoints 
included anastomotic stricture rate at one year follow up, number of dilations, dysphagia 
score, hospital stay, morbidity and mortality. Patients were blinded for the intervention. 
Results: Between August 2011 and July 2014, 174 patients with esophageal cancer under-
went esophagectomy. Some 93 patients were randomized to ETE (n=44) or SMA (n=49). 
Anastomotic leak occurred in 9 of 44 patients (20%) in the ETE group and 12 of 49 patients 
(24%) in the SMA group (absolute difference 4%, 95% CI -13% to +21%; p=0.804). There was 
no statistically significant difference in dysphagia at one year postoperatively (ETE 25% vs. 
SMA 20%; p=0.628), nor in median hospital stay (17 days in the ETE group, 13 days in the 
SMA group), morbidity (82% vs 73%, p=0.460) or mortality (0% vs 4%, p=0.175) between the 
groups. 
Conclusion: There was no statistical significant difference in anastomotic leak rate between 
ETE and SMA cervical esophagogastrostomy.
Dutch Trial Registry number: NTR3029. No source of funding. 
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introduCtion
Neoadjuvant chemotherapy or chemo radiation followed by esophagectomy is the treatment 
of choice for locally advanced esophageal cancer. Following esophagectomy, the continuity of 
the gastrointestinal tract is preferably restored with a gastric tube. Failure of the anastomo-
sis1, 2 between the remnant esophagus and the gastric tube occurs in 5-30%1, 3, 4 of patients. 
Anastomotic leakage delays oral intake, prolongs hospital stay, is associated with a deteriora-
tion of health-related quality of life5-7 and results in increased heath care costs.8, 9 Anastomotic 
leakage is a risk factor for stenosis of the anastomosis3, 10 and up to 40% of patients need 
endoscopically guided dilatations.11, 12 Anastomotic leakage is also a risk factor for in-hospital 
mortality (3-6%).1, 4, 13
The optimal technique for creating a cervical anastomosis between the esophagus and 
gastric conduit is largely unknown due to a lack of randomized trials. As patients live longer, 
perioperative morbidity and late complications of surgery tend to become more important. A 
previous randomized controlled trial compared a cervical hand-sewn end-to-end anastomosis 
(ETE) to a cervical hand-sewn end-to-side (ETS) anastomosis. This study reported that an ETE- 
anastomosis was associated with a lower leak rate, but a higher rate of stenosis compared to 
an end-to-side anastomosis.14 However, the reported leak rates were still high: 22% in the ETE 
group and 41% in the ETS group.  
In 1998 Collard17 et al. published a new technique for the cervical esophagogastrostomy. 
Retrospective studies have suggested that this semi-mechanical side-to-side anastomosis 
(SMA) is associated with low anastomotic leak rates and low rates of anastomotic strictures. 
The aim of this study was to assess the leak and stricture rate of the SMA technique. We 
hypothesized that the SMA reduces the anastomotic leak and stricture rate as compared to 
our standard ETE-anastomosis. 
patiEnts and mEthods
Trial design
This was a single center, single blinded, parallel group with balanced randomization (1:1), 
clinical trial. The trial was registered at the Dutch trial registry (NTR3029). The study took 
place at the Department of Surgery, Erasmus MC, Rotterdam, the Netherlands. The Erasmus 
MC is an academic hospital and serves as a tertiary referral center for esophageal diseases. 
Ethical approval was obtained from the ethics committee of the Erasmus MC (trial number 
NL35746.078.11). After approval of the protocol on 11 August 2011, there were no changes 
or amendments made. The trial is reported according to the CONSORT 2010 guidelines.15  
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Patients
Eligible participants were patients aged ≥ 18 years with esophageal or junctional cancer and 
who were scheduled for a transhiatal or transthoracic esophagectomy with gastric tube re-
construction and a cervical anastomosis. Only patients who underwent surgery with curative 
intent (stage cT1-4aN0-2M0) were eligible. Neoadjuvant treatment (chemotherapy or chemo 
radiation) was allowed. 
Exclusion criteria were a planned intra-thoracic anastomosis, patient not available for 
follow up (up to 1 year postoperatively), cervical esophageal cancer (extending from upper 
esophageal sphincter to the sternal notch), American Society of Anesthesiologists (ASA) score 
of ≥ 4. 
Patients were informed about the study in the outpatient clinic by one of the consultant 
surgeons 4-8 weeks before the operation.  An information leaflet was handed out. The day 
before the operation, the patient was admitted to the hospital and the patient was asked to 
participate in the study. After written informed consent the patients were registered as trial 
participant.  
Interventions
Three experienced esophageal surgeons (HWT, JJBvL, BPLW), proficient in both anastomotic 
techniques, participated in the study and performed the resection and reconstruction them-
selves or supervised the fellow.  
A three stage transthoracic esophagectomy (McKeown) or transhiatal esophagectomy (Or-
ringer) was performed depending on the patient’s condition and location of the tumor16. A 
nasojejunal feeding tube or percutaneous jejunostomy was placed. 
Surgical techniques
End-to-end anastomosis
The cervical esophagus was transected 4 to 5 cm below the upper esophageal sphincter, the 
esophageal was stripped and the resection specimen was retrieved. A 3-4 cm wide gastric 
tube was created and brought up to the neck via the prevertebral route. A hand-sewn, single 
layer running end-to-end esophagogastrostomy (ETE) was constructed with PDS 3/0 (Johnson 
& Johnson, New Brunswick, NJ, USA) as described before.14 The anastomosis was performed 
as distal as possible on the gastric tube (towards the pylorus) and any redundant gastric tissue 
was resected. However, great care was taken to prevent any tension on the anastomosis. A 
photograph is shown in Figure 2. 
Semi-mechanical anastomosis
The semi-mechanical anastomosis (SMA) was performed according to Collard et al. with 
some modifications.17 After complete mobilization of the esophagus, the cervical esophagus 
was transected with a linear stapler (Covidien, Dublin, Ireland) 8-10 cm below the upper 
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esophageal sphincter via the neck incision. Once a 3-4 cm wide gastric tube was created and 
pulled up to the neck, five stay sutures with Ti-Cron 3/0 (Medtronic, Dublin, Ireland) kept the 
esophageal remnant and gastric tube in a parallel position to each other. A small incision was 
made in the gastric tube and the cervical esophagus. Another two stay sutures were placed 
between the esophagus and gastric tube via the enterotomy. The jaws of an Endostapler 
(Ethicon, USA) were placed across the two opposing walls with the anvil in the gastric lumen 
and the cartridge of staples in the esophageal lumen. The stapler was fired to allow forward 
displacement of the knife and the delivery of three rows of staples on each side. The stapler 
was removed and a V-shaped join was created. The anterior wall of the anastomosis was 
closed using a double-layer running suture technique. A photograph is shown in Figure 3.
Outcomes
The primary endpoint was anastomotic leakage within 30 days after the operation. This was 
defined as opening of the neck wound with subsequent drainage of saliva and/or ingested 
fluids through the wound site or intrathoracic manifestations of anastomotic leak including 
mediastinitis or abscess formation detected with radiologic imaging (CT scan with oral con-
trast) or endoscopy. 
Secondary endpoints included anastomotic stricture within one year, defined as dysphagia 
with stenosis seen on endoscopy, number of dilations within one year and quality of life at 
one year follow-up.
Sample size
The reported leak rate for ETE in our center was 22%.14 SMA is associated with a leak rate of 
5%.17 Hence, a 17% reduction in the leak rate in favor of SMA was anticipated. A sample size 
was calculated using an α of 0.05 (two-sided) and a power of 85%. Seventy-six patients had 
to be included per study arm. To correct for mortality within one year, the study arms were 
enlarged to 100 patients each. No formal interim analysis was planned.
Randomization
The Department of Biostatistics supervised the randomization process (by preparing the enve-
lopes). A computer based hidden block size of 10 was used by the Department of Biostatistics. 
After the tumor was resected, the gastric tube constructed and pulled up to the neck, the lead 
surgeon decided if the patients could be randomized. Randomization took place in the operat-
ing room using sealed envelopes prepared by the Department of Biostatistics. Reasons for not 
randomizing patients were inability to construct ETE or SMA (when the esophageal remnant 
or gastric tube was too short), distant metastasis found during the operation, reconstruction 
with colon or a retrosternal or presternal route of the conduit.  Stratification was performed 
for surgical approach (i.e. transhiatal or transthoracic approach).
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Independent Data Monitoring and Safety Committee
An independent Data Safety and Monitoring Board (DSMB), consisting of two surgeons and 
a biostatistician, reviewed unblinded data for patient’s safety. No interim analysis for efficacy 
or futility was planned. The DSMB monitored the (cumulative) incidence of serious adverse 
events every 3 months.  Serious adverse events (SAEs) included anastomotic leakage requiring 
surgical re-intervention, any complication requiring prolonged hospital stay, any complication 
that results in death, re-admittance to the hospital, recurrence of disease or death. The DSMB 
could advise on the termination of the study. All SAEs were reported through the web portal 
ToetsingOnline to the accredited METC that approved the protocol, within 15 days after the 
sponsor was informed about a serious adverse event.
Statistical analysis
Analysis of data was according to intention to treat. Values are shown as means and standard 
deviation (SD) or medians with their range. Groups were compared using non-parametrical 
Mann-Whitney U test or Student’s T test, if normally distributed. For cross tabulations, Pear-
son’s Chi Square test with continuity correction or Fisher’s exact test was used, as appropriate. 
All statistical analyses were performed on the statistical package SPSS 24.0 (SPSS Inc, Chicago, 
IL, USA). A p-value < 0.05 is considered statistically significant (two-sided). No futility analysis 
was performed because the reason to end the study prematurely was slow accrual.
Postoperative care
After the operation patients were transferred to the ICU; they were extubated in the operating 
room or within the following hour, if possible. ICU staff was unaware of the anastomotic tech-
nique. Patients were transferred to the surgical ward the day after surgery if they were not on 
inotropes and were hemodynamically and respiratory stable.  At the ward a standardized care 
pathway was followed and a checklist with postoperative instructions was used by the attending 
surgeon, the nurse specialist or registrar. Patients were kept nil by mouth but ice chips were 
allowed according to the study protocol. Radiological examination of the anastomotic integrity 
was not performed routinely before oral intake was commenced on postoperative day 7. On 
postoperative day 8, thickened fluids were allowed (yoghurt/custard) and on day 9 semi-solids 
and soft foods were introduced until discharge.  Enteral feeds were given by the nasojejunal 
feeding tube or the jejunostomy starting postoperative day 1. A dietician was involved in the 
assessment of caloric intake by the patients in the hospital and after discharge. It was the inten-
tion to discharge the patients without a need for additional enteral feeding via the feeding tube. 
Follow up
Patients were seen in the outpatient clinic three weeks after discharge and every three months 
in the first year after surgery. The second year, patients were seen every 6 months and from 
year three onwards once a year. For the first year, the surgeon filled out a questionnaire 
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and case record forms regarding dysphagia and complicati ons aft er interviewing the pati ent. 
Quality of life questi onnaires (EORTC QLQ C-30 and OES-18) were answered preoperati vely 
and at 3, 6, 9 and 12 months aft er surgery.
rEsults
Pati ents
From August 2011 to July 2014, 174 pati ents with esophageal cancer underwent esophagec-
tomy with gastric tube reconstructi on for esophageal cancer. The CONSORT fl ow diagram is 
shown in Figure 1. 
figure 1. Overview of pati ent inclusion
	
	
CONSORT	2010	Flow	Diagram	
Assessed for eligibility (n=174) 
Excluded (n=81) 
¨			Not meeting inclusion criteria (n=24) 
¨			Declined to participate (n=57) 
 
Analysed (n=44) 
¨	Excluded from analysis (reasons) (n=0)	
Lost to follow-up (give reasons) (n=0) 
Allocated to intervention ETE (n=44) 
¨	Received allocated intervention (n=42)	
¨	Did not receive allocated intervention (due to 
technical difficulties) (n=2)	
Lost to follow-up (give reasons) (n=0) 
Allocated to intervention SMA (n=49) 
¨	Received allocated intervention (n=47)	
¨	Did not receive allocated intervention (due to 
technical difficulties) (n=2)	
Analysed (n=49) 
¨	Excluded from analysis (reasons) (n=0) 
	
Allocation 
Analysis 
Follow-Up 
Randomized (n=93) 
Enrollment 
Reasons for exclusion: no signed informed consent (n = 57), intra-thoracic anastomosis, no availability for follow up at 
1 year (n = 2), upper thoracic/cervical esophageal cancer, American Society of Anesthesiologists score larger or equal 
to 4. Reasons not to randomize pati ents in the operati ng room were: technically not possible to perform SMA (n = 8), 
metastasis found during the operati on (n = 5), no gastric tube created (n = 2), prevertebral route of the conduit (n = 1), 
reconstructi on aft er previous resecti on (n = 6). All 4 pati ents who were randomized but did not receive the allocated 
anastomosis received either an ETE or ETS anastomosis. 
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Due to slow accrual and the publication of a similar trial18, the DSMB recommended to 
stop the trial and report the outcomes. In total, 93 patients were randomized. The ETE group 
consisted of 44 patients and the SMA group of 29 patients. Patient characteristics are listed 
in Table 1. The mean (SD) age was 65 (8.30) years in the ETE group, and 64 (7.87) years in 
the SMA group. Neoadjuvant treatment (chemotherapy or chemo radiation) was given to 39 
(89%) of patients in the ETE group and 46 (94%) patients in the SMA group. 
Primary outcome
Anastomotic leakage occurred in 9 of 44 (20%) patients in the ETE group and in 12 of 49 (24%) 
patients in the SMA group (absolute difference 4%, 95% CI -13% to +21%; p=0.804) (Table 3). 
In one patient from the SMA group a reoperation was required because of a massive leak 
resulting in pneumohydrothorax. The gastric tube was resected and an esophagostomy in the 
table 1. Patient characteristics 
EtE* (n=44) sma** (n=49)
Age (yr) median [range] 65 [41-83] 64 [44-83]
Sex (M:F) 40:4 36:13
histology
-  Squamous cell carcinoma 7 (16%) 18 (37%)
-  Adenocarcinoma 36 (82%) 31 (63%)
-  Undifferentiated 1 (3%) 0 (0%)
tumor site
-  Esophagus 34 (77%) 38 (78%)
-  Gastro-esophageal junction 10 (23%) 11 (22%)
neo-adjuvant treatment
-  None 5 (11%) 3 (6%)
-  Chemotherapy 6 (14%) 4 (8%)
-  Chemoradiation 33 (75%) 42 (86%)
Comorbidity
-  Cardiovascular 26 (59%) 26 (53%)
-  Respiratory 3 (7%) 6 (12%)
-  Diabetes Mellitus 10 (23%) 8 (16%)
asa
-  1 4 (9%) 5 (10%)
-  2 32 (73%) 34 (69%)
-  3 8 (18%) 10 (21%)
-  4 0 (0%) 0 (0%)
-  5 0 (0%) 0 (0%)
* ETE denotes end-to-end
** SMA denotes semi-mechanical anastomosis
Semi-mechanical versus hand-sewn anastomosis
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table 2. Operative characteristics and pathology 
EtE (n=44) sma (n=49)
Mean operating time (min± sd) 398.9 (16.8) 389.9 (14.0)
surgical approach
-  Transhiatal esophagectomy 18 (41%) 20 (41%)
-  Transthoracic esophagectomy 26 (59%) 29 (59%)
pathology
radicality of the operation
-  R0 41 (93%) 42 (86%)
-  R1 3 (7%) 7 (14%)
-  R2 0 (0%) 0 (0%)
histology
-  Squamous cell carcinoma 3 (7%) 11 (22%)
-  Adenocarcinoma 29 (66%) 28 (57%)
-  No malignancy left after neoadjuvant treatment 11 (25%) 10 (20%)
-  Lymphoepithelioma 1 (3%) 0 (0%)
Median (range) number of lymph nodes resected 19 (2-43) 18 (8-41) 
pt-category
- T0 11 (25%) 13 (27%)
- T1 8 (18%) 8 (16%)
- T2 11 (25%) 5 (10%)
- T3 14 (32%) 21 (43%)
- T4 0 (0%) 2 (4%)
pn-category
- N0 26 (53%) 25 (51%)
- N1 13 (27%) 13 (27%)
- N2 4 (8%) 8 (16%)
- N3 1 (2%) 3 (6%)
pm-stage
- M0 42 (95%) 49 (100%)
- M1 2 (5%) 0 (0%)
disease stage
-  0 10 (23%) 9 (18%)
-  Ia 8 (18%) 7 (14%)
-  Ib 5 (11%) 4 (8%) 
-  IIa 3 (7%) 6 (12%)
-  IIb 6 (14%) 5 (10%)
-  IIIa 8 (18%) 8 (16%)
-  IIIb 3 (7%) 5 (10%)
-  IIIc 1 (2%) 3 (6%)
-  IV 0 (0%) 2 (4%)
Abbreviations used: ETE: End-to-end; SMA: semi-mechanical anastomosis
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table 3. Postoperative complications
EtE (n=44) sma (n=49) p-value
Any complication 36 (82%) 36 (73%) 0.460
anastomosis related complications
-  Anastomotic leakage 9 (20%) 12 (24%) 0.804
-  Reoperation required for leakage 0 (0%) 1 (2%) 1.000
Dysphagia 11 (25%) 10 (20%) 0.628
Stenosis of the anastomosis on endoscopy 11 (25%) 9 (18%) 0.460
Median (range) number of dilatations (1year) 6 [1-11] 3 [1-9] 0.276
other complications
-  Postoperative bleeding# 3 (7%) 0 (0%) 0.249
-  Chylothorax§ 4 (9%) 3 (6%) 0.704
-  Vocal cord paralysis 3 (7%) 5 (16%) 0.561
-  Wound dehiscence (abdominal) 2 (5%) 1 (2%) 0.601
-  Pneumonia† 14 (32%) 17 (35%) 0.828
-  Mediastinitis 4 (9%) 5 (10%) 1.000
-  Cardiac complication (other than AF) ‡ 8 (18%) 8 (16%) 1.000
-  Atrial fibrillation 6 (14%) 10 (20%) 0.423
-  Sepsis 1 (2%) 2 (4%) 1.000
-  Delirium 5 (11%) 1 (2%) 0.097
-  Thrombosis~ 1 (2%) 1 (2%) 1.000
Re-admission to ICU 3 (7%) 7 (14%) 0.324
Re-admission to hospital*** 6 (14%) 13 (27%) 0.186
Abbreviations: ETE: end-to-end, SMA: semi-mechanical anastomosis, ICU: intensive care unit
Adverse events were graded according to the National Cancer Institute’s Common Terminology Criteria for Adverse 
Events, version 4.0
^  Anastomotic leakage was defined as: opening of the neck wound with subsequent drainage of saliva and/or in-
gested fluids through the wound site or intrathoracic manifestations of anastomotic leak including mediastinitis or 
abscess formation detected with radiologic imaging (CT scan with oral contrast) or endoscopy
†  Pneumonia (isolation of pathogen from sputum culture and a new or progressive infiltrate on chest radiograph), 
serious atelectasis (lobar collapse on chest radiograph)
#  Postoperative bleeding was defined as blood loss with the need of transfusion or intervention.
‡  Cardiac complications were arrhythmia (any change in rhythm on the electrocardiogram, requiring treatment), 
myocardial infarction (two or three of the following: previous myocardial infarction, electrocardiographic changes 
suggesting myocardial infarction, or enzyme changes suggesting myocardial infarction), cardiac decompensation 
and left ventricular failure (marked pulmonary edema on a chest radiograph).
~  Thrombosis was defined as the physical presentation of an acute deep venous thrombosis, confirmed by radiologi-
cal exam or a pulmonary embolism, conformed by spiral computed tomography. 
§  Chylothorax was recorded when elevated levels of triglycerides in intrathoracic fluid (>1 mmol per liter [89 mg 
per deciliter]) were found in combination with high fluid production of the drain. Mediastinitis was scored when 
reported by the local investigator.
*** Reasons for re-admission: unable to maintain oral intake, pneumonia, wound infection
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neck was created together with a feeding jejunostomy. In all other pati ents, leakage was man-
aged conservati vely by opening of the neck wound, anti bioti cs or percutaneous drainage of a 
mediasti nal or pleural abscess. Operati ve characteristi cs and pathology are shown in Table 2. 
Secondary and other outcomes
Dysphagia was reported by 11 pati ents (25%) in the ETE group and 10 pati ents (20%) in the 
SMA group (p=0.628). Most pati ents required dilatati on for a benign anastomoti c stricture 
as diagnosed on endoscopy. The median(range) number of dilatati ons within one year aft er 
surgery was 6(1-11) in the ETE group and 3 (1-9) in the SMA group (p=0.628). 
Median(range) Intensive Care Unit stay was 3 (1-20) days for pati ents in the ETE group 
compared to 3 days (1-11 days) for pati ents in the SMA group. Median (range) hospital stay 
was 17 (10-95) days for pati ents in the ETE group compared to 15 days (5-78 days) for pati ents 
in the SMA group (p=0.261). In-hospital mortality for the ETE group was 0% versus 4% in 
the SMA group (p=0.175). One pati ent from the SMA group died within 30 days aft er the 
operati on due to postoperati ve complicati ons (2%). 90-day mortality was 0%in the ETE group 
versus 8% in the SMA group (p=0.118). The incidence of other postoperati ve complicati ons 
was not stati sti cally signifi cant diff erent between the groups (Table 3.)
disCussion
This study shows no stati sti cally signifi cant diff erence in anastomoti c leak rate between a 
cervical ETE and SMA aft er esophagectomy with gastric tube reconstructi on. The leak rate 
in this study of 20-24% is high, but comparable to a previous study from our group.19 The 
present study could not confi rm the hypothesis that SMA reduces the leak rate as reported by 
others17, 20. Before start of the study the experience of the surgical team with SMA was limited. 
figure 2. Photograph of the ETE-anastomosis. figure 3. Photograph of the SMA-anastomosis
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A senior surgeon from another surgical unit (Leuven, Belgium) who had a vast experience in 
SMA technique taught the study coordinator (BPLW) the details of the procedure.  During the 
study period, all anastomoses were created or supervised by a staff surgeon. Despite this, 
the learning curve for SMA may not have been passed yet and minor but crucial details in the 
construction of SMA may have been missed. However, the leak rate did not change during 
the study period.  One could argue though, that a longer pre-trial learning period should have 
been introduced to optimize the surgical technique before the start of the trial. 
Other studies using the SMA technique show lower leak rates (between 4 and 16%).21-24 The 
difference with the present study could be explained by the diligent way we scored the post-
operative complications and the prospective study design. Also, the term ‘semi-mechanical 
anastomosis‘ includes many different techniques that have similarities (usually side to side) 
but also differ in details (single versus double layered) between the studies that describe this 
technique. Hence, a comparison of the leak rate in our study with other studies is difficult. 
The leak rate of 20% in the ETE group is within the range reported in the literature. 
This is not the first trial comparing a hand-sewn anastomosis with a (semi-)mechanical anas-
tomosis. Again, the interpretation and clinical applicability of these studies and meta-analyses 
is difficult due to the different techniques used, varying definitions of leaks and strictures 
and different periods of follow up. Although previous studies have compared a hand-sewn 
end-to-side anastomosis with a circular stapled25, 26 or linear stapled anastomosis.17, 20-24, 27, 28 
In 2005, Ercan et al.22 published a cohort study of 274 patients and showed a benefit in post-
operative morbidity for the SMA (modified Collard technique) anastomosis compared to the 
hand-sewn technique. Other studies reported a low leak rate of a V-shaped SMA (modified 
Collard, Collard, Orringer, linear stapled) (5%), and described it as a major refinement of the 
surgical technique17, 20, 21, 24. Meta-analyses25, 27, 28, however, showed no statistically significant 
difference in anastomotic leakage or 3-month mortality between several techniques (circu-
lar stapled, linear stapled or hand-sewn).  A systematic review, published in 2010 showed 
a lower stricture rate in the hand-sewn group, but also concluded that there is insufficient 
evidence to recommend one anastomotic technique over the other.23 Another review showed 
an increased rate of postoperative anastomotic stricture, but shorter operating time for the 
stapled technique.29 
Dysphagia, often defined as a need for dilatation, is between 4 and 63% for patients using the 
SMA technique and 16-88% in patients with a hand-sewn anastomosis at 1 year.23, 30-32 The 
lower limit of the published percentages corresponds to studies with a short follow up (2-3 
months postoperatively). The upper margin of patients with dysphagia is derived from studies 
with follow up until 12 months postoperatively and therefore is comparable to the present 
study. Our data show a trend towards a lower percentage of patients with dysphagia in the 
SMA group. The theoretical concept of SMA is to create a wide, triangular V-shaped connec-
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tion between the gastric tube and esophagus and this might translate in reduced stricture of 
the anastomosis.  The difference between the groups was not statistically significant however, 
which may be due to the smaller sample size than anticipated. However, the number of dilata-
tions needed was less in the SMA group.
The major limitation of the present study is that it was decided to stop it prematurely because 
of slow accrual.  Hence, the anticipated number of patients to be enrolled was not met and 
the study is underpowered to show a statistically significant difference (if any) in leak rate. The 
reasons for the slow accrual were changes in regional organization and referral of esophageal 
cancer patients and a shift towards more complex patients that were not eligible for participa-
tion in the study took place. Hence, the Data Safety Monitoring Board advised the steering 
committee of the study to end the study prematurely. 
Although there was no significant difference in postoperative morbidity or mortality be-
tween the groups, the present study reports high complication rates after esophagectomy 
with gastric tube reconstruction. The prospective design of the study warrant detailed and 
timely reporting of all adverse events according to good clinical practice guidelines. Hence, 
the data reflect real practice and are in line with our nationwide prospective Dutch Upper GI 
Cancer Audit (DUCA).33
With an absolute difference of 4% and a 95% confidence interval of -13% to 21% for 
anastomotic leakage, absolute differences larger than 21% in favor of the SMA and of 13% 
in favor of ETE are unlikely. This study was underpowered to show statistically significant 
smaller differences in leak rates and it should be concluded that superiority or inferiority of 
any technique cannot be proven. A futility analysis can be done to calculate the chance for 
the trial to be successful if one would proceed with the study based on the numbers from an 
interim analysis. However, given the fact that the decision was taken to stop the trial due to 
slow accrual, a futility analysis is not useful for better interpretation of the data.
 It is unlikely that a larger study will be initiated. At least in the Netherlands, most centers 
are moving towards an intra-thoracic anastomosis (Ivor Lewis esophagectomy) instead of the 
three stage McKeown with cervical anastomosis. A recently started Dutch RCT will answer the 
question whether leak rate, stenosis and quality of life are better in patients with an intratho-
racic anastomosis compared to a cervical anastomosis (ICAN study, trial register NTR4333). 
In conclusion, this study shows no significant differences in postoperative complications 
between a hand-sewn or semi-mechanic stapled anastomosis, but is underpowered due to 
premature ending of the study. 
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abstraCt 
Background: A segment of colon can be used for reconstruction of the digestive tract after 
esophagectomy. This retrospective study assessed the indications and outcome after colon 
interposition performed in a tertiary referral center. 
Methods: All patients who underwent esophagectomy with colon interposition between 
1976 and 2016 at the Erasmus MC University Medical Center Rotterdam were identified from 
an institutional database. Data on patients characteristics, operative details, morbidity and 
mortality were retrieved from the database and patients’ charts. 
Results: 126 patients were included. Indications for colon interposition were failed gastric 
tube reconstruction (n = 18), previous gastric surgery (n = 48), esophagectomy with total 
gastrectomy for cancer (n = 40), caustic injury (n = 6) and other reasons (n = 8). Postoperative 
in-hospital mortality was 18% (23 patients). Morbidity was 66%. The most prevalent compli-
cations were pneumonia in 40 patients (32%) and anastomotic leakage in 24 patients (19%).
Conclusion: The use of a colon conduit after esophagectomy is associated with a high mortal-
ity and morbidity but it is a viable option for reconstruction of the upper gastrointestinal tract.
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introduCtion
Esophagectomy has an important place in the curative treatment of esophageal cancer and 
may be indicated for benign disorders.1,2 In the beginning of the previous century, the use of 
a segment of colon for reconstruction after esophagectomy was introduced. The technical 
details were first reported by Kelling3 and Vulliet4 in 1911. 
Theoretical advantages of colon interposition are the abundant length and the reliable 
blood supply. Furthermore, in patients that undergo neoadjuvant (chemo)radiation therapy 
for esophageal cancer, the colon is not at risk for radiation-induced damage with a possible 
impact on perturbed anastomotic healing. However, colon interposition is associated with a 
high rate of postoperative complications including leakage, pneumonia and prolonged ileus.5
Although health-related quality of life after colon interposition is at least equal compared 
to gastric tube reconstruction, gastric tube interposition is nowadays considered the standard 
technique for reconstruction after esophagectomy. The stomach is often available and easily 
mobilized via a laparotomy or laparoscopy. Gastric tube reconstruction requires just a single 
anastomosis with the esophageal remnant. A disadvantage of using a gastric tube is gastro-
duodenal reflux with possible aspiration or the re-development of Barrett’s esophagus in the 
esophageal remnant.6, 7
At present, colon interposition is only used for reconstruction due to previous gastric resec-
tions, incomplete vascularization of the stomach and patients that need an esophagogastrec-
tomy for malignant or benign disorders.8-13 There have been few reports in the literature about 
the indications and outcome of patients after colon interposition. The aim of this study was 
to report the indications, operative details and morbidity and mortality of colon interposition 
over a 40-year period. 
patiEnts and mEthods
All patients who underwent a colon interposition after esophagectomy between 1976 and 
2016 were identified from a prospective institutional database. Preoperative, peroperative 
and postoperative data were collected by a data manager who reviewed all patients that were 
discharged from the hospital on a weekly basis. Demographic data included patient’s age, 
gender and comorbidities. Tumor stage was determined after preoperative examinations that 
changed over the study period. In general, physical examination, standard laboratory tests 
and chest X-ray were performed in all patients. CT scan for staging esophageal cancer was in-
troduced in 1980, later in time (since 1991) followed by endosonography. A colonoscopy was 
not routinely performed but indicated when colon neoplasms were suspected on clinical or 
radiological grounds. A CT-angiography to assess the vasculature of the colon was performed 
in individual cases prior to surgery.
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Postoperative complications included surgical complications (anastomotic leakage, re-
operation, colon necrosis, chyle leakage, bleeding, vocal cord palsy) as well as non-surgical 
complications (cardiac and pulmonary complications). Complications were retrieved from the 
patient’s notes and entered in the database by the data manager. The attending surgeon at 
the time reviewed and evaluated all data entered in the database.
Surgical procedure 
The surgical approach for esophagectomy included transhiatal, transthoracic and thora-
coabdominal (left sided) resections. For preparation of the colon conduit, a laparotomy was 
performed. The greater omentum was dissected of the transverse colon. The right and left 
colon were fully mobilized. The adequacy of graft vascularity was assessed by temporary 
vascular occlusion. Pulsations of the marginal artery were palpated and the Doppler was 
used in some patients when there was doubt about the patency of the mesenteric vessels. 
Attention was also paid to the degree of venous distension. The choice for which segment of 
the colon (right, transverse or left) was used, was determined by the length and quality of the 
arterial and venous blood supply as well personal preference of the surgeon. The graft was 
brought up to the neck by the retrosternal, prevertebral or subcutaneous route. A single layer 
hand-sewn anastomosis was performed with the remnant esophagus. The segment of colon 
was distally anastomosed to either the remnant of the stomach or a Roux-and-Y reconstruc-
tion. Postoperative management included transfer to the Intensive Care Unit. No additional 
routine examinations were carried out apart from a swallow X-ray on day 7 postoperatively 
in most patients.
Statistical analysis
Values are shown as means and standard deviation (SD) or medians with their range, as ap-
propriate. Groups were compared using non-parametrical Mann-Whitney-U test or Student’s 
T-test, if normally distributed. For cross tabulations, Pearson’s chi-squared test with conti-
nuity correction or Fisher’s exact test was used, as appropriate. All statistical analyses were 
performed on the statistical package SPSS 20.0 (SPSS Inc, Chicago, Illinois, USA). A p-value < 
0.05 was considered statistically significant.
rEsults
Patients
In total, 126 patients underwent colon interposition for restoration of continuity after 
esophagectomy. There were 95 (75%) men and 31 (25%) women and the median (range) age 
was 61 yrs. (28-79). The indication for esophagectomy was malignant disease in 114 of 126 
patients (90%; Table 1). A previous gastrectomy was the main reason for choosing a segment 
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of colon for reconstruction (48 of 126 patients) followed by esophagectomy with (sub)total 
gastrectomy for locally advanced malignant disease (40 of 126). In 18 patients, reconstruction 
with a gastric tube had failed due to necrosis of the conduit and colon interposition was 
necessary at a later stage after resection of the gastric conduit (Table 1). 
Operative characteristics
In 72 of 126 patients (58%) the descending colon or transverse with part of the descending 
colon was used. In 66 of 126 patients (52%) in the prevertebral route was chosen to bring the 
colon segment up to the neck. For secondary reconstruction, the retrosternal or subcutane-
ous route was always used. Operative characteristics are shown in Table 2.
Morbidity and mortality
In 83 of 126 patients (66%), one or more complications occurred. Surgical complications were 
seen in 45 patients (36%). Reoperations were needed in 23 of 126 patients (18%). A reopera-
table 1. Patient and tumor characteristics
n=126
Gender (male: female) 95:31
Age (years) median, [range] 61 [28-79]
Comorbidity
- Diabetes 6 (5%)
- COPD 15 (12%)
- Cardiovascular disease (atrial fibrillation, heart failure, infarct) 22 (18%)
- Medical history with malignant tumor 31 (25%)
Neoadjuvant therapy
- None 54 (44%)
- Chemotherapy 15 (12%)
- Radiotherapy 51 (41%)
- Chemo radiation 4 (3%)
- Unknown 2 (2%)
Operation indication
- Necrotic gastric tube 18 (15%)
- Intraoperatively stomach tube judged as inadequate due to ischemia 5 (4%)
- Previous (partial) gastrectomy 48 (39%)
- Tumor with invasion of esophagus and stomach 40 (32%)
- Caustic injury 6 (5%)
- Previous Whipple-procedure 1 (1%)
- Colon as first choice 2 (2%)
- Unknown 6 (5%)
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tion for leakage was performed in 13 (10%) patients. Other reasons include chyle leak (2%), 
bleeding (4%), fascia dehiscence (5%), internal herniation (4%) and bowel perforation (2%). 
Some 57 patients (45%) had non-surgical complications mainly pulmonary and cardiac 
complications. 
In-hospital mortality was 18%. Four patients died as a result of anastomotic leakage, two 
patients because of progressive metastatic disease, seven patients of necrosis of the colon 
interposition and eight patients died of sepsis with underlying pulmonary complications. Two 
patients died because of a fistula between the colon conduit and trachea. 
Between 1976 and 2001, 94 patients (75%) underwent a colon interposition, and in the 
last 15 years (2001-2016) 32 patients (25%). Morbidity and mortality was similar between 
the groups.
table 2. Details of the operation
n=126
Segment of colon used for reconstruction
- Ascending colon 40 (33%)
- Transverse colon 11 (9%)
- Descending colon 40 (33%)
- Transverse and descending colon 35 (28%)
Surgical approach
- Transthoracic 50 (40%)
- Transhiatal 75 (60%)
- Unknown 1 (1%)
Position of graft
- An-isoperistaltic 27 (21%)
- Isoperistaltic 36 (29%)
- Unknown 63 (50%)
Anastomosis in the neck (esophago-colostomy)
- End-to-End 74 (59%)
- End-to-Side 18 (14%)
- Unknown 34 (27%)
Drainage of colon conduit
- Roux-Y reconstruction 90 (71%)
- Stomach remnant 33 (26%)
- Unknown 3 (3%)
Route of conduit
- Retrosternal 44 (35%)
- Pre-vertebral 66 (52%)
- Subcutaneous 9 (7%)
- Unknown 7 (6%)
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table 3. Postoperative complications
Complication no. of patients (%)
Any complication 83 (66%)
Leakage of the anastomosis 24 (19%)
Necrosis of colon interposition 8 (6%)
Chyle leakage 3 (3%)
Vocal cord palsy 11 (9%)
Fascia dehiscence 9 (7%)
Prolonged ileus 12 (10%)
Pneumonia 40 (32%)
Mediastinitis 9 (7%)
Cardiac complications (atrial fibrillation, heart failure, infarct) 21 (17%)
Sepsis 20 (16%)
Thrombo-embolic event 5 (4%)
Delirium 7 (6%)
In-hospital mortality 23 (18%)
table 4. Overview of the literature
author no. of patients mortality morbidity anastomotic 
leak
necrosis of 
conduit
Briel21 393 4.7% NR 10.9% 9.2%
Cerfolio20 32 9.4% 24% 3.3% 9.4%
Curet-Scot23 53 3.8% 43% 9.4% NR
DeMeester7 92 9% 15.2% 4% 7.6%
Doki9 28 NR 71% 46% NR
Furst24 53 9.4% 60.3% 16% 1.6%
Hamai25 40 2.5% 45% 17.5% 5.0%
Thomas26 60 8.3% 65% 10% NR
Wain27 52 4% 67% 5.8% 9.6%
Isolaura28 248 16% 37% 4% 3%
Fujita29 53 17 NR 22.6% 5.7%
Kolh30 38 2.5% 26% 0% 0%
Hagen31 72 5.6% 75% 12.5% 5.6%
DeMeester6 85 4.7% NR 9.4% NR
Davis5 42 16.7% NR 14.3% 2.4%
Popovici32 347 4.6% NR 6.9% 1.9%
Shirakawa33 51 0% 23.5% 7.8% 0%
Knezevic12 336 4.2% 26.5% 9.2% 2.4%
Motoyama34 34 0% NR 9% 0%
Mine35 95 5.3% 64.2% 13% 0%
Klink11 43 16% 61% 30% 9%
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disCussion
This retrospective study shows that morbidity and mortality of colon interposition after 
esophagectomy is high: two-thirds of patients had one or more complication. The most com-
mon adverse events were pulmonary and cardiac complications. Although, the type complica-
tion was not completely specified in our database in the early years of registration, data from 
previous studies from our center indicate that pulmonary include pneumonia, atelectasis as 
well as persistent pleural effusion that needs drainage. The cardiac complications are mostly 
classified as dysrhythmias.14, 15 In-hospital mortality was 18% and this is high compared to 
standard esophagectomy with gastric tube reconstruction. A recent audit from the Nether-
lands showed that postoperative mortality after esophagectomy (years 2011-2014) is around 
4%.16 The discrepancy may be explained by the poorer general health status of the patients 
in the present study. Some 40 patients had tumor invasion of the esophagus and stomach in 
such a way that esophagectomy and total gastrectomy was needed. 
These patients may be more frail and suffer from malnutrition given the extensive tu-
mor load. Other patients had previous abdominal operations (including failed gastric tube 
reconstruction) in the past that may have contributed to a poorer performance status and 
increased risk for complications. Patients age was equal compared to patients that undergo 
esophagectomy with successful gastric tube reconstruction. 
Also, a time effect may be responsible for the high morbidity and mortality. However, 
mortality was 19% between the years 1976 and 2001 and 16% in the later time period. Over 
40 years, several changes in surgical techniques have taken place including use of surgical 
devices that minimize blood loss, less liberal fluid administration and the use of enhanced 
recovery protocols after esophagectomy that may have contributed to better outcomes. 
However, these possible benefits do not translate in better outcomes in the present study. 
Minimally invasive surgery for esophageal cancer is associated with shorter hospital stay 
and less complications.17 All patients in this cohort had a laparotomy for preparation of the 
conduit. This seems inevitable given the previous surgeries and intraoperative assessment of 
colon vascularization. Laparoscopic colon mobilization and colon segmental interposition in 
adults has not been published before but recently in children this approach was described.18 
Table 4 shows morbidity and mortality rates reported by other studies. There is a wide 
variation in mortality (0-16%) and morbidity (15-71%) rates. Differences in definitions used 
as well as incomplete reporting due to the retrospective nature of the study may explain 
this. As shown by a Dutch prospective database on esophageal cancer resections, rates of 
complications are over 60% and this is higher than previous reports from single center studies 
that claim complication rates as low as 30 to 50% (16).
Several studies showed that a single dose of steroid preoperatively could reduce the compli-
cation rate in patients that undergo an esophagectomy. A meta-analysis however concluded 
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that well designed studies are still needed to substantiate the claimed benefit of steroid 
administration.19 Whether preoperative angiography is required to plan surgical treatment 
remains debatable. Some authors are very much in favor because this may guide the surgeons 
to get the most optimal graft. We feel that this does not replace intraoperative thorough 
assessment of the colon vascularization. Full mobilization of the right and left colon and tem-
porary clamping of the mesenteric vessels is still needed before a definite decision is made 
on the segment used for transposition to the neck. The rate of anastomotic leakage and colon 
conduit ischemia in our series was within the range of other studies. 
Colon interposition is a challenging operation. Not only an esophago-colostomy is created but 
the colon is often anastomosed to a Roux-and-Y loop. Hence, several intestinal anastomoses 
are created which all are at risk for anastomotic leakage. Leakage occurred in 19% of our 
patients and is a risk factor for mortality. Although in some patients, anastomotic leaks can be 
treated with a conservative management, reoperation or reinterventions are needed, as was 
the case in 10% of our patients. Given the complexity and rare indication for colon interposi-
tion, the Dutch guidelines for the treatment of esophageal cancer support the centralization 
of the procedure in just a few hospitals in the Netherlands. This study supports this view given 
the still high morbidity and mortality rate.5, 20, 21 
Limitations of this study are the long study period and the changes in surgical techniques and 
care for the patients over time. Also, neoadjuvant treatment for esophageal cancer is now 
standard of care in many countries and this may impact on complications.22 Furthermore, the 
study patients are heterogeneous in terms of indication for surgery (benign and malignant 
disease) and despite the use of an institutional database this study is retrospective. However, 
the prospective database gave us the opportunity to report on rather detailed outcome 
measures assessed by a dedicated data manager. The present series is still the largest series 
reported in the literature so far. 
In summary, colon interposition is accompanied by a substantial morbidity and mortality 
but in selected patients, the colon interposition remains the only option for restoration of 
continuity of the upper gastrointestinal tract after esophagectomy. Attempt to minimize surgi-
cal trauma, enhanced recovery of the patient and improvement of perioperative care may 
improve the outcome for these patients.
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abstraCt 
Background: Anastomotic leakage is a severe complication after esophagectomy. The objec-
tive was to investigate the diagnostic and predictive value of routine contrast swallow study 
and endoscopy for the detection of anastomotic dehiscence in patients after esophagectomy.
Methods: All patients who underwent contrast swallow and/or endoscopy within 7 days after 
esophagectomy for cancer between January 2005 and December 2009 were selected from 
an institutional database. 
Results: Some 173 patients underwent endoscopy and 184 patients underwent a contrast 
swallow study. The sensitivity of endoscopy for anastomotic leakage requiring intervention is 
56%, specificity 41%, positive predictive value (PPV) 8% and negative predictive value (NPV) 
95%. The sensitivity of contrast swallow study for detecting leakage requiring intervention in 
patients without signs of leakage was 16%, specificity 75%, PPV 11% and NPV 83%. 
Conclusion: In patients without clinical suspicion of leakage, there is no benefit to perform 
routine examinations.
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introduCtion
Leakage of the cervical esophagogastrostomy after esophagectomy with gastric tube re-
construction occurs in 5-25% of patients, and is associated with significant morbidity and 
accounts for 25-50% of postoperative deaths.1-3 Signs and symptoms of anastomotic leakage 
are fever, tachycardia and manifestations at the surgical site including redness, swelling and 
drainage of saliva and pus. Appropriate local drainage, intravenous antibiotics and enteric 
tube feeding or parental nutrition can manage the majority of anastomotic leakages conser-
vatively. Sometimes, surgical or radiological intervention may be required. In order to detect 
anastomotic leakage before clinical signs develop and the patients deteriorate, contrast swal-
low and/or endoscopy are often performed within the first week after surgery. However, it has 
been reported that contrast swallow studies have a low sensitivity and specificity, failing to 
contribute to clinical decision making. There is also a risk of aspiration leading to pulmonary 
complications.4-8 Upper gastrointestinal endoscopy (GI) has the advantage of direct visualiza-
tion and quantification of dehiscence, necrosis or ulcers and it may be performed in patients 
who are sedated and intubated. 8-11 On the other hand, there is a fear of iatrogenic injuries 
and worsening of the anastomotic dehiscence. 
The objective of this study is to investigate the diagnostic and predictive value of routine 
contrast swallow study and endoscopy in the postoperative management of patients with a 
cervical anastomosis after esophagectomy and gastric tube reconstruction (GTR) for esopha-
geal carcinoma. Our hypothesis was that routine diagnostic studies do not contribute to the 
early detection of anastomotic leakage. 
mEthods
In this retrospective cohort study, all patients who underwent esophagectomy with gastric 
tube reconstruction and a cervical anastomosis for esophageal cancer at the Erasmus 
University Medical Center Rotterdam between January 2005 and December 2009 were in-
cluded. Patient’s demographics, treatment characteristics were retrieved from a prospective, 
institutional database. This database includes age, sex, medical history, operative approach, 
site (neck or thorax) and type of anastomosis (end-to-end or end-to-side), and details on 
postoperative follow-up including complications and their treatment. As part of the postop-
erative protocol, patients were scheduled for a contrast swallow study and endoscopy 7 days 
postoperatively. 
Surgical technique
For tumors at the gastro-esophageal junction, a transhiatal esophagectomy was preferred. 
Tumors of the mid and distal esophagus were resected by a right transthoracic approach. 
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All operations were supervised by one of two specialized senior gastro-intestinal surgeons. 
A gastric tube was created by the aid of a linear stapling device, TLC 55 (Ethicon, Johnson & 
Johnson, Amersfoort, The Netherlands) or 60 mm GIA (Autosuture, Covidien, Zaltbommel, 
The Netherlands), making a 3-4 cm wide tube along the greater curvature of the stomach. 
During the period the study was done the neck incision is routinely closed with subcuticular 
stitch. Drains were not routinely placed. The anastomosis was not reinforced with an omental 
flap or other vascularized tissues. The cervical anastomosis was created end-to-end (ETE) or 
end-to-side (ETS) with a running PDS 3/0 suture (Ethicon, Johnson & Johnson, Amersfoort, 
The Netherlands) depending on the preference of the surgeon or as part of a previously 
published randomized controlled trial.12
Postoperative management
Until anastomotic integrity was proven by contrast swallow or endoscopy patients were fed 
through a nasojejunal feeding tube with the distal tip situated and fixated in the jejunum and 
kept nil by mouth. As part of the standardized clinical pathway, a contrast swallow and/or an 
endoscopy before commencing oral intake were done. This was scheduled around postopera-
tive day 7, but in some patients it was delayed due to logistical reasons. When endoscopy 
and/or contrast swallow confirmed integrity of the anastomosis, or in case of a minor anas-
tomotic dehiscence (dehiscence of less than ¼ of the circumference) without signs of sepsis, 
oral feeding was gradually resumed, starting with sips of water on the 7th postoperative day. 
Treatment of an anastomotic leakage depended on the presence of local and/or systemic 
manifestations of the leakage. In all patients the cervical wound was opened for drainage. 
In patients with a mediastinal abscess antibiotic treatment with percutaneous drainage was 
performed. In case of circular necrosis of the conduit, surgical treatment such as a revision of 
the anastomosis or takedown under general anesthesia was indicated.
Contrast swallow
Contrast swallow studies were performed using visipaque water-soluble contrast media 
(VisipaqueTM Iodixanol, GE Healthcare). The patient was instructed to swallow 200 ml of 
contrast fluid while the attending radiographer made the X-rays from three different posi-
tions (anterior-posterior, lateral and 270 degrees). The radiologist reported on the findings of 
the study with the attending surgeon at the day of the examination. Some patients received 
prophylactic antibiotic treatment when aspiration occurred, based on clinical judgment.
Upper gastrointestinal endoscopy
A trained specialist according to the hospital’s protocol performed endoscopy. If requested, 
patients were sedated. A gastrointestinal videoscope was introduced to assess the integrity 
and aspect of the esophagogastric anastomosis and gastric tube by the attending consultant 
gastroenterologist. 
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Definitions of anastomotic leakage
A clinical leak was defined according to Bruce et al.13 by ‘drainage of saliva or gastrointestinal 
content from the surgical join between the esophagus and gastric tube. Contents may emerge 
either through the wound or at the wound site, or may be collected near the anastomosis 
with or without systemic complications. Clinical leakage was defined as presence of luminal 
contents through the drain or wound site causing local inflammation, e.g. fever (temperature 
> 38.0°C) or leukocytosis (white cell count > 10,000/liter)’. Radiological leakage was defined 
as extra luminal contrast on contrast swallow study not due to aspiration, as judged by the 
attending radiologist. For endoscopy, leakage was defined as a partial or complete dehis-
cence of the esophagogastric anastomosis. Local necrosis, ischemia and ulcers without a 
visible dehiscence defined preliminary signs, and considered as an abnormal endoscopy. The 
gastroenterologist and radiologist were not aware about the results of the contrast swallow 
or endoscopy, whichever was done first.
The contrast swallow or endoscopy was considered true positive when the test showed 
anastomotic dehiscence and patients developed a clinical leak (Grade I-IV according to Cla-
vien- Dindo). When normal oral intake was started and patients did not showed signs of a 
clinical or endoscopic leak, the modality was considered false positive. The study modality 
was considered false negative if, despite normal swallow and/or endoscopy, patients devel-
oped clinical signs of leakage. It was considered true negative when patients did not develop 
a clinical leak. Leakage originating from the blind end of the gastric tube in patients with an 
end-to-side anastomosis was also considered as anastomotic leakage. An intervention was 
defined as all surgical and radiological interventions for anastomotic leakage (Clavien-Dindo 
grade I or higher) including opening the neck wound at bedside. 
Comprehensive Complication Index
Each postoperative event in each patient was assessed, and graded according to the Clavien-
Dindo classification. The Comprehensive Complication Index (CCI) is calculated as the sum 
of all complications that are weighted for their severity by patients and physicians. The final 
formula yields a score from 0 (no complication) to 100 (death). It summarizes the entire 
postoperative experience of the patient with respect to complications. 
Statistical analysis
Values are shown as means and standard deviation (SD) or as medians with their inter-quartile 
range, as appropriate. Groups were compared using non-parametrical Mann-Whitney U test 
or Student’s T-test, if normally distributed. For cross tabulations, Pearson’s Chi Square test 
with continuity correction was used. All statistical analyses were performed on the statistical 
package SPSS 20.0 (SPSS Inc, Chicago, Illinois, USA). A p-value < 0.05 was considered sta-
tistically significant. To rule out systematic differences between groups, a logistic regression 
method was used to compare groups regarding the prevalence of leakage as well as other 
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contributors, such as gender, neoadjuvant treatment, anastomosis, surgical approach and 
comorbidity and radical resection.
rEsults
Between January 1st 2005 and December 31st 2009, 308 patients underwent esophagectomy 
with gastric tube reconstruction and a cervical anastomosis. Some 173 patients underwent 
upper endoscopy, 184 patients underwent a contrast swallow and 95 patients had both 
examinations done. The median (range) time between the operation and diagnostic test 
was 7 [6-12] days. Reasons for delay beyond postoperative day 7 of the contrast swallow or 
endoscopy were: leakage already clinically evident, patient on the ventilator in ICU, logistic 
reasons and patients were too sick to undergo an endoscopy or contrast swallow. The logistic 
regression test performed to compare equality between patient populations in the two 
groups had a log likelihood of 319,417, and as shown in Table 3, no statistical differences 
were found between groups. 
Endoscopy
Clinical signs of anastomotic leakage were present in 23 of 173 patients (13%). In 14 of 23 
patients (61%), anastomotic dehiscence, ischemia of the gastric tube, ulcers and/or necrosis 
was confirmed by endoscopy and 9 patients (64%) required a reoperation (take down of the 
anastomosis (n = 1) and revision of the anastomosis (n = 5), opening neck wound (n = 3). In 
9 patients a normal anastomosis was seen by endoscopy. Of the 9 patients with a normal 
endoscopy, 5 patients required an intervention (revision of the anastomosis (n = 1), drainage 
of mediastinal abscess (n = 1), opening neck wound (n = 3)) (Figure 1). 
In 63 of 150 patients (42%) without a suspicion for leakage, an abnormal endoscopy was 
reported and 10 patients (16%) developed a clinical leak requiring an intervention (revision 
(n = 2) or takedown of the anastomosis (n = 3), or opening neck wound (n = 5)) (Figure 1). 
In 87 patients endoscopy showed a normal anastomosis but 12 patients (14%) required an 
intervention at a later time point for a clinical leak (stent placement (n = 2), disconnection 
of the anastomosis (n = 1), revision of the anastomosis (n = 1), opening neck wound (n = 8)) 
The sensitivity of endoscopy for detecting leakage (requiring intervention) in patients 
without clinical leakage is 45%, specificity 41%, positive predictive value 16% and negative 
predictive value 86% (Table 1.). 
Contrast swallow
In 15 patients, the contrast swallow study could not be evaluated due to aspiration during 
the study. Therefore, these 15 patients were excluded from the analysis. In 6 of 169 patients 
(4%) clinical leakage was present at time of the contrast swallow study and this was confirmed 
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with contrast swallow in 3 patients (Figure 2). Two patients required percutaneous CT-guided 
drainage of an abscess caused by anastomotic leakage.
In 37 of 163 patients (23%) without clinical leakage, radiological leakage was diagnosed by 
contrast swallow study. One of these patients required endoscopic stenting of the anastomo-
sis. Some 127 patients (78%) had no leakage on contrast swallow study and 21 patients (17%) 
required an intervention (revision (n = 2) or takedown of the anastomosis (n = 2), opening 
neck wound (n = 17)).
The sensitivity of the contrast swallow study for detecting leakage requiring intervention in 
patients without signs of leakage was 16%, specificity 75%, PPV 11% and NPV 83% (Table 2). 
Table 3 shows the incidence of tumor characteristics and postoperative complications di-
vided into ‘leakage’ and ‘no leakage’ groups for endoscopy, Table 4 for contrast swallow study. 
figure 1. Flowchart of patients; routine endoscopy
table 1. Endoscopy
leakage + leakage -
Endoscopy + 10 (7%) 53 (35%) 63 (42%)
Endoscopy - 12 (8%) 75 (50%) 87 (58%)
22 (15%) 128 (85%) 150
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figure 2. Flowchart of patients; routine contrast swallow study
table 2. Contrast swallow study
leakage + leakage -
Contrast swallow + 4 (2%) 33 (20%) 37 (22%)
Contrast swallow - 21 (13%) 105 (64%) 132 (80%)
25 (15%) 138 (85%) 163 
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table 3. Endoscopy group; details (n = 173)
leakage (n=36) no leakage (n=137) p-value
Age (yr.) median [range]
Sex (M:F) 29:7 104:33 0.66
Histology 0.65
-  Squamous cell carcinoma 7 (19%) 32 (23%)
-  Adenocarcinoma 28 (77%) 104 (76%)
-  No malignancy after neoadjuvant treatment 1 (4%) 3 (1%)
Tumor site 0.08
-  Esophagus 33 (92%) 115 (85%)
-  Gastro-esophageal junction 0 (0%) 15 (11%)
-  Gastric cardia 3 (8%) 7 (4%)
Tumor Stage 0.27
-  0 1 (4%) 4 (3%)
-  I 3 (9%) 11 (8%)
-  IIA 4 (11%) 35 (26%)
-  IIB 3 (9%) 10 (7%)
-  III 15 (42%) 38 (28%)
-  IVA 10 (25%) 36 (27%)
-  IVB 0 (0%) 2 (1%)
Radical resection (pR0) 26 (72%) 104 (76%) 0.73
(Neo) adjuvant treatment 10 (27%) 43 (32%) 0.81
-  Chemoradiation 3 (8%) 18 (13%)
-  Chemotherapy 7 (19%) 25 (18%)
-  None
Comorbidity 17 (47%) 51 (38%) 0.82
-  Cardiovascular 10 (27%) 25 (18%)
-  Respiratory 3 (9%) 13 (10%)
-  Diabetes Mellitus 1 (2%) 5 (4%)
-  Malignancy 3 (9%) 8 (6%)
Surgical approach 0.46
-  Transhiatal esophagectomy 20 (55%) 88 (65%)
-  Transthoracic esophagectomy 16 (45%) 49 (35%)
Anastomosis 0.26
-  End-to-end 14 (39%) 70 (53%)
-  End-to-side 22 (61%) 65 (47%)
Complications 36 (100%) 102 (74%) 0.001
Mediastinitis 18 (50%) 17 (12%) <0.001
Pneumonia 15 (42%) 49 (36%) 0.56
Delirium 11 (31%) 17 (12%) 0.012
Sepsis 8 (22%) 6 (4%) 0.002
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CCI
All complications of surgery were graded using the Clavien-Dindo classification and the CCI 
was calculated for each patient. 
In patients without clinical leakage, the median CCI for patients with an abnormal endos-
copy was 22.6 (IQR 8.7-44.9) Patients with a normal endoscopy without clinical leakage have 
a median CCI of 20.9 (IQR 0-26.2) Independently, this difference was statistically significant (p 
= 0.004). In patients without clinical leakage, the median CCI for patients with an abnormal 
contrast swallow study was 20.9 (0-29.6) as compared to patients with a normal contrast 
swallow without clinical leakage CCI 8.7 (0-22.6) with p = 0.027. 
disCussion
The present study shows that patients without signs or symptoms suggestive of an anasto-
motic leakage do not benefit from a contrast swallow or upper endoscopy for identifying leaks 
that require operative or endoscopic interventions. Whilst endoscopy and contrast swallow 
do show abnormalities in 42 and 20% of patients, respectively, it does not lead to a change 
in (conservative) patient management. Hence, aggressive radiological or surgical treatment 
of patients with abnormal endoscopic findings or contrast swallow does not seem to be indi-
cated. In only a few patients, interventions for anastomotic leakage are needed in due time. 
On the other hand, if endoscopy or the contrast swallow study do not show any abnor-
malities, this does not fully exclude the development of anastomotic leakage and subsequent 
interventions are needed in 5 and 3% of patients respectively (false negative test). The CCI for 
asymptomatic patients differs significantly for patients without clinical signs of leakage. Even 
though this difference does not reflect in interventions, it is possible that small, subclinical 
leakages result in other complications; such as a mediastinitis or pneumonia. Furthermore, 
the CCI is known to be a very sensitive endpoint, as it takes all postoperative complications 
into account. Still, close surveillance and early recognition of a complication including anasto-
motic leaks are of utmost importance for best outcomes.
table 3. Endoscopy group; details (n = 173) (continued)
leakage (n=36) no leakage (n=137) p-value
Multiorgan failure 4 (11%) 3 (2%) 0.035
Vocal cord palsy 1 (3%) 17 (12%) 0.13
Bleeding 2 (6%) 5 (4%) 0.64
Chyle leakage 1 (3%) 7 (5%) 0.69
Respiratory insufficiency 12 (33%) 16 (12%) 0.003
Routine endoscopy or contrast swallow after esophagectomy?
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table 4. Contrast swallow group, details (n = 184) (patients with aspiration during contrast swallow included 
(n = 15))
leakage (n=34) no leakage (n=150) p-value
Sex (M:F) 28:6 111:39 0.38
Histology 0.30
-  Squamous cell carcinoma 2 (6%) 32 (21%)
-  Adenocarcinoma 31 (91%) 112 (51%)
-  No malignancy after neoadjuvant treatment 1 (3%) 6 (18%)
Tumor site 0.043
-  Esophagus 27 (79%) 114 (76%)
-  Gastro-esophageal junction 1 (3%) 24 (16%)
-  Gastric cardia 6 (18%) 12 (8%)
Tumor Stage 0.12
-  0 1 (3%) 7 (5%)
-  I 4 (12%) 13 (13%)
-  IIA 1 (3%) 39 (26%)
-  IIB 5 (15%) 14 (9%)
-  III 12 (35%) 40 (27%)
-  IVA 11 (32%) 35 (23%)
-  IVB 0 (0%) 2 (1%)
Radical resection (pR0) 22 (65%) 119 (81%) 0.097
(Neo) adjuvant treatment 0.30
-  Chemoradiation 3 (9%) 28 (19%)
-  Chemotherapy 9 (26%) 29 (19%)
-  None 22 (65%) 93 (62%)
Co morbidity 0.26
-  Cardiovascular 8 (24%) 29 (19%)
-  Respiratory 1 (3%) 9 (6%)
-  Diabetes Mellitus 2 (6%) 4 (2%)
-  Malignancy 0 (0%) 10 (7%)
Operating time (mean) SD and range
Surgical approach 1.0
-  Transhiatal esophagectomy 23 (%) 101 (%)
-  Transthoracic esophagectomy 11 (%) 49 (%)
Anastomosis 0.87
-  End-to-end 19 (%) 80 (57%)
-  End-to-side 15 (%) 69 (%)
Complications 34 (100%) 95 (%) <0.001
Mediastinitis 6 (18%) 5  (3%) 0.006
Pneumonia 6 (18%) 42 (28%) 0.28
Respiratory insufficiency 3 (9%) 4 (3%) 0.12
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A contrast swallow is the most common routine examination after esophageal surgery. It has 
several benefits including the low costs and being a relatively safe first-line investigation with 
a high sensitivity and specificity when interpreted by an experienced radiologist.14 However, 
the disadvantages of aqueous contrast are that it has a low radiographic density and a low 
mucosal adherence, thus limiting the ability to detect leaks, particularly in case of subtle 
ones. Boone et al. presented a low sensitivity and positive predictive value in their series of 
207 patients, and also reported that 53% of patients already showed clinical signs of leakage. 
Doerfer et al. produced comparable results and no longer routinely perform a contrast swal-
low, and prefer a CT with contrast. Tonouchi also reviewed a large series (n=331) and found 
a low sensitivity of routine contrast swallow studies.5-7 Indeed, in the present study contrast 
swallow was reported as normal in 3 patients with clinical suspicion of anastomotic leakage 
but CT-guided drainage of a mediastinal abscess was needed in 2 patients at a later point in 
time. In these patients CT scanning with oral contrast may be superior to a contrast swallow 
as it allows detection of peri-anastomotic and mediastinal fluid collections that may need 
surgical or radiological drainage. Endoscopy is likely to be more useful to assess the severity 
of anastomotic dehiscence in symptomatic patients. In may help selecting patients that need 
surgical revision of the anastomosis including resection of an ischemic segment of the gastric 
tube. These findings are also supported by Oezcelik10, Maïsh11, Schaible8 and Page et al.9, 
who presented their retrospective data and concluded that endoscopy is a safe and accurate 
method to detect early signs of leakage. However, 2 of 8 patients with a normal endoscopy 
developed a clinical leak that needed a surgical intervention and radiological drainage. 
The present study supports the findings of a recent prospective trial that compared the 
accuracy of contrast swallow, CT with oral contrast and endoscopy for the identification of 
anastomotic leaks following esophagogastric surgery.15 The authors concluded that routine 
tests of the anastomotic integrity are unnecessary and, when clinical suspicion is high for 
an anastomotic leak, CT scan is likely the first modality to perform. Our data supports also 
another study that has shown that flexible upper gastrointestinal endoscopy is more specific 
in comparison with a contrast swallow study. While it did not improve the identification of 
table 4. Contrast swallow group, details (n = 184) (patients with aspiration during contrast swallow included 
(n = 15)) (continued)
leakage (n=34) no leakage (n=150) p-value
Delirium 3 (9%) 14 (9%) 1.0
Sepsis 1 (3%) 0 (0%) 0.19
Multiorgan failure 1 (3%) 1 (1%) 0.34
Vocal cord palsy 2 (6%) 17 (11%) 0.38
Bleeding 1 (3%) 3 (2%) 1.0
Chyle leakage 2 (6%) 5 (3%) 0.62
Routine endoscopy or contrast swallow after esophagectomy?
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clinical anastomotic leakage, it was beneficial to detect gastric necrosis or ulcers and guide 
management of these patients. 
There are several limitations of the present study. Being of retrospective nature, clinical 
management of anastomotic leaks may have changed over time. Use of self-expandable 
stents may have led to a decrease of surgical and radiological interventions for anastomotic 
dehiscence. However, within the time period of the study, the surgical experience has not 
changed and also the care pathway has remained the same over time. In order to determine 
the accuracy of diagnostic tests for the assessment of anastomotic leakage, it is of great 
importance to define the study endpoint in a consistent and unambiguous matter. In the 
present study, the definition of Bruce et al.13 was used. However, given the retrospective 
design of the study, misclassification cannot be ruled out. The Erasmus Medical Center is a 
high volume specialized center for upper GI-surgery and radiologists and gastroenterologists 
are well trained in the recognition and treatment of postoperative complications. Hence, our 
data are likely to be externally valid for other specialized centers. 
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list of abbrEviations
CCI Comprehensive Complication Index
RCT randomized controlled trial
LOS length of hospital stay
ICU intensive care unit
ETE end-to-end
ETS end-to-side
HP Hartmann’s Procedure
PA primary anastomosis
SDC Supplemental Digital Content
SD standard deviation
CI confidence interval
IQR interquartile range
mini-abstraCt
This study demonstrates superiority of the new Comprehensive Complication Index (CCI) over 
traditional endpoints in detecting between-group differences in randomized control trials. 
The CCI may therefore serve as preferred endpoint in future RCTs, and may help in designing 
RCTs with smaller sample sizes.
CCI for randomized controlled trials
7
107
abstraCt 
Objective: To test whether the newly developed Comprehensive Complication Index (CCI) is 
more sensitive than traditional endpoints for detecting between-group differences in ran-
domized controlled trials (RCTs).
Background: A major challenge in RCTs is the choice of optimal endpoints to detect treatment 
effects. Mortality is no longer a sufficient marker in studies, and morbidity is often poorly 
defined. The CCI, integrating all complications including their severity in a linear scale ranging 
from 0 (no complication) to 100 (death), is a new tool, which may be more sensitive than 
other traditional endpoints to detect treatment effects on postoperative morbidity.
Methods: The CCI was tested in three published RCTs from European centers evaluating pan-
creas, esophageal or colon resections. To compare the sensitivity of the CCI with traditional 
morbidity endpoints, e.g. presence of any (yes/no) or only the most severe complications, all 
postoperative events were assessed, and the CCI calculated. Treatment effects and sample 
size calculations were compared using the CCI and traditional endpoints. 
Results: While RCTs failed to show between-group differences using any or most severe com-
plications, the CCI revealed significant differences between treatment groups in two RCTs; 
after pancreas (p = 0.009) and esophageal surgery (p = 0.014). The CCI in the RCT on colon 
resections confirmed the absence of between-group differences (p = 0.39). The required 
sample sizes in trials are up to nine-times lower for the CCI than for traditional morbidity 
endpoints.
Conclusions: This study demonstrates superiority of the CCI to traditional endpoints. The CCI 
may serve as an appealing endpoint for future RCTs and may reduce the sample size. 
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introduCtion 
A major challenge in designing randomized controlled trials (RCTs) is the choice for objec-
tive, concise and clinically relevant endpoints. Mortality is no longer an acceptable primary 
endpoint in surgical studies given the sharp decline in mortality for most procedures in the 
past decades. Morbidity is often poorly defined, which has led to inconsistent reporting 
and confusion in the literature.1-7 Furthermore, most authors have reported only the most 
severe complications or only events judged to be relevant, but ignored complications of 
lesser magnitude as well as the total number of complications.5 To address this issue, the 
Comprehensive Complication Index (CCI) was recently introduced. It integrates all postopera-
tive complications with their respective severities, on a scale ranging from 0 (no burden from 
complications) to 100 (death).8  
The CCI, summarizing the entire postoperative experience of the patient with respect to 
complications, is based on the widely established Clavien-Dindo classification.3, 4, 8 Validations 
from four different perspectives showed that the CCI is a valid endpoint for postoperative 
overall morbidity. While the CCI is an attractive novel tool, which may serve as a primary or 
secondary endpoint in many types of studies, the external validity has not been tested in 
RCTs. Therefore, the aim of this study was to externally evaluate whether the CCI is more 
sensitive than traditional primary endpoints in detecting between-group differences. 
mEthods
We externally validated the CCI8 on recently published RCTs9-11 that reported specific compli-
cations after different surgical procedures. The first step was to identify and contact a number 
of centers, which have conducted RCTs investigating specific and non-specific morbidity 
endpoints. We considered RCTs regardless of their conclusions in the original analysis, and 
focused on different types and complexity of general surgical procedures, different diseases, 
as well as countries. All RCTs with a proper study design according to the CONSORT guidelines 
were identified by a systematic literature search in peer-reviewed high impact journals in the 
last three years (2011-2013)12-15 (Figure 2: flow diagram). After contacting several centers in 
general, cardiac and plastic surgery, we were granted full access to primary data and each 
patient record of three European trials9-11 addressing different surgical interventions and 
diseases in compliance with our study design. The first trial focused on the rate of pancreatic 
fistulas after pancreatico-duodenectomy.11 The second trial was evaluating the rate of anas-
tomotic strictures after two different types of anastomosis following esophagectomy9 and 
finally, the third trial focused on the rate of overall complications after colon resection for 
perforated diverticulitis.10  
CCI for randomized controlled trials
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Primary data9-11 were re-analyzed including calculation of the CCI in each patient. The 
CCI of the comparative groups in each trial was tested along traditional reported morbidity 
endpoints in the literature including the presence of any complication (yes/no) as well as the 
most severe complications (≥ grade IIIb according to the Clavien-Dindo classification3). The 1st 
author (KS) visited each centre to secure consistent and exhaustive re-evaluation of the data.
The multicenter RCT originating from France, published in 2011, was designed to test whether 
an external pancreatic duct stent might reduce the rate of pancreatic fistulas after pancreatico-
duodenectomy.11 A sample size calculation postulated a 10% reduction in the incidence of 
pancreatic fistulas in patients with pancreatic stents compared to those without drainage.11 
Assuming a power of 80% and an α-error of 0.05, the investigators enrolled 158 patients com-
paring 77 patients with, vs. 81 without insertion of an external stent drainage (Figure 1).11 The 
results indicated that external stent drainage of the pancreatic duct significantly reduces the 
risk of pancreatic fistulas, as well as overall morbidity rates after pancreatico-duodenectomy.11
The second RCT,9 performed in the Netherlands from 2005–2007, compared an end-to-
end (ETE) with end-to-side (ETS) esophago-gastrostomy after esophageal cancer resection 
(Figure 1).9 Their primary endpoint was the development of anastomotic stricture and need 
for dilatation within one year after surgery. They, therefore, performed a non-inferiority trial 
with one-sided testing assuming a 50% reduction in the rate of stenosis in patients with ETS- 
comparing to ETE-anastomosis. Assuming a power of 80% and an α-error of 0.05, 64 patients 
per group were required. The authors observed a lower incidence of anastomotic stricture 
in patients with ETS-anastomosis. They also concluded that ETS-anastomosis was associated 
with significantly more anastomotic leaks than ETE-anastomosis.9 The authors, however, did 
not investigate the overall morbidity expressed as the presence of any complication, nor the 
most severe complication (≥ grade IIIb).
Finally, the third multicenter RCT focused on patients with perforated left-sided diverticulitis 
enrolled from four surgical centers in Switzerland (incl. the Department of Surgery at the Uni-
versity Hospital Zurich).10 The study was designed to test whether the conventional Hartmann’s 
procedure (HP: colonic resection with closure of the rectal stump and an end-colostomy) is 
comparable to a primary anastomosis (PA) with diverting ileostomy (Figure 1) using the rate of 
overall complications, regardless of the severity, as the main endpoint. Both strategies require 
a second operation, i.e. stoma reversal and in HP a re-establishment of the continuity of the 
colon. For the sample size calculation 25% reduction in the rate of overall complications was 
assumed with a power of 80% and an α-error of 0.05. This yielded an estimated group size 
of 68 patients. The planned interim analysis, enrolling 62 patients, lead to a discontinuation 
of the trial, as recommended by the data-monitoring board, due to significant differences in 
adequately powered relevant secondary endpoints. Thirty patients had been randomized for 
the HP and 32 for a primary anastomosis. While the overall complication rates for both resec-
tion and stoma reversal operations were comparable, severe complications (grades ≥ IIIb) were 
significantly reduced after reversal operations in the PA group.10
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figure 1. The three European randomized controlled trials9-11
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figure 2. Flow diagram for the selecti on of trials for analysis.
From the 15 RCTs identi fi ed in high impact journals (New England Journal of Medicine, Lancet, JAMA, Annals of Sur-
gery, Briti sh Journal of Surgery and Briti sh Journal of Medicine), seven were excluded because complicati ons were not 
a primary endpoint. Aft er assessment fi ve trials could not be included because the authors did not respond or declined 
to parti cipate.
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Data collection & primary endpoint
We used the existing databases of these three RCTs, and calculated the CCI for each patient.9-11 
Each postoperative event in each patient was assessed on site, and graded according to the 
Clavien-Dindo classification, which is based on the treatment used to correct the postopera-
tive complication.3 For the development of the CCI, we used the established Clavien-Dindo 
classification system3 for complications, adopting methods from operation-risk-index analysis 
in marketing research and developed a formula that considers any combination of complica-
tions.16-18 The CCI was finally calculated as the sum of all complications that are weighted 
for their severity by patients and physicians.8,19 The final formula yields a score from 0 (no 
complication) to 100 (death).8 The CCI can easily be calculated online by free access at www.
assessurgery.com. 
Additionally, for each patient we assessed traditional morbidity endpoints: the total num-
ber of complications, the presence of any (yes/no), as well as the most severe (≥ grade IIIb3) 
complications. In the esophageal stricture trial we also calculated the CCI at discharge and a 
long-term CCI after one year following initial surgery in all patients. The longitudinal assess-
ment of the overall morbidity using the CCI is novel allowing to present the cumulative effects 
of complication over time. 
In-hospital-costs, the length of hospital (LOS) and ICU stays were also extracted from the 
respective original database. LOS and ICU stay were available in all three RCTs, whereas the 
in-hospital costs were only available in the multicenter colon RCT.
We additionally performed a sample size calculation to properly evaluate the sensitivity 
of the CCI as primary endpoint in trials. We assumed a difference of 10 points for the CCI, a 
relative risk reduction of 40% for the specific and traditional morbidity endpoints, a power of 
80% and an α-error of 0.05. The difference of 10 points on the CCI scale is chosen because 
it reflects one grade difference in the established Clavien-Dindo classification. For the colon 
trial, we were not able to calculate a sample size because of premature termination of the 
initial trial, a two-step procedure and therefore unequal group sizes (n = 15 vs. n = 22) in the 
second surgery.
Eligibility criteria (SDC 2) and the paragraph about the statistical analysis (SDC 3) are re-
ported in detail in the supplemental material online.20-22 For all results, we reported point 
estimates, 95% confidence intervals (CI) and p-values (≤ 0.05 considered significant). We 
performed statistical analyses using STATA (version 11, Stata Corp., College Station, Texas).
rEsults
As summarized in Figure 1, we re-analyzed 348 patients for which detailed characteristics 
were reported previously.9-11
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Conventional morbidity endpoints versus CCI
In the pancreatic fistula trial, the overall burden of the postoperative morbidity represented 
by the median CCI after pancreatico-duodenectomy was significantly lower in patients with 
an external pancreatic stent, than in those without any drainage (0 (IQR 0-26.2) vs. 20.9 (IQR 
0-29.6), p = 0.009) (Table 1). In contrast, there was no between-group difference considering 
the ‘most severe complication’ in patients with the external stent compared to those ones 
without stent (13% vs. 11%, 95% CI: 0.5 – 3.1, p = 0.72). The authors of this trial published a 
significant between-group difference in the rate of pancreatic fistulas (42% without stent vs. 
26% with stent, p = 0.035).11 These findings support the higher sensitivity of the CCI because 
the between-group difference for the CCI presented lower p-values (p = 0.009) as indirect 
comparison of effect sizes, than the differences for the specific complication ‘pancreatic 
fistula’ (p = 0.035), as well as for the ‘most severe complication’ (p = 0.72) in the same patient 
population.20,21 The p-values for the CCI (p = 0.009) compared to those ones for the presence 
of any complications (p = 0.008) were similar in the same patient population (Table 1). 
In the esophageal anastomosis trial, patients with an ETS anastomosis disclosed significantly 
higher CCI at discharge, than patients with an ETE-anastomosis (22.6 (IQR 0-41.2) vs. 10.5 (IQR 
0-24.4), p = 0.014). In contrast, this trial failed to show any statistically significant between-
group differences using traditional endpoints such as the presence of any or the most severe 
complications (≥ grade IIIb) (Table 2).
The original analysis of this trial reported a significantly higher rate of stricture in the anas-
tomosis one year following the initial surgery (40% in ETE vs. 18% in ETS, p < 0.01).9 The CCI 
directly after discharge was significantly different between both groups, mostly related to a 
significantly higher rate of anastomotic leaks in the ETS-anastomosis group (odds ratio 3.4 
table 1. Effects of stent vs. no stent on postsurgical morbidity using different measurements in patients with 
pancreatic fistula following pancreaticoduodenectomy11 
without stent
n = 81
with stent
n = 77
unadjusted difference
(95% Ci, p-value)
CCI 20.9 (0 – 29.6) 0 (0- 26.2) -12.2 (-4.5 to -16.7, p=0.009)
CCI of the pancreatic fistula 0 (0 – 20.9) 0 (0 – 8.7) -3.2 (-6.8 – 0.5, p=0.091)
Number of complications 1 (0 – 2) 0 (0 – 1) -0.5 (-0.9 to -0.1, p=0.021)
without stent
n = 81
with stent
n = 77
unadjusted odds ratio
(95% Ci, p-value)
Presence of any complication (%) 50 (61.7%) 32 (41.5%) 0.4 (0.2 – 0.8, p=0.008)
Severe complications ≥ IIIb* (%) 9 (11.1%) 10 (13.0%) 1.2 (0.5 – 3.1, p=0.72)
Pancreatic fistula (%) 34 (42%) 20 (26%) 0.5 (0.2 – 0.95, p=0.035)
CI = confidence interval, CCI = Comprehensive Complication Index; all results reported as median and interquartile 
range; * grading of complications according to the Clavien-Dindo classification system3
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(95% CI 1.4 – 8.2, p = 0.04). After calculating the CCI at one-year follow-up (including stricture), 
however, the median CCI was similar between patients with ETE- and ETS-anastomosis (26.2 
(20.9–40.6) vs. 26.2 (8.7-38.2), p = 0.75). This new finding suggests that there is no long-term 
difference (after one year) in the morbidity between both types of anastomoses. The CCI 
allows reporting of complications that occur during different time periods. After one-year 
follow-up the CCI (p = 0.75) balances the initially higher rate of anastomotic leaks in patients 
with ETS-anastomosis (p = 0.04) with the increasing rate of anastomotic strictures in patients 
with ETE-anastomosis (Table 2). Thus, although initially one patient group appears to have an 
advantage, long-term observations reverse this observation by considering late complications 
experienced by the other group of patients.
In the multicenter colon trial, there was no significant difference in the overall CCI, neither 
for the overall procedures nor in the respective steps (1st and 2nd operation). Nevertheless, 
the between-group difference of the CCI demonstrated a lower p-value than the differences 
in traditional morbidity endpoints that emphasize the higher sensitivity of the CCI over the 
traditional endpoints (Table 3).20,21 This trial showed comparable between-group complica-
tion rates for both surgical steps. Comparing the outcome of the 1st operation between the 
groups, there was also no significant difference in the rate of severe complications (44% vs. 
37%, p = 0.57; Table 3).
table 2. Effects of end-to-end vs. end-to-side anastomosis on postsurgical morbidity using different measure-
ments in patients with anastomotic stricture following esophagectomy9
EtE
n = 64
Ets
n = 64
unadjusted difference
(95% Ci, p-value)
CCI at discharge 10.5 (0 – 24.4) 22.6 (0 – 41.2) 11.6 (2.4 – 20.8, p=0.014)
CCI after one year 26.2 (20.9 – 40.6) 26.2 (8.7 – 38.2) -1.4 (-10.3 – 7.4, p=0.75)
Number of complications 1 (0 – 2) 1 (0 – 2.5) 0.5 (-0.1 – 1.1, p=0.08)
EtE
n = 64
Ets
n = 64
unadjusted odds ratio
(95% Ci, p-value)
Presence of any complication (%) 42 (65.6%) 47 (73.4%) 1.5 (0.7 – 3.1, p=0.34)
Severe complications ≥ IIIb* (%) 11 (17.2%) 20 (31.3%) 2.2 (0.95 – 5.1, p=0.07)
Anastomotic stricture (%) after one year 20 (40%) 10 (18%) 0.3 (0.1 – 0.7, p=0.004)
Anastomotic leakage (%) 14 (22%) 26 (41%) 3.4 (1.4 – 8.2, p=0.04)
ETE = end-to-end esophagogastrostomy; ETS = end-to-side esophagogastrostomy; CI = confidence interval; CCI = Com-
prehensive Complication Index; all results were presented in median and interquartile range; * grading of complica-
tions according to the Clavien-Dindo classification system3
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The CCI and the sample size
For two trials a sample size calculation was performed for their specific endpoint, the CCI 
and traditional morbidity endpoints (any or most severe complications). The sample sizes 
are clearly lower for the CCI compared to the original and traditional endpoints as shown in 
Table 4. This illustrates the putative benefits of the CCI compared to complication endpoints 
such as any and more severe in minimizing the need for large sample sizes in the future. 
For example, in the pancreatic fistula trial, the required sample size would decrease from 
695 patients/group to 76 patients per group when using the primary endpoint CCI vs. ‘most 
severe complication’. Similar results were seen in the esophageal anastomosis trial (Table 4). 
CCI associated to LOS, ICU stay, and in-hospital costs
The CCI was significantly associated to LOS and ICU stay in all three trials. We also evalu-
ated the costs of complications in the colon trial. An increase in one point on the CCI scale 
created additional costs of CHF 883 (95% CI: 222 – 1543, p = 0.010) (about US $ 980, 95% 
CI: 247-1714). In other words, an increase of the CCI of 10 points on the scale increases the 
in-hospital costs to additional US $ 9800. 
table 3. Effects of the Hartmann’s procedure vs. primary anastomosis on postsurgical morbidity using different 
measurements in patients with perforated diverticulitis10
hartmann’s procedure
n = 30
primary anastomosis
n = 32
unadjusted difference
(95% Ci, p-value)
CCI for both surgeries 40.3 ± 32.6 33.5 ± 28.3 6.8 (-8.7 – 22.3, p=0.39)
CCI after 1st surgery 37.3 ± 33.1 32.2 ± 28.4 5.1 (-10.5 – 20.7, p=0.52)
CCI after 2nd surgery n = 15
12.4 ± 16.7
n = 22
5.2 ± 9.7
7.2(-1.7 – 16.0, p=0.11)
1st surgery hartmann’s procedure
n = 30
primary anastomosis
n = 32
unadjusted odds ratio
(95% Ci, p-value)
Any Morbidity (%) 24 (80%) 27 (84.4%) 0.74 (0.20 – 2.74; p=0.65)
Severe complications ≥ IIIb* (%) 11 (36.7%) 14 (43.8%) 0.74 (0.27 – 2.1, p=0.57)
2nd surgery hartmann’s procedure
n = 15
primary anastomosis
n = 22
unadjusted odds ratio
(95% Ci, p-value)
Any Morbidity (%) 6 (40%) 6 (27.3%) 1.78 (0.44 – 7.18, p=0.42)
Severe complications ≥IIIb* (%) 3 (20%) 0% -
CCI = Comprehensive Complication Index; CI = confidence interval; all results reported as mean ± standard deviation.
No statistical analysis was performed if ≤ 5 events in a group; * grading of complications according to the Clavien-Dindo 
classification system.3
CCI for randomized controlled trials
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disCussion
This study demonstrates the superiority of the CCI over traditionally reported morbidity 
endpoints ‘most severe complication’ and specific complications by detecting between-group 
differences in three external trial populations. Another finding is the easy and new applicabil-
ity to longitudinal assessment of complications over time, as illustrated in the analysis of the 
one-year CCI follow up in the esophageal anastomosis trial. Finally, the CCI is associated to 
LOS, length of ICU stay and in-hospital costs, which add clinical value to this morbidity index. 
The most relevant finding for the CCI is that the required sample sizes in trials are up to nine 
times lower for the CCI than for other endpoints.
Reporting outcomes of surgical or other invasive procedures using morbidity, as the primary 
endpoint, has been associated with serious limitations due to various definitions and dif-
ferent interpretation of postoperative events.1, 2, 4, 5 Assessing the overall morbidity by the 
presence of any complication causes the problem of ignoring either the number of differ-
ent complications occurring in a patient after surgery or, more importantly, the severity of 
complications. Recording only the most severe complication does not give weight to either 
any complication of lesser importance or the total number of complications, even though 
they affect the patient. As one of the first attempts in outcome standardization, in 1992, a 
classification system was proposed to grade the severity of complications according to the 
degree of treatment needed to correct the complications.23 In 2004, this original classification 
was revised to generate the Clavien-Dindo classification based on the same principles, but 
eliminating criteria such as the length of stay and newly grading complications with readmis-
table 4. Sample size calculation for surgical RCTs using different measurements for postsurgical morbidity
assumptions sample size
pancreatic fistula trial11
Pancreatic fistula11 40% relative risk reduction 149 patients/group
Presence of any complication (yes/no) 40% relative risk reduction 75 patients/group
Most severe complication ≥ IIIb* 40% relative risk reduction 695 patients/group
CCI ∆ 10 points, SD 22 76 patients/group
Esophageal anastomosis trial9
Anastomotic stricture9 40% relative risk reduction 132 patients/group
Presence of any complication (yes/no) 40% relative risk reduction 76 patients/group
Most severe complication ≥ IIIb* 40% relative risk reduction 220 patients/group
CCI ∆ 10 points, SD 20 63 patients/group
Beta = 0.8; alpha = 0.05; ∆ = difference in 10 points in the CCI scale; SD = standard deviation; RCT: randomized con-
trolled trial; CCI = Comprehensive Complication Index; * grading of complications according to the Clavien-Dindo clas-
sification system.3 Sample sizes were shown without considering loss of follow up.
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sion to ICU units due to organ dysfunction.3, 6 The Clavien-Dindo classification gained wide 
acceptance, and became increasingly used in a variety of studies and registries.24-28 However, 
with this system, each complication is graded separately. For ease of reporting, usually only 
the most severe complication was included, which does not represent the ‘true’ overall 
morbidity burden of surgical procedures.5 The recently developed CCI is based on a formula 
used in the economy, which incorporates multiple factors influencing the globalization of a 
corporation decision. With this formula all complications, weighted by severity, are integrated 
in a linear scale. It facilitates reporting not only of the in-hospital morbidity, but also at various 
postoperative follow up, e.g. the 90-day morbidity or other time-span. Furthermore, the CCI 
is a primary outcome measure, which is calculated separately for each patient regardless of 
the population studied. Individual grade of complications or the CCI represent endpoints, and 
thus a risk-adjustment is necessary for proper interpretation in specific groups of patients. 
For example, a higher median CCI in a hospital compared to others might not mean better 
quality, particularly if the population of this specific center is at higher risk for surgery with 
high incidence of co-morbidities. 
If future trials aim at focusing on the ‘overall morbidity’ and not on a specific complication 
related to the procedure under investigation, our current data strongly support the use of 
the CCI as a primary endpoint. It appears that the required sample size for superiority trials is 
impressively lower for the CCI than traditional endpoints, particularly the ‘most severe com-
plications’ endpoint. Surgical trials often require large sample sizes to detect a between-group 
difference, which are only feasible in large and costly multicentre endeavour. Switching to the 
CCI may result in a dramatic reduction of the required sample size, so the feasibility of a trial 
increases, whereas costs decrease. In addition, the number of negative trials associated with 
a type II error may be reduced. It is obvious that there is a substantial number of false nega-
tive results in the surgical trial literature that are solely the result of insensitive endpoints.29
The strength of the current study is that the CCI was externally tested and was apparently 
more responsive than existing outcome endpoints. It may, therefore, serve as a standardized 
and easily applicable primary endpoint in surgical trials and other medical specialties. Fur-
thermore, the CCI was performed on three different European patient populations enrolled 
for different surgical procedures and diseases supporting its broad use. Further strength 
in this report is the one-year CCI as a longitudinal measure of the overall morbidity over a 
certain time. The three trials all enrolled patients by randomization to control for confounding 
factors and bias. 
There are also some limitations. Even though the CCI was externally tested on a broad spec-
trum of patients undergoing a variety of major abdominal surgical procedures, it might be still 
important to test the CCI in other medical fields such as interventional radiology, urology and 
CCI for randomized controlled trials
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cardiology. A further limitation might be that the three trials were not powered for the CCI 
as primary endpoint. Nevertheless, this current study already showed in rather small patient 
populations significant between-group differences in the CCI whereas the differences in the 
frequencies of any and/or most severe complications were similar. 
In conclusion, the CCI offers a novel sensitive endpoint for clinical trials that can be readily 
calculated (available at www.assessurgery.com). The CCI may also allow in future better in-
formation of patients, standardized reporting in outcome research including readily available 
assessment of morbidity at various time points, and increased comparability of quality of 
surgery across centers worldwide. Perhaps, one of the most attractive aspects of the CCI is 
the possibility to conduct conclusive trials with smaller sample sizes when focusing on the 
‘overall morbidity’ as surgical outcome. 
118 Chapter 7
supplEmEntal digital ContEnt 1: Eligibility CritEria
Eligibility criteria were described in the published RCTs.9-11. We did not exclude any patient 
of the existing databases. The trials were all approved by the local IRB and internationally 
registered at clinicaltrials.gov (NCT01068886, NCT01233713) and the Dutch Trial Registry 
(OND1317772).
supplEmEntal digital ContEnt 2: samplE sizE & statistiCal 
analysis
The sample size calculation in each trial was described in detail in the original articles.9-11 We 
expressed the distribution of variables using means and standard deviation (SD) for normally 
distributed data, and medians and interquartile ranges for non-normally distributed data. We 
tested the data for normality with the Kolmogorow-Smirnov test and performed quantile-
quantile plots of dependent variables. We compared the CCI and the total number of compli-
cations between the comparative groups in each RCTs using simple linear regression (without 
adjusting for confounders). With the same statistical method, we compared the in-hospital 
costs between the patient groups of the multicentre colon trial. Due to the randomization in 
all three trials, there was no imbalance in variables, so that a multivariable linear regression 
adjusting for potential confounders was deemed unnecessary. We performed univariate logis-
tic regression analyses for conventional binary morbidity endpoints such as ‘any complication’ 
(yes/no) or ‘most severe complication’ (complications ≥ Clavien-Dindo grade IIIb). Testing the 
sensitivity by comparing p-values of the between-group differences allows an indirect com-
parisons of effect sizes among various defined endpoints (continuous vs. categorical) in the 
same patient population.16, 17. Comparing the effects of a treatment on different endpoints by 
p-values is only possible because the size of the population does not vary.16, 17. Linear regres-
sion was finally used to test the association of CCI to in-hospital costs, length of hospital 
(LOS) and ICU stay. For all results, we reported point estimates, 95% confidence intervals (CI) 
and p-values (≤ 0.05 considered significant). We performed the statistical analyses using the 
statistical program STATA (version 11, Stata Corp., College Station, Texas). 
supplEmEntal digital ContEnt 3: CCi assoCiatEd to los, iCu stay, 
and in-hospital Costs 
Recent studies suggest that the cost of complications may far exceed the costs of the original 
operation.18 Hence, economic aspects of the procedure in combination with potential com-
plications may be a decisive element in patient selection. In the multicenter pancreatic fistula 
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trial the CCI strongly associated with the LOS (unadjusted difference 0.26; 95% CI 0.18 – 0.35, 
p < 0.001). The CCI in the anastomosis study after esophagectomy is significantly associated 
with the LOS (0.47; 95% CI 0.27 – 0.67, p < 0.001), and with the length of ICU stay (0.19; 95% 
CI 0.14 – 0.23, p < 0.001). Similar results were observed for the association between the CCI 
and LOS (0.14; 95% CI 0.01 – 0.27, p = 0.036) and the length of ICU stay (0.07; 95% CI 0.02 
– 0.11, p = 0.005) in the multicenter colon trial. Interestingly, this trial also shows a negative 
association between the CCI and the overall survival (-0.40, 95% CI: -0.57 to -0.22, p < 0.001). 
Finally, we evaluated the costs of the complications in the colon trial by normalizing them to 
the CCI. We found that an increase in one point on the CCI scale created additional costs of 
CHF 883 (95% CI: 222 – 1543, p = 0.010) (about US $ 980, 95% CI: 247-1714). In other words, 
an increase of the CCI of 10 points on the scale increases the in-hospital costs to additional 
US $ 9800. 
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abstraCt
Background: Neoadjuvant chemo radiotherapy (nCRT) followed by surgery for patients with 
esophageal or junctional cancer has become a standard of care. The Comprehensive Compli-
cation Index (CCI) has recently been developed and accounts for all postoperative complica-
tions. Hence, CCI better reflects the burden of all combined postoperative complications in 
surgical patients than the Clavien-Dindo score alone, which incorporates only the most severe 
complication. The aim of this study was to further evaluate the severity of complications in 
patients treated with nCRT followed by esophagectomy versus in patients who underwent 
esophagectomy alone using the Comprehensive Complication Index (CCI). 
Study-design: All patients included in the CROSS trial, a randomized clinical trial on the value 
of nCRT followed by esophagectomy, were included. Complications were assessed and graded 
using the Clavien-Dindo classification. CCI was derived from these scores, using the CCI calcu-
lator available online (www.assessurgery.com). CCI of patients who underwent nCRT followed 
by surgery was compared with the CCI of patients who underwent surgery alone. 
Results: In both groups 161 patients were included. The median (and interquartile range) 
CCI of patients with nCRT and surgery was 26.22 (17.28-42.43) versus 25.74 (8.66-43.01) 
in patients who underwent surgery alone (p = 0.58). There also was no difference in CCI 
between subgroups of patients with anastomotic leakage, pulmonary complications, cardiac 
complications, thromboembolic events, chyle leakage and wound infections. 
Conclusion: Neoadjuvant chemo radiotherapy according to CROSS did not have a negative 
impact on postoperative complication severity expressed by CCI compared with patients who 
underwent surgery alone for potentially curable esophageal or junctional cancer. 
CCI to assess complication severity of neoadjuvant chemo radiation
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introduCtion
Esophageal cancer remains one of the most common cancers worldwide.1 Treatment for 
patients with potentially curable esophageal cancer is an esophagectomy with gastric tube 
reconstruction. Meta-analyses of randomized controlled trials comparing neoadjuvant 
chemo radiotherapy plus surgery to surgery alone2-9 showed that multimodality treatment 
improves overall survival, but side-effects (e.g. radiofibrosis, suppressed immune function, 
impaired nutritional and hematological status) could increase morbidity and mortality after 
esophagectomy.2-17 
The largest published randomized clinical trial on the value of neoadjuvant chemo radio-
therapy (CROSS-trial)8 also showed a survival benefit. Importantly, there was no difference 
in the frequency of complications and postoperative mortality between the patients who 
were treated with neoadjuvant chemo radiotherapy followed by surgery and the patients 
who underwent surgery alone. 
In the past decades, not only the frequency but also the severity of postoperative complica-
tions has become an important quality measure in surgical studies. Also, patients’ reported 
grading of complications gives a better insight into the burden of a complicated postoperative 
course. Therefore, several severity-scoring systems have been developed.18-22 A novel and 
validated scoring system is the Comprehensive Complication Index (CCI).20, 23 CCI summarizes 
the frequency, severity and patient’s rating of complications by using the adopted ‘operating 
risk index’ in a single score that ranges between 0 (no complication) and 100 (death) based 
on the established Clavien-Dindo classification.22 Therefore, it accounts for the whole burden 
of all complications. A recent study20 showed that CCI is a sensitive method that is superior 
to traditional endpoints, because it summarizes the whole burden of postoperative complica-
tions to the patient with respect to complications. Whereas traditional endpoints showed no 
significant differences for incidence of postoperative complications within the CROSS trial, 
the current study was designed to evaluate the overall effect of neoadjuvant chemo radio-
therapy on the severity of postoperative complications, and the overall burden in patients 
of the CROSS trial. Therefore, the CCI was compared between patients with esophageal or 
esophagogastric junction cancer who underwent chemo radiotherapy plus surgery versus 
patients who underwent surgery alone. 
patiEnts and mEthods
Patients with esophageal cancer or cancer of the esophagogastric junction (cT1-4aN0-3M0) who 
underwent a curative surgical resection of the esophagus and who participated in the CROSS 
trial were selected from the study database. The CROSS trial is a multicenter randomized con-
trolled trial that compared overall survival for patients who were treated with neoadjuvant 
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chemo radiotherapy followed by esophagectomy and the patients who underwent esopha-
gectomy alone. The inclusion and exclusion criteria as well as staging procedures have been 
described previously.24 As the study focuses on complication severity after esophagectomy, 
patients who did not undergo resection were removed from the study cohort.
Complications
Complications were defined using the complete and commonly applicable National Cancer 
Institute’s Common Terminology Criteria for Adverse Events, 4.0.25 Because these criteria do 
not provide a definition of anastomotic leakage, the definition according to Bruce et al.26 
was used: drainage of saliva or gastrointestinal content from the surgical join between the 
esophagus and gastric tube. The luminal contents may emerge externally or internally, or may 
be collected near the anastomosis with or without systemic complications. Only complica-
tions within 30 days after the operation and/or during hospital stay were assessed.
CCI
The CCI is a complication index introduced by Slankamenac et al.23 in 2013 and is based on 
the Clavien-Dindo classification22 (Table 4). In the development of the CCI, data on common 
postoperative complications were gathered and rated by both patients and physicians. By this 
method, each complication is validated and given a fixed number and also includes patient’s 
perspective about the severity. After this, a score is calculated for each grade in the Clavien-
Dindo classification. To calculate the CCI, all complications that a patient develops after sur-
gery are summarized and computed through the operation risk index approach (commonly 
used in economics). This can be done easily and free of charges at www.assessurgery.com. 
The final index yields a score from 0 (no complication) to 100 (death).27
To investigate whether postoperative complication severity is influenced by neoadjuvant 
treatment, the severity of all combined complications was measured using the CCI. Based 
on results in earlier studies of patients who underwent esophageal cancer surgery in which 
specific complications have shown an increase in incidence, six subgroups were formed in this 
study. For example, some studies show influence of neoadjuvant treatment on pulmonary 
complications, due to the radiation field. In subgroup 2, patients with pulmonary complica-
tions are compared. Only patients with the specific complication were used to calculate the 
specific complication CCI.
Grading of complications
We used the original database of the CROSS study in which postoperative complications were 
scored by data managers in each participating center. Cross checking of these complications 
and grading every complication according to the Clavien-Dindo classification was done by one 
of the authors (NN). The CCI was calculated afterwards.
CCI to assess complication severity of neoadjuvant chemo radiation
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In addition, for each patient the traditional endpoints, the total number of complications, 
the presence of any complication (yes/no) and the most severe complications (≥IIIb according 
to the Clavien-Dindo classification) were assessed. 
Treatment
As previously described24, patients randomized to neoadjuvant chemo radiotherapy under-
went five weekly cycles of chemo radiotherapy (carboplatin/paclitaxel with 41.1 Gy concur-
rent radiotherapy) followed by surgery, preferably within 4-6 weeks of completion. Patients 
randomized to the surgery alone arm underwent esophagectomy as soon as possible.
Statistical analysis
Adjustment for possible confounders was not necessary, because the data were controlled 
for confounding by randomization. Baseline continuous data were described as means with 
standard deviation, or in case of a not-normally distributed variable, with the median and 
interquartile range. Normal distribution was calculated using the Kolmogorov-Smirnov test. 
Groups were compared using the non-parametric Mann-Whitney-U test. For cross tabula-
tions, Pearson’s chi-squared test with continuity correction was used. All statistical analyses 
were performed on the statistical package SPSS 22.0 (SPSS Inc., Chicago, Illinois, USA). A p-
value < 0.05 two-sided was considered statistically significant. 
rEsults
Of the 368 patients randomized in the CROSS trial8, 322 patients were included in the present 
study. An overview of inclusion and exclusion of patients in the present study is shown in 
Figure 1.
Patient’s characteristics including age, sex, comorbidity and surgical approach were similar 
between both groups (Table 1). More R0 resections were performed in patients who received 
nCRT before esophagectomy (p < 0.001). In patients who were analyzed in the current study 
(n = 322), the combined treatment group 136 (85%) patients developed at least one compli-
cation versus 125 (78%) in the surgery alone group (p = 0.13) (Table 2).
Grade I complications were seen in 43% of patients after neoadjuvant chemo radiotherapy 
plus surgery versus 49% of patients after surgery alone (p = 0.37). There also was no statisti-
cally significant difference for grade II  - grade V complications (Table 2).
Analyses in six subgroups showed that respiratory complications, i.e. pneumonia were the 
most common (30% vs. 21%, p = 0.32), followed by anastomotic leakage (23% vs. 30%, p = 
0.13) and cardiac arrhythmias (20% vs. 12%, p = 0.29). Significantly more infections of the 
chest wound were found in patients with neoadjuvant treatment who underwent a transtho-
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racic esophagectomy (0% vs. 6%, p = 0.007). The incidence of all other complications was not 
significantly different between the two groups.
There was no statistically significant difference in the CCI between both groups. Median CCI 
in the combined treatment group was 26.22 (IQR 17.28 – 42.43) compared with 25.74 (IQR 
8.66  - 43.01) in the surgery alone group (p = 0.58), Table 3.
In subgroup analyses of the specific complications, CCI for patients who underwent neoad-
juvant chemo radiotherapy and developed an anastomotic leak was not statistically different 
from patients who underwent surgery alone: 8.66 [8.66 – 33.73] versus 8.66 [8.66 – 33.73] (p 
= 0.78). The same was true for the other subgroups with patients who developed pulmonary 
or cardiac complications, thromboembolic event, chyle leakage or wound infection (Table 3).
figure 1. Flowchart of patients.
CCI to assess complication severity of neoadjuvant chemo radiation
8
129
disCussion
The Dutch CROSS study showed an absolute 5-years survival benefit of 13% for patients who 
underwent neoadjuvant chemo radiotherapy followed by an esophagectomy for esophageal 
or esophagogastric cancer. Hence, neoadjuvant chemo radiotherapy is nowadays widely used 
in clinical practice. However, it is important to consider the possible harm of neoadjuvant 
chemo radiotherapy because trials frequently focus on the benefit of a treatment.28-30 This 
may be caused by a lack of sensitive outcome parameters, by underreporting and by the 
table 1. Patient and tumor characteristics 
nCrt** and surgery (161) surgery alone (161) p-value
Age (yr) median [range] 60 [37-76] 60 [36-76] 0.72
Sex (M:F) 129:34 123:38 0.41
WHO* Performance status±
-  0 27 20 0.28 
-  1 134 140 0.34 
Co morbidity 
-  Cardiovascular  45 (28%) 40 (25%) 0.48 
-  Respiratory  17 (11%) 19 (12%) 0.69 
-  Diabetes mellitus  14 (9%) 11 (7%) 0.55 
Histology 
-  Squamous cell carcinoma  37 37 1.0 
-  Adenocarcinoma  121 120 1.0 
-  Undifferentiated carcinoma  3 4 1.0 
Tumor site 
-  Proximal esophagus 2 (1%) 3 (2%) 1.0 
-  Mid esophagus 24 (15%) 16 (10%) 0.23 
-  Distal esophagus 112 (70%) 123 (76%) 0.20 
-  Gastro-esophageal junction  23 (14%) 17 (12%) 0.40 
Mortality
-  30-day  3 (2%) 4 (3%) 1.00 
-  In-hospital  5 (3%) 6 (4%) 0.99 
Surgical approach 
-  Transhiatal esophagectomy 72 (45%) 72 (45%) 1.0 
Transthoracic esophagectomy 89 (55%) 87 (54%) 0.91 
Resection with tumour free margins p(R0) 148 (92%) 111 (69%) <0.001
Percentages may not add up to 100 because of rounding. 
*  WHO denotes World Health Organization.
**  nCRT denotes Neoadjuvant Chemo radiotherapy
±.  WHO performance status scores are on a scale of 0 to 5, with lower numbers indicating better performance status; 
0 indicates fully active, and 1 unable to carry out heavy physical work.
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table 2. Frequencies of Clavien-Dindo grades and postoperative complications in patients of the current study
nCrt** and surgery (161) surgery alone (161) p-value
Any complication 136 (85%) 125 (78%) 0.13
Grade I complication 70 (43%) 79 (49%) 0.37
Grade II complication 90 (56%) 85 (53%) 0.65
Grade IIIa complication 58 (36%) 52 (32%) 0.56
Grade IIIb complication 25 (13%) 28 (15%) 0.76
Grade IVa complication 28 (15%) 33 (20%) 0.57
Grade IVb complication 3 (2%) 6 (3%) 0.50
Grade V complication 5 (3%) 6 (3%) 1.00
Subgroup 1; Anastomotic leakage || 37 (23%) 49 (30%) 0.16
Subgroup 2; Pulmonary complications † 81 (50%) 82 (50%) 1.00
Subgroup 3; Cardiac complications ‡ 34 (21%) 23 (14%) 0.57
Subgroup 4; Trombo-embolic events 6 (3%) 4 (2%) 1.00
Subgroup 5; Chyle leakage § 16 (10%) 11 (7%) 0.41
Subgroup 6; Wound infections 18 (11%) 21 (13%) 0.60
Anastomotic leakage 37 (23%) 49 (30%) 0.16
Leakage requiring surgical intervention 8 (4%) 6 (3%) 0.59
Pneumonia 49 (30%) 40 (21%) 0.32
Atelectasis 17 (11%) 22 (14%) 0.49
Empyema 14 (9%) 25 (16%) 0.09
Pneumothorax 10 (6%) 14 (9%) 0.52
Respiratory insufficiency 29 (15%) 33 (20%) 0.67
Re-intubation 33 (20%) 33 (20%) 1.00
Trombo-embolism 6 (3%) 4 (2%) 0.75
Cardiac arrhythmia 30 (20%) 22 (12%) 0.29
Myocardial infaction 0 (0%) 1 (1%) 1.00
Cardiac decompensation 4 (2%) 0 (0%) 0.13
Mediastinitis 6 (3%) 11 (7%) 0.32
Chylothorax 16 (10%) 11 (7%) 0.41
Vocal cord palsy 19 (12%) 12 (7%) 0.66
Wound infection neck 9 (6%) 6 (3%) 0.60
Wound infection thorax 0 (0%) 9 (6%) 0.007
Wound infection abdomen 9 (6%) 6 (3%) 0.60
Renal failure 4 (2%) 1 (1%) 0.37
Sepsis 7 (4%) 10 (6%) 0.62
Multi-organ failure 0 (0%) 4 (2%) 0.13
Re-admittance ICU 30 (19%) 27 (17%) 0.66
**  nCRTS denotes Neoadjuvant Chemo radiotherapy
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strict inclusion criteria of trials that are frequently broadened after closure of the trial and the 
specifics of positive results. Also, sample sizes often are rather small masking the incidence 
of selectively rare but potentially serious complications. This study used the novel outcome 
measure for postoperative complicated course (CCI) to compare the additive impact of neoad-
juvant chemo radiotherapy on the severity of complications in patients after esophagectomy, 
as the incidence of complications is already reported in the CROSS study. Our results show 
neither a significant difference in CCI between both groups nor in the incidence of specific 
common complications. 
The benefit of neoadjuvant treatment has been a topic of many studies but the harm has 
been described less extensively. The Cochrane review, published in 20107 demonstrates that 
postoperative complications often are ill described or missing at all.31 Herefore, in their meta-
analysis no overall complication rate could be calculated. In a retrospective study published 
by Morita et al.32 containing 686 patients, the total number of complications, as well as 
pulmonary complications and anastomotic leakage developed more frequently in patients 
with neoadjuvant treatment in comparison with patients without neoadjuvant treatment. 
Bosch et al.16 confirmed an increase in cardiopulmonary complications in the neoadjuvant 
treatment group (pneumonia and cardiac arrhythmias). Merrit et al.10, in a retrospective 
cohort study of 138 patients, showed no increase in postoperative morbidity and mortality, 
but concluded that major postoperative complications are rather due to surgical technique 
and preoperative morbidity rather than to neoadjuvant therapy. Furthermore, Kelley et al.13 
performed a prospective trial in 2004, showing no significantly higher complication rate in 
patients with preoperative chemo radiotherapy. In a study of 40 patients by Bagheri et al.15, 
respiratory complications were closely analyzed and although there was a significant correla-
tion between the number of microorganisms in the sputum and difficulty in weaning, there 
Adverse events were graded according to the National Cancer Institute’s Common Terminology Criteria for Adverse 
Events, version 4.0
||  Anastomotic leakage was defined as: drainage of saliva or gastrointestinal content from the surgical join between 
the esophagus and gastric tube. The luminal contents may emerge externally or internally, or may be collected 
near the anastomosis with or without systemic complications 
†  Pulmonary complications were pneumonia (isolation of pathogen from sputum culture and a new or progressive 
infiltrate on chest radiograph), serious atelectasis (lobar collapse on chest radiograph), pneumothorax (collection 
of air between the visceral and parietal pleural surfaces, requiring drainage), pleural effusion (collection of fluid 
between the visceral and parietal pleural surfaces, requiring drainage), pulmonary embolus (embolus detected on 
spiral CT or a ventilation–perfusion mismatch on a lung scintigram), and acute respiratory failure (partial pressure 
of arterial oxygen < 60 mm Hg while breathing ambient air).
‡  Cardiac complications were arrhythmia (any change in rhythm on the electrocardiogram, requiring treatment), 
myocardial infarction (two or three of the following: previous myocardial infarction, electrocardiographic changes 
suggesting myocardial infarction, or enzyme changes suggesting myocardial infarction), cardiac decompensation 
and left ventricular failure (marked pulmonary edema on a chest radiograph).
§  Chylothorax was recorded when elevated levels of triglycerides in intrathoracic fluid (> 1 mmol per liter [89 mg per 
deciliter]) were found. Mediastinitis was scored when reported by the local investigator.
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was no correlation found between neoadjuvant treatment and pulmonary complications. 
Several meta-analyses showed a decrease in mortality without any proof of a decrease in 
postoperative complications4, 6, 9, 17 but most trials failed to produce information about postop-
erative complications. Greer et al.5 found no difference in their meta-analysis and concluded 
that there was a need for large randomized trials.
With the recently developed sensitive Comprehensive Complication Index20, 23, it is possible to 
take the severity of all complications in consideration; thus improving the accuracy of report-
ing the impact of all side effects combined. The CCI has been validated already in different 
surgical trials, showing its value. The CCI incorporates patients’ opinion on a complication, as 
well as the physicians’ opinion. It also takes into account low-grade complications, which are 
normally not considered as an endpoint but adds up to the patients’ postoperative experi-
ence. Additionally, the CCI can be used to compare the severity of a specific complication (i.e. 
anastomotic leakage) between different patient groups (Table 3).
table 3. Comprehensive Complication Index computed for the whole study group as well as subgroups of com-
mon postoperative complications
Crtx and surgery surgery alone p-value
CCI (whole group; N=322) 26.22 [17.28 -  42.43] 25.73 [8.66 -  43.01] 0.58
CCI patients with anastomotic leakage (N=86) 8.66 [8.66 – 33.73] 8.66 [8.66 – 33.73] 0.78
CCI patients with pulmonary complications  (N=163)  20.92 [20.92 – 
42.43]
20.92 [20.92 – 42.43] 0.59
CCI patients with cardiac complications  (N=57) 20.92 [20.92 -  20.92] 20.92 [20.92 -  20.92] 0.64
CCI patients with trombo-embolic events  (N=10) 20.92 [20.92 -  20.92] 20.92 [20.92 -  20.92] 1.0
CCI patients with chyle leak  (N=27) 8.66 [8.66 – 20.92] 14.79 [8.66 – 31.85] 0.65
CCI patients with wound infections  (N=39) 8.66 [8.66 – 8.66] 8.66 [8.66 – 8.66] 0.93
The CCI for the whole group was computed on all patients. CCI of subgroups were calculated only in patients with the 
specific complication, to compare the severeness of the specific complications between groups. Values are shown as 
median with interquartile range and p-value.
*  Anastomotic leakage was defined as: drainage of saliva or gastrointestinal content from the surgical join between 
the esophagus and gastric tube. The luminal contents may emerge externally or internally, or may be collected 
near the anastomosis with or without systemic complications 
‡  Pulmonary complications were pneumonia (isolation of pathogen from sputum culture and a new or progressive 
infiltrate on chest radiograph), serious atelectasis (lobar collapse on chest radiograph), pleural effusion (collection 
of fluid between the visceral and parietal pleural surfaces, requiring drainage) and acute respiratory failure (partial 
pressure of arterial oxygen < 60 mm Hg while breathing ambient air).
§  Cardiac complications were arrhythmia (any change in rhythm on the electrocardiogram, requiring treatment), 
myocardial infarction (two or three of the following: previous myocardial infarction, electrocardiographic changes 
suggesting myocardial infarction, or enzyme changes suggesting myocardial infarction), cardiac decompensation 
and left ventricular failure (marked pulmonary edema on a chest radiograph).
±  Trombo-embolic events were defined as a deep venous thrombosis (shown on echo) or pulmonary embolus (em-
bolus detected on spiral CT or a ventilation–perfusion mismatch on a lung scintigram)
**  Chylothorax was recorded when elevated levels of triglycerides in intrathoracic fluid (> 1 mmol per liter [89 mg per 
deciliter]) were found. §§ Wound infections were defined as redness, inflammation, with extravasation of pus after 
drainage.
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There are several limitations to the current study. As our study included patients from 7 
participating hospitals, it may be possible that there is some difference in reporting and treat-
ment of complications. All complications were reviewed by one of the authors to preserve 
uniformity in application of the Clavien-Dindo classification. In the Netherlands, the transfer-
ence to the Medium or Intensive Care Unit for more intensive monitoring of the patients is 
relatively low, which in the Clavien-Dindo system directly results in a grade IV complication, 
but is not always accompanied by organ failure. The difference in complications scored in 
the CROSS trial differ because of the difference between the Clavien-Dindo classification 
and the CCI. In the CROSS study, only the most severe complication counted. This study only 
reports early complications, within 30 days and/or within hospital admission. Later complica-
tions, e.g. stenosis or complications due to recurrence were not included. Another possible 
limitation of this study is that postoperative complications were not the primary endpoint of 
the CROSS trial. The study was powered to show a difference in overall survival, therefore 
the sample size of this study might be too small to show differences in rare complications. 
However, as described by Slankamenac et al.20, when using the CCI as opposed to the original 
Clavien-Dindo classification as an endpoint, meaningful comparison can be obtained with 
smaller sample sizes.
The CCI can be used as a tool to monitor postoperative recovery in a detailed and structured 
way. Because all data in the present study were prospectively registered, this study shows a 
realistic view of postoperative complications in patients with cancer of the esophageal and 
esophagogastric junction. This study shows that the frequency of complications described in 
table 4. Clavien-Dindo classification
grade description
Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment 
or surgical, endoscopic, and radiological interventions
Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics, electrolytes, 
and physiotherapy. This grade also includes wound infections opened at the bedside
Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications 
Blood transfusions and total parenteral nutrition are also included
Grade III Requiring surgical, endoscopic or radiological intervention
IIIa Intervention not under general anesthesia 
IIIb Intervention under general anesthesia 
Grade IV Life-threatening complication (including CNS complications) requiring IC/ICU management
IVa Single organ dysfunction (including dialysis) 
IVb Multiorgan dysfunction 
Grade V Death of a patient
Suffix ‘d’ If the patient suffers from a complication at the time of discharge, the suffix ‘d’ (for ‘disability’) is added 
to the respective grade of complication. This label indicates the need for a follow-up to fully evaluate 
the complication.
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patients extracted from CROSS trial is similar in the two groups; and the outcome of specific 
complications in the two groups is similar. Neoadjuvant chemo radiotherapy does not show 
a negative impact on the overall postoperative morbidity as expressed by the CCI compared 
with patients who underwent surgery alone for potentially curable esophageal or esophago-
gastric junctional cancer.
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summary and ConClusions
This thesis discusses complications after esophageal surgery with special emphasis on surgi-
cal techniques in relation to outcome. part 1 described surgical techniques and postoperative 
imaging after esophagectomy and the creation of a esophagogastrostomy. Furthermore, 
postoperative complications and technical aspects of the esophago-gastric anastomosis and 
the use of a colon interposition for reconstruction is described. part 2 focusses on the use 
of the Comprehensive Complication Index (CCI) in surgical trials with special attention to 
anastomotic complications.
Part 1 Surgical techniques
Chapter 2 deals with postoperative complications after esophageal resection and gastric tube 
reconstruction including anastomotic leakage, anastomotic stricture, morbidity and mortality 
of different anastomotic techniques. Outcome after a stapled anastomosis was compared 
to a hand-sewn anastomosis and a cervical anastomosis was compared to an intra-thoracic 
anastomosis. The 25 reviewed articles show that cervical and intra-thoracic anastomosis are 
equal with regard to leakage and stricture rate, although there was a trend towards more 
leakage in the groups with patients with a cervical anastomosis. A stapled (either circular, 
linear or semi-mechanical) anastomosis or a hand-sewn anastomosis did not differ in anasto-
motic leakage, but there were higher incidences of dysphagia and strictures reported in the 
circular stapled anastomosis. 
Previous studies attempted to define the optimal site of anastomosis and the optimal anas-
tomotic techniques. However, anastomotic stricture formation and leakage still remains an 
important clinical problem. Chapter 3 reports a randomized controlled trial comparing a 
single-layered hand-sewn cervical end-to-side (ETS) anastomosis with an end-to-end (ETE) 
anastomosis. From May 2005 to September 2007, 128 patients (64 in each group) were 
randomized between ETE- and ETS-anastomosis after esophagectomy for cancer with gastric 
tube reconstruction. Contrast swallow studies and endoscopy were routinely performed 
in all patients. Anastomotic stricture within one year requiring dilatation, was the primary 
endpoint. Secondary endpoints were anastomotic leak rate and mortality. 99 men and 29 
women underwent esophagectomy and gastric tube reconstruction. Benign stenosis of the 
anastomosis, for which dilatation was required, occurred more often in the ETE group (40% 
vs. ETS 18%, p < 0.01) after one year of follow-up. The overall (clinical and radiological) anas-
tomotic leak rate was lower in the ETE group (22% vs. ETS 41%, p = 0.04). Patients with an 
ETE-anastomosis suffered less often from pneumonia (17% vs. ETS 44%, p = 0.002) and had 
subsequently significantly shorter in-hospital stay (15 days vs. 22 days, p = 0.02). In-hospital 
mortality did not differ between both groups. In conclusion, the ETS-anastomosis was as-
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sociated with a lower anastomotic stricture rate, compared to ETE-anastomosis. However, 
prevention of stricture formation was at high costs with increased anastomotic leakage and 
longer in-hospital stay.
In Chapter 4 the leak rate of a hand-sewn end-to-end anastomosis (ETE) is compared with 
a semi-mechanical anastomosis (SMA) after esophagectomy with gastric tube reconstruc-
tion. No randomized controlled studies had been performed that compared a hand-sewn 
ETE-anastomosis with a SMA. Patients with esophageal cancer were scheduled for esopha-
gectomy with gastric tube reconstruction and cervical anastomosis were eligible for participa-
tion. Patients were randomized to an ETE- or SMA-anastomosis. The primary endpoint was 
anastomotic leak rate. Secondary endpoints included anastomotic stricture at one year follow 
up, number of dilations, dysphagia score, hospital stay, morbidity and mortality. Patients were 
blinded for the type of anastomosis. Between August 2011 and July 2014, 174 patients with 
esophageal cancer underwent esophagectomy of whom 93 patients were randomized to ETE 
(n = 44) or SMA (n = 49) groups. Unfortunately, due to slow accrual and publication of a similar 
study, the study was stopped prematurely. Anastomotic leak occurred in 9 of 44 patients (20%) 
in the ETE group and 12 of 49 patients (24%) in the SMA group (p = 0.804) with a confidence 
interval of -13% to 21%. There was no statistically significant difference in dysphagia at one 
year postoperatively (ETE 25% vs. SMA 20%; p = 0.628). There was no difference in in-hospital 
stay, morbidity or mortality. Our study was stopped prematurely, with a confidence interval 
of -13 to 21% for leakage rate. Therefore, it is concluded that differences greater than 21% do 
not significantly differ. Smaller differences in leak rates cannot be proven equal or different. 
Chapter 5 describes our 40-year experience with colon interpositions. All patients who un-
derwent esophagectomy with a colon interposition between 1976 and 2016 in the Erasmus 
MC were identified from an institutional database. Data on patient’s characteristics, operative 
details, morbidity and mortality were retrieved from the institutional database and patients’ 
charts. 126 patients were included. Indications for colon interposition were failed gastric 
tube reconstruction (n = 18), previous gastric surgery (n = 48), esophagectomy with total 
gastrectomy for cancer (n = 40), caustic injury (n = 6) and other reasons (n = 8). Postoperative 
in-hospital mortality was 18% (23 patients). Morbidity was 66%. The most prevalent complica-
tions were pneumonia in 40 patients (32%) and anastomotic leakage in 24 patients (19%). The 
use of a colon conduit after esophagectomy is associated with a high mortality and morbidity 
but is a viable option for reconstruction of the upper gastrointestinal tract. 
Chapter 6 investigates the diagnostic and predictive value of routine contrast swallow study 
and endoscopy for the detection of anastomotic dehiscence in patients after esophagectomy. 
All patients who underwent contrast swallow and/or endoscopy within 7 days after esopha-
gectomy for cancer between January 2005 and December 2009 were selected from an insti-
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tutional database. 173 patients underwent endoscopy and 184 patients underwent a contrast 
swallow study. The sensitivity of endoscopy for anastomotic leakage requiring intervention is 
56%, specificity 41%, positive predictive value (PPV) 8% and negative predictive value (NPV) 
95%. The sensitivity of contrast swallow study for detecting leakage requiring intervention in 
patients without signs of leakage was 16%, specificity 75%, PPV 11% and NPV 83%. In patients 
without clinical suspicion of leakage, there is no benefit to perform routine diagnostic tests. 
Part 2 Comprehensive Complication Index
Whether the recently developed Comprehensive Complication Index (CCI) is more sensitive 
than traditional endpoints for detecting between-group differences in randomized controlled 
trials (RCTs), is described in Chapter 7. A major challenge in RCTs is the choice of optimal 
endpoints to measure treatment effects in an accurate and reliable way. The CCI, integrating 
all complications including their severity in a linear scale ranging from 0 (no complication) to 
100 (death), is a new tool, which may be more sensitive than other traditional endpoints to 
detect treatment effects on postoperative morbidity. The CCI was tested in three published 
RCTs from European centres evaluating pancreas, esophageal or colon resections. To compare 
the sensitivity of the CCI with traditional morbidity endpoints, e.g. presence of any (yes/no) 
or only the most severe complications, all postoperative events were re-assessed, and the 
CCI calculated. Treatment effects and sample size calculations were compared using the CCI 
and traditional endpoints. While RCTs failed to show between-group differences using any 
or most severe complications, the CCI revealed significant differences between treatment 
groups in two RCTs after pancreas (p = 0.009) and esophageal surgery (p = 0.014). The CCI in 
the RCT on colon resections confirmed the absence of between-group differences (p = 0.39). 
The required sample sizes in trials are up to nine-times lower for the CCI than for traditional 
morbidity endpoints. This study demonstrated superiority of the CCI to traditional endpoints. 
The CCI may serve as an appealing endpoint for future RCTs and may reduce the sample size. 
Chapter 8 concentrates on neoadjuvant chemo radiotherapy (nCRT) followed by surgery for 
patients with esophageal or junctional cancer. nCRT has become a standard of care. The aim 
of this study was to further evaluate the severity of complications in patients treated with 
nCRT followed by esophagectomy versus in patients who underwent esophagectomy alone 
using the comprehensive complication index (CCI). All patients included in the CROSS trial, 
a randomized clinical trial on the value of nCRT followed by esophagectomy, were included. 
Complications were assessed and graded using the Clavien-Dindo classification. The CCI was 
derived from these scores, using the CCI calculator available online (www.assessurgery.com). 
The CCI of patients who underwent nCRT followed by surgery was compared with the CCI 
of patients who underwent surgery alone. In both groups, 161 patients were included. The 
median (and interquartile range) CCI of patients with nCRT and surgery was 26.22 (17.28-
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42.43) versus 25.74 (8.66-43.01) in patients who underwent surgery alone (p = 0.58). There 
was also no difference in the CCI between subgroups of patients with anastomotic leakage, 
pulmonary complications, cardiac complications, thromboembolic events, chyle leakage 
and wound infections. Neoadjuvant chemo radiotherapy according to the CROSS-regimen 
did not have a negative impact on postoperative complication severity expressed by the CCI 
compared to patients who underwent surgery alone for potentially curable esophageal or 
junctional cancer. 
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samEnvatting En ConClusiEs
In dit proefschrift worden de complicaties besproken van slokdarmchirurgie, en in het bij-
zonder de verschillende chirurgische technieken in relatie tot het ontstaan van postoperative 
complicaties. In deel 1 worden chirurgische technieken en postoperatieve beeldvorming na 
slokdarmresectie beschreven, evenals postoperatieve complicaties met betrekking tot de 
anastomose en het gebruik van een coloninterponaat. deel 2 richt zich op het gebruik van de 
Comprehensive Complication Index (CCI) in chirurgische studies.
Deel 1 Chirurgische technieken
hoofdstuk 2 beschrijft op systematische wijze de literatuur omtrent naadlekkage, strictuur 
van de anastomose, morbiditeit en mortaliteit van verschillende anastomosetechnieken. 
Gestaplede anastomoses werden vergeleken met handgelegde anastomoses, de locatie van 
de anastomose werd vergeleken (cervicaal versus intra-thoracaal), en het gebruik van een 
smalle buismaagreconstructie werd vergeleken met de gehele maag als interponaat. De 25 
gereviewde artikelen tonen aan dat cervicale en intra-thoracale anastomoses even veilig zijn 
met betrekking tot lekkage en de vorming van strictuur, hoewel er een trend naar meer lek-
kage was in de groep patiënten met een cervicale anastomose. Een gestaplede anastomose 
(hetzij circulair, lineair of semi-mechanisch) en een handgelegde anastomose verschillen 
niet in het percentage naadlekkage, maar er was een hogere incidentie van dysfagie en stric-
tuur bij de circulair gestapelde anastomose. hoofdstuk 3 bestaat uit een gerandomiseerde 
gecontroleerde trial met vergelijking van een met de hand gelegde, cervicale end-to-side 
(ETS) anastomose en een end-to-end (ETE) anastomose. In eerdere studies is geprobeerd 
om de optimale plaats van anastomose en anastomosetechniek te definiëren. Echter, lekkage 
en strictuur van de anastomose bleef een belangrijk klinisch probleem. Van mei 2005 tot 
september 2007 zijn 128 patiënten (64 in elke groep) gerandomiseerd tussen een ETE- en 
ETS-anastomose na slokdarmresectie voor slokdarmcarcinoom met buismaagreconstructie. 
Om de anastomose te beoordelen werden routinematig een slikfoto en gastroscopie uitge-
voerd. Strictuur van de anastomose binnen een jaar, waarvoor dilatatie nodig was, was het 
primaire eindpunt. Secundaire eindpunten waren lekkage van de anastomose en mortaliteit. 
99 mannen en 29 vrouwen ondergingen een slokdarmresectie met buismaagreconstructie. 
Benigne stenose van de anastomose, waarbij dilatatie nodig was, kwam vaker in de ETE-groep 
voor (40% vs. ETS 18%, p < 0,01) na één jaar follow-up. De totale (klinische en radiologische) 
lekkage van de anastomose was lager in de ETE-groep (22% vs. ETS 41%, p = 0,04). Patiënten 
met een ETE-anastomose ontwikkelden minder vaak een pneumonie; (17% vs. ETS 44%, 
p = 0,002) en hadden een significant korter ziekenhuisverblijf (15 dagen versus 22 dagen, 
p = 0,02). De ziekenhuismortaliteit verschilde niet tussen beide groepen. De ETS-anastomose 
werd geassocieerd met een lager percentage strictuur, vergeleken met ETE-anastomose. 
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Echter, het voorkomen van strictuur woog niet op tegen de verhoogde kans op naadlekkage 
en de langere opnameduur.
In hoofdstuk 4 wordt een vergelijking gemaakt in de lekkage tussen een hand gelegde end-
to-end anastomose (ETE) en een semi-mechanische anastomose (SMA) na resectie met 
maagsondereconstructie. Tot op de start van de studie waren geen gerandomiseerde gecon-
troleerde studies uitgevoerd waarin een handgelegde ETE-anastomose met een SMA werd 
vergeleken. Patiënten met slokdarmkanker die gepland werden voor een slokdarmresectie 
met buismaagreconstructie met cervicale anastomose kwamen, na schriftelijke toestemming, 
in aanmerking voor deelname. Patiënten werden gerandomiseerd in een 1:1 verhouding 
voor een ETE- of SMA-anastomose. Het primaire eindpunt was naadlekkage, gedefinieerd 
als uitvloed van speeksel of ingenomen vloeistoffen uit de halswond, of een intra-thoracale 
manifestatie van lekkage (abces of mediastinitis). Secundaire eindpunten omvatten: strictuur 
na een jaar follow-up, het aantal dilataties, de dysfagie-score, opnameduur, de morbiditeit en 
mortaliteit. Tussen augustus 2011 en juli 2014 ondergingen 174 patiënten met slokdarmkan-
ker een slokdarmresectie met buismaagreconstructie, waarvan 93 patiënten gerandomiseerd 
werden voor een ETE (n = 44) of SMA (n = 49) anastomose. Vanwege lage inclusie-aantallen en 
publicaties van vergelijkbare studies werd de studie voortijdig gestaakt. Naadlekkage trad op 
bij 9 van 44 patiënten (20%) in de ETE-groep en 12 van 49 patiënten (24%) in de SMA-groep 
(p = 0,804) met een 95% betrouwbaarheidsinterval van  -13% tot 21%. Er was geen statistisch 
significant verschil in dysfagie na een jaar na de operatie (ETE 25% vs. SMA 20%; p = 0,628).
Er was geen verschil in opnameduur in het ziekenhuis, ziekte of sterfte. Verschillen van 
meer dan 21% zijn niet aangetoond. Kleinere percentages kunnen echter vanwege het be-
trouwbaarheidsinterval niet significant worden aangetoond of uitgesloten. 
hoofdstuk 5 beschrijft onze 40-jarige ervaring met coloninterponaten. Een segment van 
de dikke darm kan worden gebruikt voor de reconstructie van het spijsverteringskanaal na 
resectie. Alle patiënten die tussen 1976 en 2016 in het Erasmus MC een slokdarmresectie 
ondergingen met een coloninterponaat werden geïdentificeerd uit een institutionele data-
base. In totaal werden 126 patiënten geïncludeerd. Indicaties voor een coloninterponaat 
waren: gefaalde buismaagreconstructie (n = 18), eerdere maagchirurgie (n = 48), resectie 
met totale gastrectomie bij kanker (n = 40), caustisch letsel (n = 6) en andere redenen (n = 
8). Postoperatieve sterfte in het ziekenhuis was 18% (23 patiënten). Morbiditeit was 66%. De 
meest voorkomende complicaties waren pneumonie (40 patiënten, 32%) en naadlekkage bij 
24 patiënten (19%). Het gebruik van een coloninterponaat werd geassocieerd met een hoge 
mortaliteit en morbiditeit, maar is een acceptabele optie voor reconstructie van het bovenste 
maagdarmkanaal. 
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hoofdstuk 6 onderzoekt de diagnostische en voorspellende waarde van routinematige slik-
foto’s en gastroscopie voor het aantonen van naadlekkage. Alle patiënten die een slikfoto en/
of gastroscopie ondergingen binnen 7 dagen na een slokdarmresectie voor slokdarmkanker 
tussen januari 2005 en december 2009, werden geïdentificeerd uit de institutionele data-
base. 173 patiënten ondergingen gastroscopie en 184 patiënten ondergingen een slikfoto. De 
sensitiviteit van gastroscopie voor naadlekkage is 56%, de specificiteit 41%, positief voorspel-
lende waarde (PPV) 8% en negatief voorspellende waarde (NPV) 95%. De sensitiviteit van 
de slikfoto bij patiënten zonder tekenen van lekkage was 16%, specificiteit 75%, PPV 11% en 
de NPV 83%. Bij patiënten zonder klinisch vermoeden van lekkage is er geen voordeel voor 
routineonderzoek aangetoond.
Deel 2 Comprehensive Complication Index
Om te testen of de nieuw ontwikkelde Complicatie Index (CCI) gevoeliger is dan de traditionele 
eindpunten voor het detecteren van verschillen tussen de groepen in gerandomiseerde ge-
controleerde studies (RCT’s), werd de studie uit hoofdstuk 7 uitgevoerd. Een grote uitdaging 
van een RCT is de keuze van optimle eindpunten om behandelingseffecten aan te tonen. Mor-
taliteit is niet langer voldoende in studies, en morbiditeit wordt vaak slecht gedefinieerd. De 
CCI integreert van alle complicaties de ernst (op een lineaire schaal van 0 (geen complicatie) 
tot 100 (dood)) en is een nieuwe tool, die gevoeliger is dan andere traditionele eindpunten. 
De CCI werd getest in drie gepubliceerde RCT’s van Europese centra. Om de gevoeligheid van 
de CCI te vergelijken met traditionele eindpunten (morbiditeit, aanwezigheid van een com-
plicatie of alleen de meest ernstige complicaties) werden alle postoperatieve complicaties 
beoordeeld, en werd de CCI berekend. Behandelingseffecten en ‘sample size’-berekeningen 
werden vergeleken met behulp van de CCI en traditionele eindpunten. Hoewel RCT’s geen 
significante verschillen aantoonden in de aanwezigheid van een of de meest ernstige com-
plicatie, toonde de CCI aan dat er significante verschillen tussen de behandelingsgroepen in 
twee RCT’s waren: na pancreas- (p = 0,009) en slokdarmchirurgie (p = 0,014). De CCI in de 
RCT op dikkedarmresecties bevestigt dat er geen verschillen tussen de groepen aan te tonen 
waren (p = 0,39). De vereiste steekproefomvang in studies is tot negen keer lager voor de CCI 
dan bij traditionele morbiditeiteindpunten. Deze studie toonde de superioriteit van de CCI 
ten aanzien van de traditionele eindpunten. De CCI kan dienen als een aantrekkelijk eindpunt 
voor toekomstige RCT’s en kan de steekproefgrootte verkleinen. 
hoofdstuk 8 concentreert zich op neoadjuvante chemo-radiotherapie (nCRT) gevolgd door 
chirurgie voor patiënten met slokdarmkanker. Het doel van deze studie was de ernst van 
complicaties bij patiënten die nCRT ondergingen gevolgd door resectie, versus patiënten 
die alleen resectie ondergingen, te vergelijken met behulp van de CCI. Alle patiënten uit 
de CROSS-studie werden geïncludeerd. Complicaties werden beoordeeld en ingedeeld met 
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behulp van de Clavien-Dindo classificatie. De CCI werd afgeleid van deze scores, met behulp 
van de CCI calculator die online beschikbaar is (www.assessurgery.com). De CCI van patiënten 
die nCRT ondergingen gevolgd door chirurgie werd vergeleken met de CCI van patiënten 
die alleen chirurgie ondergingen. In beide groepen werden 161 patiënten geïncludeerd. De 
mediaan (en interquartile range) van CCI patiënten met nCRT en chirurgie was 26,22 (17,28-
42,43) versus 25,74 (8,66-43,01) bij patiënten die alleen chirurgie ondergingen (p = 0,58). Er 
was geen verschil in CCI tussen subgroepen van patiënten met een naadlekkage, pulmonale 
complicaties, cardiale complicaties, trombo-embolische complicaties, chyluslekkage en wond-
infecties. Neoadjuvante chemo radiotherapie volgens CROSS-schema heeft geen invloed op 
postoperatieve complicaties en ernst van de complicaties, gemeten met de CCI. 
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gEnEral disCussion and futurE pErspECtivEs
Anastomosis
The frequent and still important problem of esophago-gastric anastomotic failure after 
esophagectomy being leakage or stricture, has instigated the search for novel anastomotic 
techniques. The best technique to perform this anastomosis is still subject of debate. Recently, 
the data from the DUCA was presented; between 2011 and 2014, a total of 2786 patients 
with esophageal cancer were registered. Postoperative mortality remains stable (around 4%) 
for patients with esophageal cancer and leak rate is stable around 19%.1
To understand more about the failure of the anastomosis, it might be helpful to investigate 
the healing process of the anastomosis. Healing consists of three phases; at first inflammation 
(day 0-4), followed by proliferation (day 5-10) and finally remodeling (> day 10).2,3 These three 
phases can be influenced by the suture materials, and some researchers hypothesize the pos-
sibility of the suture materials to be a cause of further inflammation, scar tissue and fibrosis, 
resulting in stricture. Healing is multifactorial, failing occurs if any phase is interrupted or 
shortened.2 Studies suggest that inflammation, shock, hypo-perfusion, negative pressure 
inside the thoracic cavity, diabetes, steroid use and malnutrition have influence on healing of 
the anastomosis, as well as smoking and alcohol consumption.4 For example, some studies 
show that a continuous suture in a hand-sewn anastomosis lead to better mucosal apposition 
and vascular bed preservation, and therefore less stricture than interrupted sutures.5,6 
Comparing the hand-sewn technique with a circular stapler shows a shorter operation 
time, but an increase in stricture rate.7-12 Hand-sewn versus linear stapled anastomoses 
show less operation time and a lower risk of postoperative stricture formation.4, 13-16 Factors 
influencing anastomotic leakage also include adequate blood supply, degree of tension on the 
anastomosis and tight closure of the mucosal layer.17 
To enhance adequate blood supply, the ‘supercharged’ anastomosis has been subject of 
research. In this technique, the anastomosis is provided with extra blood supply by adding a 
microvascular anastomosis (supercharging) at the distal end of the gastric tube. This has now 
become an established method of reconstruction, especially in Asia.18-22 Studies remain small, 
and nonrandomized studies have been reported that show a superior outcome compared to 
a standard technique. 
The use of fluorescence or intravenously injected indocyanine green (ICG) is known for 
enhancement of visualization of tissue microvasculature and blood supply23-25 and has been 
adopted for assessment of blood flow in the esophageal conduit.26 This technique, first 
described in cardiovascular and neurosurgery, is thought to assess whether the tip of the 
gastric tube has sufficient blood supply for healing of the anastomosis. The use of fluores-
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cence angiography is not yet widely accepted, but it might help to prevent leakage in the 
future. So far, there is no randomized controlled trial in which results from peroperative use of 
indocyanine green is used to determine the site of the anastomosis, only prospective cohort 
studies.27 Intraoperative assessment of intestinal perfusion provides us with an opportunity 
to insure sufficient blood supply to the anastomosis, and therefore, large randomized studies 
should be performed in which this technique is compared to the ‘normal’ assessment of the 
anastomotic site by the surgeon. 
The use of an omentoplasty for wrapping around the anastomosis has been studied and in 
2014, an update of the Cochrane review was published.28 Three randomized trials show that it 
might provide additional benefit in decreasing the incidence of anastomotic leakage. Results 
are significantly better, but only in a subgroup of patients that underwent transhiatal resec-
tion. It also does not result in better long-term survival, as might be expected if postoperative 
morbidity is lowered. Other postoperative complications such as stricture are not improved 
by the omentoplasty. It could be argued that it might give some discomfort in the neck, as it 
bulges around the anastomosis. Further research in the form of large randomized trials with 
quality of life assessment is due. 
Postoperative imaging
Diagnostic evaluation of the anastomosis consists in most centers of a contrast swallow study. 
It has several benefits including the low costs and being a relatively safe with a high sensitivity 
and specificity when interpreted by an experienced radiologist.29 But aqueous contrast has 
a low radiographic density and a low mucosal adherence thus limiting the ability to detect 
small leaks. In chapter 6, the routine use of contrast swallow study and/or gastroscopy is not 
recommended. Recently, studies were published in which serial drain amylase is proven to 
detect anastomotic leak accurately. Amylase levels in drain fluid on day 4 showed to be more 
accurate for the detection of esophageal anastomotic leak than a contrast swallow study, 
and adds to the sensitivity of a CT.30, 31 Other studies suggest the use of a CT-scan instead 
of a contrast swallow study or endoscopy. Possible advantages are a higher sensitivity and 
specificity, it is easier to perform in very ill patients and shows secondary findings as well 
(abscesses, pleural effusion, pneumothorax, pulmonary abnormalities).32, 33 
The treatment of leakage can either be conservative, in most patients with a cervical anasto-
mosis, by opening the cervical wound, nasogastric decompression, nil per mouth, parenteral 
feeding and medication (such as antibiotics). For intra-thoracic anastomoses, treatment is 
more often more aggressive including (re-)thoracotomy, thoracoscopy and percutaneous 
thoracic drainage. These measures are often needed because the impact of intra-thoracic 
leakage, with empyema, mediastinitis, and consequently (severe) sepsis and even mortality 
can occur if left untreated. 
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Colon interposition
Morbidity and mortality of colon interposition after esophagectomy is high: two-thirds of 
patients has one or more complications. A recent audit from the Netherlands showed that 
postoperative morbidity after esophagectomy is still high (around 60%) but mortality has 
decreased to 4%.16 Over 40 years, several changes in surgical techniques have taken place 
including use of surgical techniques that minimize blood loss, less liberal fluid administration 
and the use of enhanced recovery protocols after esophagectomy. 
To perform a colon interposition, the right colon (using the middle colic vessels as a pedicle) 
can be used, or the left colon (using the ascending branch of the left colic artery and the infe-
rior mesenteric vein as a pedicle). In some patients, a pedicled jejunal graft is performed when 
the stomach is not available for reconstruction. Advantages of the jejunal graft include fewer 
anastomoses and vigorous peristalsis. Disadvantages include restricted graft length (because 
of the mesenteric arcade), no reservoir function and ischemia or congestion may occur in a 
long graft. The technique is challenging and often a supercharged technique has to be applied 
as well (microvascular anastomosis in the neck). The use of the colon provides a long graft, 
less reflux and a reservoir-like-capacity. On the other hand, the variation in mesenteric vessels 
is a risk factor for ischemia. It is also a formidable operation and there is a need for three or 
four anastomoses. Albeit very small, there is a small risk of carcinoma in the interposition. A 
comparison between right and left colon shows advantages of the right colon as a prevention 
of regurgitation by the Bauhin valve and a more a close match in diameter of esophagus and 
ileum which facilitates an end-to-end anastomotic technique. The left colon however, has a 
more reliable blood supply and adequate length for reconstruction but patients may suffer 
more from regurgitation. 
In the near future, popularization of microvascular surgical techniques in the western world 
and use of combined colon-small bowel grafts in highly complex patients may further impact 
on the outcomes of esophageal reconstruction. Prospective comparisons of short-term 
outcomes as well as long-term quality of life are needed to identify the best reconstructive 
method.34
Comprehensive Complication Index
Reporting outcomes of surgical or other invasive procedures using morbidity as primary 
endpoint has been associated with serious limitations due to various definitions and different 
interpretation of postoperative events. Assessing the overall morbidity by the presence of any 
complication causes the problem of ignoring either the number of different complications 
occurring in a patient after surgery or, more importantly, the severity of complications. This 
thesis shows the superiority of the CCI over traditionally reported morbidity endpoints ‘most 
severe complication’ and specific complications by detecting between-group differences in 
three external trial populations.35 Another finding is the easy and new applicability to longi-
tudinal assessment of complications over time, as illustrated in the analysis of the one-year 
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CCI follow up in the esophageal anastomosis trial. The CCI is now widely used (> 200 trials) 
as a secondary, and primary endpoint. Several studies show the importance of an overall 
complication index, and in future research, the implementation of this sensitive tool will be 
further explored. 
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Aan al het goede komt een eind. Gelukkig ook aan proefschriften en promotietrajecten. Graag 
wil ik iedereen bedanken die op welke wijze dan ook een bijdrage heeft geleverd aan het 
halen van de eindstreep, en de totstandkoming van dit proefschrift. Een aantal mensen in het 
bijzonder…
Mijn promotor, prof.dr. H.W. Tilanus, lieve professor. Toen ik in mijn tweede jaar de zorgstage 
liep, en door u gemotiveerd werd ‘overal mijn neus in te steken’ begon het avontuur. Urenlang 
meekijken op de operatiekamers leverde mij stapels met statussen op voor het eerste artikel. 
Samen met Jeroen en met Khe hebben we er een prachtartikel van gemaakt. U hebt nooit 
aan mij getwijfeld, me altijd gesteund, ook als het minder goed liep. Zelfs aan het filmpje voor 
mijn sollicitatie in Maastricht hebt u meegewerkt. Lieve prof, u bent een instituut. Ik heb er 
eigenlijk geen woorden voor. De laatste maanden hebt u bergen verzet. Zonder u had ik het 
niet gekund. Dank.
Mijn copromotor, dr. B.P.L. Wijnhoven, beste Bas. Wat een reis was het. Je was nog maar net 
in het EMC, of ik werd in je schoenen geschoven. Een student, niet gehinderd door enige 
voorkennis over publiceren, promoveren of statistiek. Dank voor de uren die je in mijn artike-
len hebt gestoken, de raad, de daad, de rode pen, de huiswerkbegeleiding, de tips en trucs. 
Ik heb het je niet altijd makkelijk gemaakt, maar je bleef geduldig. Zeker de laatste maanden 
hebben we intensief samengewerkt. Ik heb van jou het allermeest geleerd over wetenschap-
pelijk onderzoek. Zonder jou was het absoluut niet gelukt. Dank.
Leden van de leescommissie, prof. dr. R. van Hillegersberg, prof. dr. C. Verhoef, prof. dr. M.J. 
Bruno, dank voor het beoordelen van mijn proefschrift.
Prof. dr. C.H.J. van Eijck, beste Casper, dr. M.I. van Berge Henegouwen, beste Mark, dr. W.C.J. 
Hop, beste Wim, dr. V.M.C.W. Spaander, beste Manon en dr. P.P.L.O. Coene, beste Peter-Paul, 
veel dank voor uw bereidheid zitting te nemen in mijn commissie. 
Dr. T. den Hoed, beste Ted, vanaf het moment dat ik het Ikazia binnen stapte heb je me 
gecoacht in het behalen van het (eerste) beloofde doel... hier is het dan. Met feestje; zoals 
afgesproken! Dank voor alle begeleiding, de ruimte en het vertrouwen. Nu onverdeelde 
aandacht voor de opleiding!
Ook de andere stafleden van het Ikazia wil ik bedanken voor hun geduld en voor de momen-
ten dat de moed me even in de schoenen zonk... Kees van Steensel voor de nimmer aflatende 
stroom van oneliners, grappen en adviezen (en zo ook mijn laatste stelling cadeau gekregen), 
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Annemarie van Well voor alle cappuchino’s en minstens evenveel adviezen, Wouter Vles voor 
het vertrouwen, Boudewijn Toorenvliet voor je enthousiasme en kritische noot, Tim Damen 
en DJ van der Avoort voor het behoud van het plezier, Akkie Ringburg omdat je iedere vrijdag 
alles relativeert op de OK met vrijdag-grappen en je er altijd bent als het nodig is. Nike Han-
neman, jij hebt alles meegemaakt, en me altijd onvoorwaardelijk gesteund. Op de momenten 
dat ik dacht dat niet meer goed zou komen was je er, en ik ben blij dat je deel uit maakt van 
mijn opleidingsziekenhuis. Dank.
Dr. R.A. Klaassen, beste René. Twee jaar lang ANIOS in het Maasstad ziekenhuis. Jij gaf me 
de mogelijkheid om 1 dag in de week aan mijn promotie te werken na de eerste sollicitatie. 
Je staat altijd klaar met goede raad, en jouw nuchtere kijk op zaken heeft me meer dan eens 
gestimuleerd om zaken anders aan te pakken. Nu met Mareille (en Teun) een nieuw avontuur 
in de oude Dierenkliniek... veel geluk! Dank.
Carola en Conny. Zonder jullie was mijn gastvrijheidsverklaring denk ik nog 60 keer kwijtge-
raakt, en was er niets terecht gekomen van alle administratie en afspraken. Dank!
Alle coauteurs, dank voor de kritische noot, tips en aanvullingen op de manuscripten.
Dr. J. de Jonge, lieve Jeroen. Wat hebben we gelachen. En gestreden. En eindeloos shit op-
geruimd. Jij hebt altijd een oplossing, of goede raad. Ik sta versteld van wat jij allemaal weet, 
doet en kunt. Intens veel dank. Juli 2018, dan kom ik naar de academie... zet je maar vast 
schrap!
T.C.K. Tran, lieve Khe, Ron, Noa, Roan. Mijn tweede thuis in Rotterdam. Khe, jij hebt me altijd 
gemotiveerd om beter te doen en te zijn. Altijd energie voor 10, thuis nog een driegangen-
menu op tafel. Van jouw moeder leerde ik (een beetje) Vietnamees koken, en van jou leerde 
ik zoveel meer. Ron, jouw ondernemersmentaliteit leerde me op andere manieren kijken naar 
de problemen waar ik tegen aan liep. Roan, en Noa, mijn kleine Noa. Wat ben je al groot. Jij 
zal altijd stiekem een klein beetje van mij blijven. 
Dr. Marjolein Morak, en soon-to-be dr. Mareille Verseveld. Tijdens mijn coschappen kwam 
ik jullie tegen... Man, wat een machtig stel. Ik heb zoveel geleerd van jullie, niet alleen een 
centrale lijn prikken, maar ook een goede dokter zijn. Stoere vrouwen, en ongelofelijk goede 
dokters. Dank. 
Dank aan alle collega’s in het Ikazia ziekenhuis voor de flexibiliteit en ondersteuning als het 
nodig was! Met name de laatste maanden in het Ikazia kon een dienst geruild worden, of 
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werd er ruimte gemaakt in het rooster. Leendert, Wijnand, Kirstin, Joost, Kim, Franny, Jeff, 
Inge, Annemarie. Dank. 
Dank aan de ROC. Tijdens mijn sollicitatie beloofde ik het af te maken… het is gelukt!
Lieve vrienden en vriendinnen, dank voor jullie vriendschap, interesse en steun.
Lieve Ivana, vriendschap hoeft niet lang te duren om intensief te zijn. We hebben een hoop 
meegemaakt samen! Koningin van de peptalk, relativeren en eindeloos luisteren. Koppen 
thee, groene smoothies, avondeten als ik thuiskwam...  Jij hebt de mooie en de minder mooie 
kanten gezien. Dank voor alles. Ik ben ongelofelijk trots op jou en wat jij voor elkaar hebt 
gebokst het afgelopen jaar, en geloof in je. Je staat altijd klaar, en het is je nooit te veel. Je 
weet misschien nog niet precies hoe en wat, maar dat het bijzonder wordt weet ik wel zeker. 
Ik ben dan ook heel blij en vereerd dat jij en Manon mijn ‘onofficiële’ paranimfen willen zijn. 
Mijn broers hebben geluk dat ze zo geholpen worden door twee toffe meiden! 
Lieve Manon… Weet je nog, dat je kwam hospiteren? Wat leken we op elkaar… Ook voor 
jou heb ik niets dan bewondering. Tegenslagen in het onderzoek kwam je te boven, na kort 
collega-ANIOS (oké, de Gynaecologie, maar dat zeggen we tegen niemand) in het Maasstad 
ben je op nieuwe avonturen gegaan in Leiden. Jij slaat je werkelijk overal doorheen. Ik heb 
groot respect voor je, en ben trots dat je mijn vriendinnetje bent. Ik hoop je nog jaren tegen 
te komen in het ziekenhuis, en dat je dromen waar mogen worden. Binnenkort ook jouw 
promotie!
Lieve Cordula, ik heb me werkelijk suf gelachen met jou in de nachtdiensten. Het is zeldzaam 
dat je iemand tegen komt met wie je een instant begrip hebt. Een half woord is vaak genoeg, 
maar o zo fijn is het ook om met elkaar de frustraties van het medisch wetenschappelijk 
onderzoek te ‘bespreken’. Ook jouw promotietraject kent dalen, maar je weet toch maar weer 
een fulltime baan met 2 mooie jongens, sport en een vriend te combineren… Respect. Dat je 
het specialisme waarin je gelukkig gaat worden maar snel mag vinden, en geloof me, als ook 
jouw datum achter ons ligt gaan we het vieren!!
Met een relatie komt ook een schoonfamilie. En niet zomaar een. Ik ben trots om jullie mijn 
schoonfamilie te mogen noemen. Dank voor jullie interesse. Ik hoop nog lange tijd deel uit te 
maken van deze nuchtere, liefdevolle en eerlijke familie Baan. Pa en Ma, Teus en Trijnie, Arie 
en Maria, Nelly en Kees, Wim en Liza, Kees en Karin, Willie en Henk, Alma en Leo en Marian 
en Kees (en alle bijbehorende neefjes en nichtjes!). 
En dan mijn eigen familie. Op ons weekend was een van de vragen in de familiequiz waar 
mijn promotie over ging. In koor werd het goede antwoord genoemd, met details. Een teken 
van echte interesse. Ton en Ilse, Karel en Mirjam, Leo en Brigitte, alle neven… dank voor 
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de etentjes, het relativeren, de grappen en de interesse. Ik ben blij en trots dat jullie er bij 
zijn vandaag! En voor mijn nichtje Bente, wie ongetwijfeld een glanzende carrière als arts 
tegemoet gaat… succes! 
Lieve oma. Je bent zo trots op me, en hebt dat nooit onder stoelen of banken gestoken. Zo’n 
lieve, stoere en eigenwijze (tjsa, die eigenschap hebben mam en ik geërfd) oma. Dankjewel 
voor je vertrouwen oma. Dat we samen mogen genieten van alle jaren die komen!
Mijn broers, Alex en Olaf. Mijn paranimfen. Wat is het mooi om zus te zijn van twee van zulke 
kerels. Alex, jouw intelligentie zal ik nooit overtreffen. Wat heb ik een respect voor wat jij 
doet, en hoe hard je werkt. Zelfs op onze reis door Azië kon je het niet laten, wat eigenlijk ook 
direct je liefde voor je werk toont. Olaf, mijn grootste kleine broer. Je hebt je de afgelopen 
jaren door allerlei tegenslagen heen geslagen. Ik ben ontzettend trots op jou. Even bellen, 
even kletsen, altijd lachen. Samen chillen op de bank. 
Dank dat jullie naast me willen staan. 
Lieve pap en mam. Pap, jij hebt altijd gezegd dat ik alles kan, als ik het maar wil. Mam, jij staat 
op ieder moment van de dag voor me klaar, en helpt me (zelfs als ik het niet durf te vragen) 
met alles. Ik ben jullie ongelofelijk dankbaar voor alle keuzes die ik gekregen heb in mijn leven, 
de ondersteuning, het rotsvaste vertrouwen. Van papa leerde ik rekenen, wiskunde, logisch 
nadenken en optimisme. Mam, jij hebt me leren koken, voor- en nadelen goed overwegen, wil 
altijd mijn teksten nakijken, en je kan me altijd kalmeren als ik me opwind over zaken die er 
soms wel, soms niet, toe doen. Samen zorgden jullie voor een warm thuis, waar ik kon komen 
om uit te rusten, op te laden of te discussiëren. Dank. 
Gerard. Mijn lief. Wat bof ik, dat ik jou ben tegengekomen. Je hebt me zoveel moois gegeven. 
Samen is het leven nog zoveel leuker dan voorheen. Sinds ik je ken heb je me geholpen, bij-
gestaan, adviezen gegeven, met beide benen op de grond gezet, gemotiveerd, liefde gegeven 
en eindeloos gesteund. Op een mooie toekomst, vol avonturen. Samen kunnen we alles aan. 
Ik hou van jou. 
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CurriCulum vitaE
Nina Nederlof werd geboren op 7 mei 1985 te Zevenhuizen. Na haar eindexamen vwo aan 
het Coenecoop College in Waddinxveen begon zij in 2004 aan haar studie Geneeskunde aan 
de Erasmus Universiteit in Rotterdam. Tijdens haar studie begon zij met werkzaamheden op 
8Noord; de Gastro-Intestinale Chirurgie, waar ook de eerste stappen in het wetenschappelijk 
onderzoek werden gezet. De laatste fase van haar coschappen liep zij op de afdeling Heel-
kunde in het Flevoziekenhuis in Almere en de afdeling Heelkunde in het IJsselland ziekenhuis 
in Capelle aan den IJssel. In 2012 behaalde zij haar artsexamen, waarna zij als arts-assistent 
eerst een jaar is gaan werken op de afdeling Heelkunde van het Erasmus MC en vervolgens 
nog twee jaar in het Maasstad Ziekenhuis in Rotterdam. Zij solliciteerde in 2015 voor de 
opleiding, en is op 1 juli 2015 gestart met de opleiding Heelkunde in het Ikazia ziekenhuis in 
Rotterdam. Het wetenschappelijk onderzoek wat zij tijdens haar studie Geneeskunde, werk 
als ANIOS en ook AIOS heeft verricht heeft uiteindelijk geleid tot de totstandkoming van dit 
proefschrift.
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Name PhD student: Nina Nederlof
Erasmus MC department: Surgery
PhD period: August 2011 – May 2017
Promotor: Prof. dr. H.W. Tilanus
Copromotor: dr. B.P.L. Wijnhoven
1. PhD training
Year Workload 
(ECTS)
General Courses
BROK (‘Basiscursus Regelgeving Klinisch Onderzoek’) 2011 1.0 
NIHES cursus Statistical Methods and Data-analysis (CC02)  2011 3.0 
Presentations (international conferences)
Annual meeting ESA (European Surgical Association), Vienna (oral presentation) 2009 2.0 
Annual meeting ESA (European Surgical Association), Athens (oral presentation)  2014 2.0 
International Society for Diseases of the Esophagus, 19-21 September 2016, 
Singapore, Singapore Republic. (oral presentation) 
2015 2.0 
European Society for Diseases of the Esophagus (ESDE) (poster) 2016 2.0 
  
Presentations (national conferences)
Chirurgendagen NVvH (oral presentation, best abstract session) 2011 1.0 
Chirurgendagen NVvH (oral presentation) 2014 1.0 
Digestive Disease Days (oral presentation) 2017 1.0 
Conferences:
ESA 2014, 2017 2.0 
Chirurgendagen NVvH 2011-2017 2.0 
2. Teaching
Year Workload
(ECTS)
Examination Basic Life Support 2012-2015 0.4 
Supervising medical students  2013-2017 5.0 
Com
plications in Esophageal Surgery
Nina Nederlof
Nina Nederlof
